OG_ID,loading,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_08097,1.265830523424472,OG_08097,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_00082,1.076051289641575,OG_00082,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_06046,1.0692466999913726,OG_06046,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_02948,1.0492265588576943,OG_02948,FUN_012066-T1,Peve_00004089,Pocillopora_meandrina_HIv1___RNAseq.g23637.t1,three_way,63.71233333333333,FUN_012066-T1,Q7Z020,,,,,25.4,562.0,7.2e-37,157.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_07118,1.03068644083455,OG_07118,FUN_032395-T1,Peve_00036447,Pocillopora_meandrina_HIv1___RNAseq.g29833.t1,three_way,64.09349999999999,FUN_032395-T1,Q76LC6,RBM24_DANRE,,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding protein SEB-4),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,89.0,7.2e-27,122.5,sp|Q76LC6|RBM24_DANRE RNA-binding protein 24 OS=Danio rerio OX=7955 GN=rbm24 PE=2 SV=1,GO:0000381; GO:0001654; GO:0001756; GO:0001947; GO:0003228; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006974; GO:0007519; GO:0008380; GO:0010830; GO:0010831; GO:0035315; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0048702; GO:0060297; GO:0060298; GO:0061157; GO:0061158; GO:0071599; GO:0072359; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; atrial cardiac muscle tissue development [GO:0003228]; circulatory system development [GO:0072359]; DNA damage response [GO:0006974]; embryonic neurocranium morphogenesis [GO:0048702]; eye development [GO:0001654]; hair cell differentiation [GO:0035315]; heart looping [GO:0001947]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; otic vesicle development [GO:0071599]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; regulation of sarcomere organization [GO:0060297]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_10157,1.0168713450486624,OG_10157,FUN_043552-T1,Peve_00009534,Pocillopora_meandrina_HIv1___RNAseq.g8003.t1,three_way,72.05633333333333,,,,,,,,,,,,,,,,,
OG_09440,0.9994997193825256,OG_09440,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_07947,0.99465863803865,OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_02929,0.984800737939139,OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_01897,0.9757702729604252,OG_01897,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_08098,0.969013995325994,OG_08098,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_02828,0.9681277860857024,OG_02828,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_05854,0.9593334659281302,OG_05854,FUN_025929-T1,Peve_00027749,Pocillopora_meandrina_HIv1___RNAseq.g10531.t1,three_way,67.36683333333333,FUN_025929-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),33.6,529.0,5.6e-76,287.0,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_06998,0.9583449273659288,OG_06998,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08842,0.9572800742674228,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_08661,0.9572651991398344,OG_08661,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_04783,0.9535397039141074,OG_04783,FUN_022694-T1,Peve_00045101,Pocillopora_meandrina_HIv1___RNAseq.g4831.t1,three_way,58.6035,,,,,,,,,,,,,,,,,
OG_02666,0.951352228358738,OG_02666,FUN_010885-T1,Peve_00035837,Pocillopora_meandrina_HIv1___RNAseq.g21004.t1,three_way,46.05866666666667,FUN_010885-T1,Q5VXM1,,,,,36.7,109.0,4e-09,64.7,sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2,,,,,,
OG_04514,0.9490717649804672,OG_04514,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_03558,0.9458963150619528,OG_03558,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_01177,0.9458430423542512,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_01155,0.9447733321566782,OG_01155,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_09007,0.9385575740953508,OG_09007,FUN_038557-T1,Peve_00020191,Pocillopora_meandrina_HIv1___RNAseq.g1024.t1,three_way,38.4565,,,,,,,,,,,,,,,,,
OG_01645,0.9366106178592236,OG_01645,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_02998,0.9315611553053136,OG_02998,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00938,0.92745011843399,OG_00938,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_03309,0.9221175572005516,OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09472,0.9208046995809318,OG_09472,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_05743,0.9201019162328564,OG_05743,FUN_025670-T1,Peve_00042194,Pocillopora_meandrina_HIv1___TS.g15944.t1,three_way,81.551,FUN_025670-T1,O09012,PEX5_MOUSE,,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),Mus musculus (Mouse),47.9,645.0,2.2e-117,424.5,sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2,GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006629; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016020; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597,"cell development [GO:0048468]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267],GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0006629; GO:0006886; GO:0006914; GO:0007005; GO:0007031; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0061024; GO:0140104,mitochondrion; peroxisome; Golgi apparatus; cytosol; lipid metabolic process; intracellular protein transport; autophagy; mitochondrion organization; peroxisome organization; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; membrane organization; molecular carrier activity
OG_04624,0.91609159106605,OG_04624,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_07872,0.9159743500507876,OG_07872,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_04592,0.9144967323801168,OG_04592,FUN_022267-T1,Peve_00043987,Pocillopora_meandrina_HIv1___RNAseq.g4714.t2,three_way,76.18966666666667,FUN_022267-T1,Q63357,MYO1D_RAT,,Unconventional myosin-Id (Myosin heavy chain myr 4),Rattus norvegicus (Rat),52.1,637.0,3e-186,653.3,sp|Q63357|MYO1D_RAT Unconventional myosin-Id OS=Rattus norvegicus OX=10116 GN=Myo1d PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0030900; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0061502; GO:0097440,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; forebrain development [GO:0030900]; protein transport [GO:0015031],actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904],GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01576,0.9133990602673302,OG_01576,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_02805,0.9130463004562132,OG_02805,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02927,0.9124434136345124,OG_02927,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_04747,0.8850967865686946,OG_04747,FUN_022630-T1,Peve_00012283,Pocillopora_meandrina_HIv1___RNAseq.g2910.t1,three_way,68.43933333333334,FUN_022630-T1,P07228,,,,,38.2,815.0,1.2e-144,515.4,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_05777,0.8806425355317677,OG_05777,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_00767,0.8788007771164902,OG_00767,FUN_003693-T1,Peve_00040660,Pocillopora_meandrina_HIv1___RNAseq.g30052.t1,three_way,45.812,FUN_003693-T1,P06582,,,,,43.8,80.0,2.9e-12,75.1,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_05506,0.8700873260390388,OG_05506,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_01583,0.8590380048110688,OG_01583,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_07250,0.8539481800715794,OG_07250,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_04811,0.8521514252329828,OG_04811,FUN_022775-T1,Peve_00043390,Pocillopora_meandrina_HIv1___RNAseq.g4768.t1,three_way,88.94066666666666,FUN_022775-T1,F1R4U0,TXTPB_DANRE,,"Tricarboxylate transport protein B, mitochondrial (Citrate transport protein B) (Solute carrier family 25 member 1b)",Danio rerio (Zebrafish) (Brachydanio rerio),64.8,307.0,8.1e-116,418.3,"sp|F1R4U0|TXTPB_DANRE Tricarboxylate transport protein B, mitochondrial OS=Danio rerio OX=7955 GN=slc25a1b PE=3 SV=2",GO:0005739; GO:0005743; GO:0006843; GO:0007528; GO:0015142; GO:0015297; GO:0071913,mitochondrial citrate transmembrane transport [GO:0006843]; neuromuscular junction development [GO:0007528],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],antiporter activity [GO:0015297]; citrate secondary active transmembrane transporter activity [GO:0071913]; tricarboxylic acid transmembrane transporter activity [GO:0015142],GO:0005215; GO:0005739; GO:0034330; GO:0043226; GO:0055085,transporter activity; mitochondrion; cell junction organization; organelle; transmembrane transport
OG_02473,0.8511230022968196,OG_02473,FUN_009675-T1,Peve_00009262,Pocillopora_meandrina_HIv1___RNAseq.g24569.t1,three_way,75.73666666666666,FUN_009675-T1,Q8K078,SO4A1_MOUSE,,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Mus musculus (Mouse),38.1,637.0,2.3e-114,414.5,sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2,GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015711,monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711],plasma membrane [GO:0005886],organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_07882,0.8398988896312763,OG_07882,FUN_035257-T1,Peve_00032647,Pocillopora_meandrina_HIv1___RNAseq.g27885.t1,three_way,70.81866666666667,FUN_035257-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.3,1072.0,9.4e-262,904.8,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_06305,0.8392432292229524,OG_06305,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_04911,0.8389638534833842,OG_04911,FUN_022963-T1,Peve_00011891,Pocillopora_meandrina_HIv1___RNAseq.g3767.t1,three_way,65.58466666666666,FUN_022963-T1,P29275,AA2BR_HUMAN,,Adenosine receptor A2b,Homo sapiens (Human),30.9,304.0,7e-20,99.8,sp|P29275|AA2BR_HUMAN Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=1 SV=1,GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311],glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930],GO:0002376; GO:0003012; GO:0003013; GO:0005886; GO:0016192; GO:0060089,immune system process; muscle system process; circulatory system process; plasma membrane; vesicle-mediated transport; molecular transducer activity
OG_08614,0.8322516289044822,OG_08614,FUN_037761-T1,Peve_00014333,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2a,three_way,37.405,,,,,,,,,,,,,,,,,
OG_01784,0.8304106273870394,OG_01784,FUN_007160-T1,Peve_00028234,Pocillopora_meandrina_HIv1___RNAseq.g19727.t1,three_way,78.381,FUN_007160-T1,Q9JMD3,STA10_MOUSE,,START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10),Mus musculus (Mouse),43.5,237.0,4.3e-54,213.0,sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1,GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581,bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226,cytosol; cilium; lipid binding; organelle
OG_01089,0.8296231708880869,OG_01089,FUN_004582-T1,Peve_00012392,Pocillopora_meandrina_HIv1___RNAseq.g6604.t1,three_way,71.762,,,,,,,,,,,,,,,,,
OG_02602,0.8290164791882707,OG_02602,FUN_010728-T1,Peve_00038973,Pocillopora_meandrina_HIv1___RNAseq.g20945.t1,three_way,73.28566666666667,FUN_010728-T1,Q503V9,,,,,57.0,186.0,2.6e-54,213.4,sp|Q503V9|ENDUB_DANRE Uridylate-specific endoribonuclease B OS=Danio rerio OX=7955 GN=endoub PE=2 SV=1,,,,,,
OG_08355,0.8265532303993787,OG_08355,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_04585,0.8226044327045865,OG_04585,FUN_022251-T1,Peve_00021288,Pocillopora_meandrina_HIv1___RNAseq.g4724.t1,three_way,52.4535,FUN_022251-T1,P35969,,,,,30.3,511.0,3.1999999999999996e-49,198.7,sp|P35969|VGFR1_MOUSE Vascular endothelial growth factor receptor 1 OS=Mus musculus OX=10090 GN=Flt1 PE=1 SV=1,,,,,,
OG_08249,0.821493749630167,OG_08249,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_01092,0.8180528992230103,OG_01092,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01642,0.8172464888101907,OG_01642,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_09204,0.814908126472511,OG_09204,FUN_039892-T1,Peve_00021860,Pocillopora_meandrina_HIv1___RNAseq.g7364.t1,three_way,45.9685,FUN_039892-T1,Q9JK41,COPT1_RAT,,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],Rattus norvegicus (Rat),31.9,144.0,2e-09,64.3,sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1,GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601,angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0065003,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; protein-containing complex assembly
OG_07112,0.809232251245563,OG_07112,FUN_032385-T1,Peve_00007850,Pocillopora_meandrina_HIv1___RNAseq.g29733.t1,three_way,82.91166666666666,FUN_032385-T1,P52649,,,,,54.6,467.0,1.3e-138,494.6,sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3,,,,,,
OG_04008,0.8086987836040115,OG_04008,FUN_016308-T1,Peve_00032290,Pocillopora_meandrina_HIv1___RNAseq.g10037.t1,three_way,81.12333333333333,,,,,,,,,,,,,,,,,
OG_05226,0.8084139926664478,OG_05226,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_05922,0.8042137872917272,OG_05922,FUN_026145-T1,Peve_00014871,Pocillopora_meandrina_HIv1___RNAseq.g3240.t1,three_way,90.387,FUN_026145-T1,Q2KJA2,,,,,72.2,540.0,1.6999999999999999e-233,810.1,sp|Q2KJA2|ABCF2_BOVIN ATP-binding cassette sub-family F member 2 OS=Bos taurus OX=9913 GN=ABCF2 PE=2 SV=1,,,,,,
OG_00672,0.7978456522743481,OG_00672,FUN_002080-T1,Peve_00042452,Pocillopora_meandrina_HIv1___TS.g4232.t1,three_way,60.9945,FUN_002080-T1,P22607,FGFR3_HUMAN,,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333),Homo sapiens (Human),42.2,792.0,4.3e-148,526.9,sp|P22607|FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens OX=9606 GN=FGFR3 PE=1 SV=1,GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004713; GO:0005007; GO:0005524; GO:0005576; GO:0005783; GO:0005794; GO:0005886; GO:0007259; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0030133; GO:0030282; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0048640; GO:0051897; GO:0060349; GO:0070374; GO:0070977; GO:1902178,bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; skeletal system development [GO:0001501],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_09235,0.7965022253689493,OG_09235,FUN_039980-T1,Peve_00014321,Pocillopora_meandrina_HIv1___RNAseq.g7547.t1,three_way,79.15883333333333,FUN_039980-T1,Q55G75,,,,,35.5,265.0,6.200000000000001e-44,179.5,sp|Q55G75|Y7786_DICDI PH domain-containing protein DDB_G0267786 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267786 PE=4 SV=1,,,,,,
OG_09037,0.7955768780103915,OG_09037,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_07934,0.7907664875987085,OG_07934,FUN_035428-T1,Peve_00007632,Pocillopora_meandrina_HIv1___RNAseq.g27576.t1,three_way,53.50966666666667,,,,,,,,,,,,,,,,,
OG_07470,0.7859656357175696,OG_07470,FUN_033980-T1,Peve_00004847,Pocillopora_meandrina_HIv1___RNAseq.g26110.t1,three_way,64.06066666666666,FUN_033980-T1,Q1EHB4,SC5AC_HUMAN,,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),Homo sapiens (Human),34.5,560.0,3.3e-86,320.9,sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2,GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161,monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293],GO:0005215; GO:0005654; GO:0005886; GO:0043226,transporter activity; nucleoplasm; plasma membrane; organelle
OG_00676,0.7834901728701958,OG_00676,FUN_002091-T1,Peve_00006423,Pocillopora_meandrina_HIv1___RNAseq.g1728.t1,three_way,69.36916666666666,FUN_002091-T1,Q08E39,SPY2_BOVIN,,Protein sprouty homolog 2 (Spry-2),Bos taurus (Bovine),55.8,77.0,2.6e-20,100.9,sp|Q08E39|SPY2_BOVIN Protein sprouty homolog 2 OS=Bos taurus OX=9913 GN=SPRY2 PE=2 SV=1,GO:0000132; GO:0005634; GO:0005829; GO:0007605; GO:0008285; GO:0008543; GO:0010628; GO:0010719; GO:0015629; GO:0016525; GO:0019901; GO:0030291; GO:0030335; GO:0030512; GO:0031345; GO:0031397; GO:0032587; GO:0035924; GO:0040037; GO:0042472; GO:0043066; GO:0043539; GO:0045165; GO:0045742; GO:0046580; GO:0048513; GO:0051387; GO:0051897; GO:0055105; GO:0060437; GO:0060449; GO:0070371; GO:0070373; GO:0070374; GO:1900747; GO:1902747; GO:1990752; GO:1990830,animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung growth [GO:0060437]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell migration [GO:0030335]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; microtubule end [GO:1990752]; nucleus [GO:0005634]; ruffle membrane [GO:0032587],protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ubiquitin-protein transferase inhibitor activity [GO:0055105],GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0043226; GO:0048856; GO:0050877; GO:0098772,nucleus; cytosol; cytoskeleton; cytoskeleton organization; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_06480,0.7804392914788372,OG_06480,FUN_029250-T1,Peve_00024382,Pocillopora_meandrina_HIv1___TS.g9401.t1,three_way,59.02816666666666,FUN_029250-T1,Q8IZF6,AGRG4_HUMAN,,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)]",Homo sapiens (Human),26.0,665.0,5.0999999999999985e-55,218.4,sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06275,0.7777460047645334,OG_06275,FUN_028312-T1,Peve_00025176,Pocillopora_meandrina_HIv1___RNAseq.g16422.t1,three_way,50.10016666666667,FUN_028312-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),47.0,304.0,1.7e-73,279.3,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07630,0.7744106795452368,OG_07630,FUN_034382-T1,Peve_00027165,Pocillopora_meandrina_HIv1___RNAseq.g26151.t3,three_way,63.092,FUN_034382-T1,Q15723,ELF2_HUMAN,,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),61.7,94.0,5.3e-27,123.6,sp|Q15723|ELF2_HUMAN ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837,cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_06101,0.7697486890227137,OG_06101,FUN_027779-T1,Peve_00034984,Pocillopora_meandrina_HIv1___RNAseq.g12667.t1,three_way,61.244166666666665,FUN_027779-T1,Q7Z408,CSMD2_HUMAN,,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),Homo sapiens (Human),23.2,921.0,4.8e-24,116.7,sp|Q7Z408|CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CSMD2 PE=1 SV=2,GO:0097107; GO:0098839; GO:0098978; GO:0099562,maintenance of postsynaptic density structure [GO:0099562]; postsynaptic density assembly [GO:0097107],glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839],,GO:0034330,cell junction organization
OG_08906,0.7695131385302187,OG_08906,FUN_038337-T1,Peve_00000101,Pocillopora_meandrina_HIv1___RNAseq.g1113.t1,three_way,71.11383333333333,FUN_038337-T1,Q553D3,,,,,30.7,212.0,2.5e-20,102.4,sp|Q553D3|GXCJJ_DICDI Rac guanine nucleotide exchange factor JJ OS=Dictyostelium discoideum OX=44689 GN=gxcJJ PE=1 SV=1,,,,,,
OG_10116,0.7693279684347751,OG_10116,FUN_043491-T1,Peve_00008684,Pocillopora_meandrina_HIv1___RNAseq.g7963.t1,three_way,83.608,FUN_043491-T1,A8WGF7,,,,,26.4,406.0,2.9e-13,78.6,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_01605,0.7690473073654748,OG_01605,FUN_006649-T1,Peve_00029032,Pocillopora_meandrina_HIv1___RNAseq.g19952.t1,three_way,81.72066666666667,FUN_006649-T1,Q9W7L4,,,,,61.3,333.0,1.2e-117,424.5,sp|Q9W7L4|LDHB_SCEUN L-lactate dehydrogenase B chain OS=Sceloporus undulatus OX=8520 GN=LDHB PE=2 SV=3,,,,,,
OG_05294,0.7669549438132393,OG_05294,FUN_023962-T1,Peve_00043985,Pocillopora_meandrina_HIv1___RNAseq.g18585.t1,three_way,84.302,,,,,,,,,,,,,,,,,
OG_06622,0.7665051177178426,OG_06622,FUN_029891-T1,Peve_00008454,Pocillopora_meandrina_HIv1___RNAseq.g17343.t1,three_way,56.2075,FUN_029891-T1,O15146,,,,,37.1,318.0,1.7e-61,239.2,"sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1",,,,,,
OG_08928,0.7657888322037303,OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_00453,0.7652324681985696,OG_00453,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_08566,0.7641474134216896,OG_08566,FUN_037567-T1,Peve_00035306,Pocillopora_meandrina_HIv1___RNAseq.g1583.t1,three_way,65.91883333333334,FUN_037567-T1,Q6DDX3,,,,,42.9,77.0,8.7e-12,72.8,sp|Q6DDX3|F19XB_XENLA Protein FAM199X-B OS=Xenopus laevis OX=8355 GN=fam199x-b PE=2 SV=1,,,,,,
OG_09797,0.7637504931989617,OG_09797,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_08202,0.7600241020240611,OG_08202,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.2999999999999997e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_01399,0.7562330842167898,OG_01399,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_09120,0.7553726805593469,OG_09120,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_02454,0.7548474098332332,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_07095,0.7547036960872162,OG_07095,FUN_032353-T1,Peve_00026256,Pocillopora_meandrina_HIv1___RNAseq.g29804.t1,three_way,66.072,FUN_032353-T1,Q8BL06,,,,,55.3,342.0,2.5e-110,401.7,sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2,,,,,,
OG_04693,0.7545702014846521,OG_04693,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_02395,0.7537669872959558,OG_02395,FUN_009023-T1,Peve_00044350,Pocillopora_meandrina_HIv1___RNAseq.g3942.t1,three_way,93.496,FUN_009023-T1,Q92519,TRIB2_HUMAN,,Tribbles homolog 2 (TRB-2),Homo sapiens (Human),54.1,338.0,2.2000000000000001e-100,367.1,sp|Q92519|TRIB2_HUMAN Tribbles homolog 2 OS=Homo sapiens OX=9606 GN=TRIB2 PE=1 SV=1,GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629,negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106],GO:0005634; GO:0005856; GO:0043226; GO:0098772,nucleus; cytoskeleton; organelle; molecular function regulator activity
OG_08392,0.7526318608324493,OG_08392,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02972,0.7524286081075793,OG_02972,FUN_012136-T1,Peve_00035460,Pocillopora_meandrina_HIv1___RNAseq.g23778.t1,three_way,82.50333333333333,FUN_012136-T1,Q5XFX0,,,,,41.0,200.0,5.1e-33,142.5,sp|Q5XFX0|TAGL2_RAT Transgelin-2 OS=Rattus norvegicus OX=10116 GN=Tagln2 PE=1 SV=1,,,,,,
OG_04759,0.7523136229997792,OG_04759,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_09806,0.7518694392156958,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_07426,0.7513770299900366,OG_07426,FUN_033906-T1,Peve_00039887,Pocillopora_meandrina_HIv1___TS.g8165.t1a,three_way,38.5305,FUN_033906-T1,Q704V6,TLR6_BOVIN,,Toll-like receptor 6 (CD antigen CD286),Bos taurus (Bovine),37.8,111.0,1.4e-16,89.0,sp|Q704V6|TLR6_BOVIN Toll-like receptor 6 OS=Bos taurus OX=9913 GN=TLR6 PE=2 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227,cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_03876,0.7498690933790343,OG_03876,FUN_015407-T1,Peve_00000205,Pocillopora_meandrina_HIv1___RNAseq.g21678.t1,three_way,83.027,FUN_015407-T1,P55088,,,,,45.0,222.0,3.6e-50,199.9,sp|P55088|AQP4_MOUSE Aquaporin-4 OS=Mus musculus OX=10090 GN=Aqp4 PE=1 SV=2,,,,,,
OG_06608,0.7477005070241205,OG_06608,FUN_029758-T1,Peve_00019497,Pocillopora_meandrina_HIv1___TS.g3083.t1,three_way,75.64366666666666,FUN_029758-T1,O75694,NU155_HUMAN,,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),Homo sapiens (Human),46.4,1399.0,0.0,1191.4,sp|O75694|NU155_HUMAN Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014,atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913; GO:0061024,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport; membrane organization
OG_00843,0.7475946807022175,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_05440,0.7456574668481549,OG_05440,FUN_024393-T1,Peve_00005016,Pocillopora_meandrina_HIv1___RNAseq.g18624.t1,three_way,66.556,FUN_024393-T1,P42674,,,,,48.3,201.0,1.4e-44,182.2,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_09142,0.7427036426108667,OG_09142,FUN_039789-T1,Peve_00017600,Pocillopora_meandrina_HIv1___RNAseq.g7463.t1,three_way,74.41883333333334,FUN_039789-T1,O54714,,,,,50.4,468.0,2.5e-120,434.1,sp|O54714|PIAS3_MOUSE E3 SUMO-protein ligase PIAS3 OS=Mus musculus OX=10090 GN=Pias3 PE=1 SV=3,,,,,,
OG_04351,0.7422516920197093,OG_04351,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_07731,0.7418577757750877,OG_07731,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_04350,0.741836867788105,OG_04350,FUN_017986-T1,Peve_00004549,Pocillopora_meandrina_HIv1___RNAseq.g25273.t2,three_way,67.53116666666666,FUN_017986-T1,Q9GZT9,,,,,54.3,208.0,4.6e-62,240.0,sp|Q9GZT9|EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1,,,,,,
OG_03670,0.7415755644489747,OG_03670,FUN_014912-T1,Peve_00003532,Pocillopora_meandrina_HIv1___RNAseq.g21075.t1,three_way,60.845,,,,,,,,,,,,,,,,,
OG_05949,0.7399697540489534,OG_05949,FUN_026199-T1,Peve_00010232,Pocillopora_meandrina_HIv1___RNAseq.g3044.t1,three_way,45.858,,,,,,,,,,,,,,,,,
OG_06417,0.7390921759385259,OG_06417,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_01995,0.7380909689075706,OG_01995,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_08337,0.7376573435426144,OG_08337,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_05497,0.7334390475222246,OG_05497,FUN_024556-T1,Peve_00039499,Pocillopora_meandrina_HIv1___RNAseq.g18655.t1,three_way,76.91333333333333,FUN_024556-T1,Q9GKT2,,,,,52.6,310.0,6.9e-100,365.5,sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1,,,,,,
OG_05328,0.7328754558269689,OG_05328,FUN_024026-T1,Peve_00024951,Pocillopora_meandrina_HIv1___RNAseq.g19281.t1,three_way,75.564,FUN_024026-T1,Q5S1U6,,,,,41.0,390.0,1.3e-78,295.0,sp|Q5S1U6|IFRD1_PIG Interferon-related developmental regulator 1 OS=Sus scrofa OX=9823 GN=IFRD1 PE=2 SV=1,,,,,,
OG_07120,0.7326612167798371,OG_07120,FUN_032405-T1,Peve_00009164,Pocillopora_meandrina_HIv1___RNAseq.g29839.t1,three_way,82.7025,FUN_032405-T1,Q6GNS3,,,,,57.4,509.0,6.3000000000000005e-168,592.0,sp|Q6GNS3|NMD3_XENLA 60S ribosomal export protein NMD3 OS=Xenopus laevis OX=8355 GN=nmd3 PE=2 SV=1,,,,,,
OG_07000,0.7322972124770111,OG_07000,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_00613,0.7309979014855759,OG_00613,FUN_001779-T1,Peve_00026506,Pocillopora_meandrina_HIv1___TS.g5198.t1,three_way,47.594,,,,,,,,,,,,,,,,,
OG_03895,0.72992233012701,OG_03895,FUN_015470-T1,Peve_00009523,Pocillopora_meandrina_HIv1___RNAseq.g20981.t1,three_way,61.727,FUN_015470-T1,Q12872,SFSWA_HUMAN,,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",Homo sapiens (Human),40.4,451.0,5e-19,97.8,"sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_05998,0.7295736982675847,OG_05998,FUN_026487-T1,Peve_00037220,Pocillopora_meandrina_HIv1___RNAseq.g4189.t1,three_way,92.38083333333331,FUN_026487-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),73.8,172.0,7.299999999999998e-68,258.1,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_00615,0.7283969207147061,OG_00615,FUN_001781-T1,Peve_00011615,Pocillopora_meandrina_HIv1___RNAseq.g2692.t1,three_way,85.85766666666667,FUN_001781-T1,A0A2R8QP51,DPP9_DANRE,,Dipeptidyl peptidase 9 (EC 3.4.14.5),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,852.0,7.8e-219,761.9,sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1,GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727,proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727],nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06561,0.7266999791660681,OG_06561,FUN_029445-T1,Peve_00025077,Pocillopora_meandrina_HIv1___RNAseq.g17165.t1,three_way,60.66566666666667,FUN_029445-T1,Q6IQH6,,,,,34.5,232.0,2.4e-29,131.0,sp|Q6IQH6|PLPR1_DANRE Phospholipid phosphatase-related protein type 1 OS=Danio rerio OX=7955 GN=plppr1 PE=2 SV=1,,,,,,
OG_00430,0.7261447380708009,OG_00430,FUN_001338-T1,Peve_00036941,Pocillopora_meandrina_HIv1___TS.g4798.t2,three_way,67.19033333333333,FUN_001338-T1,Q8C9W3,ATS2_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),Mus musculus (Mouse),31.2,954.0,4.4e-135,484.6,sp|Q8C9W3|ATS2_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Mus musculus OX=10090 GN=Adamts2 PE=1 SV=2,GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588,collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00611,0.7255804026779316,OG_00611,FUN_001777-T1,Peve_00035594,Pocillopora_meandrina_HIv1___RNAseq.g2684.t2,three_way,77.261,FUN_001777-T1,Q969G6,RIFK_HUMAN,,Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase),Homo sapiens (Human),63.0,154.0,5.6e-51,202.2,sp|Q969G6|RIFK_HUMAN Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072388; GO:0072593,apoptotic process [GO:0006915]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05724,0.7235949979877978,OG_05724,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_02014,0.7214785865463681,OG_02014,FUN_008187-T1,Peve_00010858,Pocillopora_meandrina_HIv1___RNAseq.g29995.t1,three_way,91.01733333333334,FUN_008187-T1,O75582,KS6A5_HUMAN,,Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL),Homo sapiens (Human),63.9,723.0,1.5e-266,920.2,sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1,GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310,axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06307,0.7205854429049278,OG_06307,FUN_028513-T1,Peve_00008089,Pocillopora_meandrina_HIv1___TS.g11902.t2,three_way,40.3635,,,,,,,,,,,,,,,,,
OG_05341,0.7198323087580487,OG_05341,FUN_024067-T1,Peve_00000150,Pocillopora_meandrina_HIv1___RNAseq.g19254.t1,three_way,69.05799999999999,FUN_024067-T1,Q54RA4,,,,,34.9,352.0,9.9e-50,198.7,sp|Q54RA4|Y3291_DICDI Probable iron/ascorbate oxidoreductase DDB_G0283291 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0283291 PE=3 SV=1,,,,,,
OG_07633,0.7197198926958871,OG_07633,FUN_034391-T1,Peve_00002468,Pocillopora_meandrina_HIv1___TS.g18897.t1,three_way,58.58133333333333,,,,,,,,,,,,,,,,,
OG_00483,0.7190501944883091,OG_00483,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_02540,0.7188648405318067,OG_02540,FUN_010623-T1,Peve_00004505,Pocillopora_meandrina_HIv1___RNAseq.g21294.t1,three_way,68.17916666666667,FUN_010623-T1,Q91VZ6,SMAP1_MOUSE,,Stromal membrane-associated protein 1,Mus musculus (Mouse),63.0,138.0,4.2999999999999996e-46,187.2,sp|Q91VZ6|SMAP1_MOUSE Stromal membrane-associated protein 1 OS=Mus musculus OX=10090 GN=Smap1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_02403,0.7178144675281865,OG_02403,FUN_009044-T1,Peve_00002709,Pocillopora_meandrina_HIv1___RNAseq.g14411.t2,three_way,67.5345,FUN_009044-T1,O35604,NPC1_MOUSE,,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),Mus musculus (Mouse),48.0,1270.0,1.3e-312,1073.5,sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2,GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016236; GO:0016242; GO:0022008; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0051649; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900,adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020],GO:0005215; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0005975; GO:0006486; GO:0006629; GO:0006914; GO:0008289; GO:0012501; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0061024,transporter activity; extracellular region; nuclear envelope; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; carbohydrate metabolic process; protein glycosylation; lipid metabolic process; autophagy; lipid binding; programmed cell death; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; membrane organization
OG_05794,0.717715335549172,OG_05794,FUN_025775-T1,Peve_00012555,Pocillopora_meandrina_HIv1___RNAseq.g10363.t1,three_way,91.0985,FUN_025775-T1,P79145,,,,,50.4,254.0,2.7e-39,164.1,sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2,,,,,,
OG_09269,0.7148016852410296,OG_09269,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_03915,0.7136545908826701,OG_03915,FUN_016001-T1,Peve_00004543,Pocillopora_meandrina_HIv1___RNAseq.g21372.t1,three_way,70.03,FUN_016001-T1,Q8N6T3,ARFG1_HUMAN,,ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein),Homo sapiens (Human),47.5,318.0,2.6000000000000004e-57,224.6,sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2,GO:0000139; GO:0005096; GO:0005829; GO:0008270; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202,protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_04784,0.7133761616859579,OG_04784,FUN_022696-T1,Peve_00045102,Pocillopora_meandrina_HIv1___TS.g22242.t1,three_way,67.26566666666666,,,,,,,,,,,,,,,,,
OG_09621,0.712853185725812,OG_09621,FUN_041784-T1,Peve_00025206,Pocillopora_meandrina_HIv1___RNAseq.g15487.t1,three_way,95.13633333333333,FUN_041784-T1,P16912,KAPC3_DROME,,cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2),Drosophila melanogaster (Fruit fly),66.2,314.0,8.1e-132,471.5,sp|P16912|KAPC3_DROME cAMP-dependent protein kinase catalytic subunit 3 OS=Drosophila melanogaster OX=7227 GN=Pka-C3 PE=2 SV=2,GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007165; GO:0007476; GO:0106310,cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005829; GO:0007155; GO:0016740; GO:0140096,"catalytic activity; cytosol; cell adhesion; transferase activity; catalytic activity, acting on a protein"
OG_09645,0.7125221363519869,OG_09645,FUN_041840-T1,Peve_00009640,Pocillopora_meandrina_HIv1___RNAseq.g15080.t1,three_way,69.50733333333334,,,,,,,,,,,,,,,,,
OG_03495,0.7118253277328681,OG_03495,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_00043,0.7118030451211598,OG_00043,FUN_000270-T1,Peve_00027796,Pocillopora_meandrina_HIv1___RNAseq.g28983.t1,three_way,78.31466666666667,FUN_000270-T1,Q0P483,S2542_DANRE,,Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42),Danio rerio (Zebrafish) (Brachydanio rerio),51.5,324.0,5.3e-87,322.8,sp|Q0P483|S2542_DANRE Mitochondrial coenzyme A transporter SLC25A42 OS=Danio rerio OX=7955 GN=slc25a42 PE=2 SV=1,GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0035349; GO:0043262; GO:0080121; GO:0080122,ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ADP phosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228],GO:0003824; GO:0005215; GO:0005739; GO:0007005; GO:0016787; GO:0043226; GO:0055085; GO:0061024,catalytic activity; transporter activity; mitochondrion; mitochondrion organization; hydrolase activity; organelle; transmembrane transport; membrane organization
OG_05100,0.7109199189970243,OG_05100,FUN_023352-T1,Peve_00035608,Pocillopora_meandrina_HIv1___RNAseq.g17431.t1,three_way,88.21533333333333,FUN_023352-T1,Q8R367,,,,,42.9,161.0,3.8999999999999986e-28,126.7,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_07427,0.7082051419496064,OG_07427,FUN_033911-T1,Peve_00035948,Pocillopora_meandrina_HIv1___RNAseq.g28376.t1,three_way,39.52483333333333,,,,,,,,,,,,,,,,,
OG_06279,0.7080343545867418,OG_06279,FUN_028447-T1,Peve_00026233,Pocillopora_meandrina_HIv1___RNAseq.g16195.t1,three_way,59.692,FUN_028447-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.3,573.0,9.700000000000001e-117,423.7,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09808,0.707978237401955,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02469,0.7078562205865927,OG_02469,FUN_009671-T1,Peve_00009662,Pocillopora_meandrina_HIv1___RNAseq.g24573.t3,three_way,83.01083333333334,FUN_009671-T1,Q9NQB0,,,,,67.8,143.0,2.4e-48,194.5,sp|Q9NQB0|TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens OX=9606 GN=TCF7L2 PE=1 SV=2,,,,,,
OG_05502,0.7069813497303358,OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09596,0.7068118916061578,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_07039,0.7059466623431372,OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_02806,0.7053335716234914,OG_02806,FUN_011777-T1,Peve_00006119,Pocillopora_meandrina_HIv1___RNAseq.g23293.t1,three_way,79.81966666666666,FUN_011777-T1,O75486,,,,,41.0,339.0,1.9e-50,201.4,sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3,,,,,,
OG_07286,0.7046444953396924,OG_07286,FUN_033666-T1,Peve_00006805,Pocillopora_meandrina_HIv1___RNAseq.g28824.t1,three_way,56.083,,,,,,,,,,,,,,,,,
OG_02112,0.7032676534707015,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_06119,0.7024914789942517,OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_10135,0.7000178894873677,OG_10135,FUN_043520-T1,Peve_00016242,Pocillopora_meandrina_HIv1___RNAseq.g8031.t1,three_way,87.03166666666667,FUN_043520-T1,Q6QLW4,,,,,84.7,85.0,1e-39,163.7,sp|Q6QLW4|CYC_PECGU Cytochrome c OS=Pectinaria gouldii OX=260746 PE=3 SV=1,,,,,,
OG_02190,0.6995815721674233,OG_02190,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_07699,0.696417954122351,OG_07699,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_01371,0.6957729817467525,OG_01371,FUN_005321-T1,Peve_00003307,Pocillopora_meandrina_HIv1___TS.g19924.t1,three_way,52.27433333333333,FUN_005321-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),45.8,155.0,2.6000000000000003e-32,141.0,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_04560,0.6956042131113496,OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_02141,0.6954829780754634,OG_02141,FUN_008447-T1,Peve_00025571,Pocillopora_meandrina_HIv1___TS.g21055.t1,three_way,82.89383333333333,FUN_008447-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),54.9,495.0,6.1e-121,436.0,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_10002,0.6945529348988622,OG_10002,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_05457,0.6939753181426165,OG_05457,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_08301,0.6932048217762788,OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_05916,0.6928627288052228,OG_05916,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_06109,0.6926412083219244,OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05807,0.6915289344011809,OG_05807,FUN_025803-T1,Peve_00017929,Pocillopora_meandrina_HIv1___RNAseq.g10355.t1,three_way,75.95183333333334,FUN_025803-T1,Q9LI61,,,,,28.9,284.0,7.3e-13,76.3,sp|Q9LI61|AVT6A_ARATH Amino acid transporter AVT6A OS=Arabidopsis thaliana OX=3702 GN=AVT6A PE=2 SV=1,,,,,,
OG_04997,0.691251349321533,OG_04997,FUN_023132-T1,Peve_00008526,Pocillopora_meandrina_HIv1___RNAseq.g1755.t1,three_way,43.72866666666667,FUN_023132-T1,O16264,,,,,38.7,75.0,4.9e-09,62.4,sp|O16264|PEBPH_CAEEL Phosphatidylethanolamine-binding protein homolog F40A3.3 OS=Caenorhabditis elegans OX=6239 GN=F40A3.3 PE=3 SV=1,,,,,,
OG_04677,0.6901569813181317,OG_04677,FUN_022446-T1,Peve_00037587,Pocillopora_meandrina_HIv1___RNAseq.g4330.t1,three_way,71.33800000000001,FUN_022446-T1,Q29496,CP3AO_SHEEP,,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),Ovis aries (Sheep),38.8,485.0,1.4999999999999999e-92,341.7,sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0016712; GO:0020037; GO:0050649; GO:0070989,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_06366,0.6898447951985875,OG_06366,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_09230,0.6896358415477571,OG_09230,FUN_039968-T1,Peve_00039036,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1c,three_way,57.724,,,,,,,,,,,,,,,,,
OG_05874,0.6891983858321493,OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_01322,0.6890608930130967,OG_01322,FUN_005189-T1,Peve_00017153,Pocillopora_meandrina_HIv1___TS.g19845.t2b,three_way,59.13133333333333,FUN_005189-T1,Q6PD21,SHB_MOUSE,,SH2 domain-containing adapter protein B,Mus musculus (Mouse),57.5,106.0,1.9e-31,138.7,sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2,GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleoplasm; cytosol; plasma membrane; programmed cell death; organelle; anatomical structure development; molecular adaptor activity
OG_07838,0.6882228770820366,OG_07838,FUN_035169-T1,Peve_00036181,Pocillopora_meandrina_HIv1___RNAseq.g27918.t1,three_way,87.309,FUN_035169-T1,Q9JK84,,,,,54.5,299.0,5.5000000000000004e-80,299.3,sp|Q9JK84|PAR6G_MOUSE Partitioning defective 6 homolog gamma OS=Mus musculus OX=10090 GN=Pard6g PE=2 SV=1,,,,,,
OG_07564,0.6864780933855593,OG_07564,FUN_034211-T1,Peve_00027535,Pocillopora_meandrina_HIv1___RNAseq.g26168.t1,three_way,46.269333333333336,,,,,,,,,,,,,,,,,
OG_00355,0.6859743097098581,OG_00355,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_08222,0.6852425482957535,OG_08222,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08293,0.6846726524054976,OG_08293,FUN_036231-T1,Peve_00032844,Pocillopora_meandrina_HIv1___RNAseq.g27552.t1,three_way,77.99933333333334,FUN_036231-T1,Q8WTS1,ABHD5_HUMAN,,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),Homo sapiens (Human),56.8,315.0,1.9000000000000002e-110,400.6,sp|Q8WTS1|ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens OX=9606 GN=ABHD5 PE=1 SV=1,GO:0003841; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006631; GO:0006654; GO:0010891; GO:0010898; GO:0030154; GO:0042171; GO:0043231; GO:0052689; GO:0055088; GO:0060229,cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of triglyceride storage [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of triglyceride catabolic process [GO:0010898],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lipase activator activity [GO:0060229]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098772,catalytic activity; nucleoplasm; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; cell differentiation; organelle; molecular function regulator activity
OG_03559,0.6840459318852011,OG_03559,FUN_014706-T1,Peve_00021213,Pocillopora_meandrina_HIv1___RNAseq.g22534.t1,three_way,85.49499999999999,FUN_014706-T1,Q2KIR8,,,,,63.2,307.0,4.6e-117,422.5,"sp|Q2KIR8|TDH_BOVIN L-threonine 3-dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=TDH PE=2 SV=1",,,,,,
OG_07907,0.6836832753163339,OG_07907,FUN_035351-T1,Peve_00016239,Pocillopora_meandrina_HIv1___RNAseq.g12260.t1,three_way,72.70233333333333,FUN_035351-T1,Q6XPZ3,PAG15_CANLF,,Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV),Canis lupus familiaris (Dog) (Canis familiaris),40.4,394.0,2.3999999999999998e-82,307.4,sp|Q6XPZ3|PAG15_CANLF Lysosomal phospholipase A and acyltransferase OS=Canis lupus familiaris OX=9615 GN=PLA2G15 PE=1 SV=1,GO:0004622; GO:0005615; GO:0005654; GO:0005764; GO:0006631; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499,ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipase A1 activity [GO:0008970]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005654; GO:0005764; GO:0005773; GO:0006575; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; nucleoplasm; lysosome; vacuole; modified amino acid metabolic process; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_00622,0.6831559034105342,OG_00622,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_05644,0.6830210030366218,OG_05644,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_01792,0.6824984739094552,OG_01792,FUN_007172-T1,Peve_00019754,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1b,three_way,69.35266666666666,FUN_007172-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.9,1072.0,5.8e-264,912.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_07062,0.6820534007073548,OG_07062,FUN_032288-T1,Peve_00015511,Pocillopora_meandrina_HIv1___RNAseq.g24311.t1,three_way,76.559,FUN_032288-T1,Q6P5E8,DGKQ_MOUSE,,Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta),Mus musculus (Mouse),40.0,879.0,2.1e-185,651.0,sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1,GO:0004143; GO:0004697; GO:0005524; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016363; GO:0016607; GO:0030297; GO:0030971; GO:0043274; GO:0046339; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506],alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270],GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleolus; endosome; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05235,0.6820292855847425,OG_05235,FUN_023671-T1,Peve_00012777,Pocillopora_meandrina_HIv1___RNAseq.g17761.t1,three_way,50.331833333333336,,,,,,,,,,,,,,,,,
OG_06957,0.6814712215153514,OG_06957,FUN_032082-T1,Peve_00039909,Pocillopora_meandrina_HIv1___RNAseq.g5228.t1,three_way,70.91216666666666,FUN_032082-T1,Q6UWX4,,,,,47.1,605.0,4.7e-163,576.2,sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1,,,,,,
OG_04264,0.6806808531444062,OG_04264,FUN_017814-T1,Peve_00006860,Pocillopora_meandrina_HIv1___RNAseq.g9542.t1,three_way,84.417,FUN_017814-T1,Q91029,WNT1_CHICK,,Protein Wnt-1,Gallus gallus (Chicken),51.2,283.0,2.4e-87,323.6,sp|Q91029|WNT1_CHICK Protein Wnt-1 OS=Gallus gallus OX=9031 GN=WNT1 PE=1 SV=3,GO:0005102; GO:0005576; GO:0006915; GO:0009953; GO:0016055; GO:0030509; GO:0031334; GO:0048263,apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of protein-containing complex assembly [GO:0031334]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0012501,extracellular region; programmed cell death
OG_07287,0.6804955279671229,OG_07287,FUN_033668-T1,Peve_00006804,Pocillopora_meandrina_HIv1___RNAseq.g28825.t1,three_way,80.98966666666666,FUN_033668-T1,O70579,,,,,61.8,204.0,3.6e-63,243.0,sp|O70579|PM34_MOUSE Peroxisomal membrane protein PMP34 OS=Mus musculus OX=10090 GN=Slc25a17 PE=1 SV=1,,,,,,
OG_03659,0.680204968152878,OG_03659,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_07050,0.6800413307908765,OG_07050,FUN_032270-T1,Peve_00014263,Pocillopora_meandrina_HIv1___RNAseq.g24972.t1,three_way,76.632,,,,,,,,,,,,,,,,,
OG_06271,0.6793373723782119,OG_06271,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_07730,0.6784001536536881,OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_07150,0.6775987891978108,OG_07150,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_04478,0.6775519908303499,OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09847,0.6767855721926548,OG_09847,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_06978,0.675769605278944,OG_06978,FUN_032113-T1,Peve_00030230,Pocillopora_meandrina_HIv1___RNAseq.g5388.t1,three_way,75.95,,,,,,,,,,,,,,,,,
OG_00474,0.6751177833097995,OG_00474,FUN_001413-T1,Peve_00008749,Pocillopora_meandrina_HIv1___RNAseq.g2101.t1,three_way,46.56633333333333,,,,,,,,,,,,,,,,,
OG_04601,0.6713163467389025,OG_04601,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_05344,0.6712569309688702,OG_05344,FUN_024075-T1,Peve_00000135,Pocillopora_meandrina_HIv1___TS.g28590.t2,three_way,90.34133333333334,FUN_024075-T1,Q3T0T7,SAR1B_BOVIN,,Small COPII coat GTPase SAR1B (EC 3.6.5.2),Bos taurus (Bovine),71.3,195.0,4.5e-82,305.8,sp|Q3T0T7|SAR1B_BOVIN Small COPII coat GTPase SAR1B OS=Bos taurus OX=9913 GN=SAR1B PE=2 SV=1,GO:0003400; GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032368; GO:0032580; GO:0042953; GO:0046872; GO:0048208; GO:0055088; GO:0061024; GO:0070971; GO:0090110; GO:0140353; GO:0140785; GO:1904262; GO:1990253,cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; regulation of COPII vesicle coating [GO:0003400]; regulation of lipid transport [GO:0032368]; vesicle organization [GO:0016050],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765],amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0061024; GO:0065003; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_03948,0.6711980535784572,OG_03948,FUN_016087-T1,Peve_00010774,Pocillopora_meandrina_HIv1___RNAseq.g21606.t1,three_way,69.82266666666666,FUN_016087-T1,Q92667,AKAP1_HUMAN,,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",Homo sapiens (Human),36.7,316.0,8.2e-45,183.0,"sp|Q92667|AKAP1_HUMAN A-kinase anchor protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP1 PE=1 SV=1",GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0034237; GO:0140374,antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005739; GO:0005829; GO:0012501; GO:0043226; GO:0098542,immune system process; RNA binding; mitochondrion; cytosol; programmed cell death; organelle; defense response to other organism
OG_03306,0.6711464233917751,OG_03306,FUN_013378-T1,Peve_00020455,Pocillopora_meandrina_HIv1___RNAseq.g22985.t2,three_way,65.02866666666667,FUN_013378-T1,Q5QD15,TAAR4_MOUSE,,Trace amine-associated receptor 4 (TaR-4) (Trace amine receptor 4) (mTaar4) (2-phenylethylamine receptor),Mus musculus (Mouse),26.1,272.0,6.8e-16,86.7,sp|Q5QD15|TAAR4_MOUSE Trace amine-associated receptor 4 OS=Mus musculus OX=10090 GN=Taar4 PE=1 SV=1,GO:0001594; GO:0001662; GO:0005886; GO:0007606; GO:0007635; GO:0008227; GO:1990080,behavioral fear response [GO:0001662]; chemosensory behavior [GO:0007635]; sensory perception of chemical stimulus [GO:0007606],plasma membrane [GO:0005886],2-phenylethylamine receptor activity [GO:1990080]; G protein-coupled amine receptor activity [GO:0008227]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_08000,0.6702763314345641,OG_08000,FUN_035645-T1,Peve_00022823,Pocillopora_meandrina_HIv1___RNAseq.g12089.t1,three_way,63.82933333333334,FUN_035645-T1,Q94BV5,,,,,38.8,400.0,1.3e-72,276.2,sp|Q94BV5|GSXL4_ARATH Flavin-containing monooxygenase FMO GS-OX-like 4 OS=Arabidopsis thaliana OX=3702 GN=At1g62600 PE=2 SV=1,,,,,,
OG_04032,0.6698779523153832,OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03616,0.6689681845399484,OG_03616,FUN_014798-T1,Peve_00028870,Pocillopora_meandrina_HIv1___RNAseq.g22416.t1,three_way,83.49866666666667,FUN_014798-T1,O00560,SDCB1_HUMAN,,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),Homo sapiens (Human),53.2,301.0,5.7e-84,312.4,sp|O00560|SDCB1_HUMAN Syntenin-1 OS=Homo sapiens OX=9606 GN=SDCBP PE=1 SV=1,GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0070062; GO:0072562; GO:0140311; GO:1903543; GO:1903553; GO:1903561,"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; syndecan binding [GO:0045545]",GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0008289; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0140313,extracellular region; extracellular space; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; lipid binding; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular sequestering activity
OG_08484,0.668448433423395,OG_08484,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08126,0.6677145225825816,OG_08126,FUN_035885-T1,Peve_00029403,Pocillopora_meandrina_HIv1___TS.g3340.t1,three_way,58.976333333333336,FUN_035885-T1,P0C0T2,ANKS6_RAT,,Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),Rattus norvegicus (Rat),30.4,717.0,2.1e-37,159.1,sp|P0C0T2|ANKS6_RAT Ankyrin repeat and SAM domain-containing protein 6 OS=Rattus norvegicus OX=10116 GN=Anks6 PE=1 SV=2,GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0045087; GO:0097543,determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; kidney development [GO:0001822],ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737],identical protein binding [GO:0042802],GO:0002376; GO:0048856; GO:0098542,immune system process; anatomical structure development; defense response to other organism
OG_02343,0.6676790662008337,OG_02343,FUN_008944-T1,Peve_00011189,Pocillopora_meandrina_HIv1___RNAseq.g4060.t1,three_way,64.23383333333334,FUN_008944-T1,Q6P0U3,,,,,31.3,211.0,1.6000000000000002e-23,112.1,sp|Q6P0U3|RSLBB_DANRE Ras-like protein family member 11B OS=Danio rerio OX=7955 GN=rasl11b PE=2 SV=1,,,,,,
OG_03743,0.6675564865897067,OG_03743,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_04199,0.6667766409699226,OG_04199,FUN_016732-T1,Peve_00014684,Pocillopora_meandrina_HIv1___RNAseq.g234.t1,three_way,56.1385,,,,,,,,,,,,,,,,,
OG_08641,0.6667068548748697,OG_08641,FUN_037826-T1,Peve_00002905,Pocillopora_meandrina_HIv1___RNAseq.g1449.t1,three_way,85.02733333333333,FUN_037826-T1,Q9JHI5,IVD_MOUSE,,"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)",Mus musculus (Mouse),73.5,388.0,3.4e-169,597.0,"sp|Q9JHI5|IVD_MOUSE Isovaleryl-CoA dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Ivd PE=1 SV=1",GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0031966; GO:0042802; GO:0050660,branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-methylbutanoyl-CoA dehydrogenase activity [GO:0008470]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_01450,0.6666725902175683,OG_01450,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_02910,0.6652572032327272,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,39.1,266.0,5e-53,210.7,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02910,0.6652572032327272,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,55.6,36.0,3.2e-07,58.5,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_03731,0.6644369680613402,OG_03731,FUN_015024-T1,Peve_00004784,Pocillopora_meandrina_HIv1___RNAseq.g21180.t1,three_way,68.43833333333333,FUN_015024-T1,Q3T0M7,,,,,55.6,180.0,7e-47,188.7,sp|Q3T0M7|RANG_BOVIN Ran-specific GTPase-activating protein OS=Bos taurus OX=9913 GN=RANBP1 PE=2 SV=1,,,,,,
OG_08984,0.6643892849454957,OG_08984,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_07289,0.6642168950215841,OG_07289,FUN_033670-T1,Peve_00037062,Pocillopora_meandrina_HIv1___RNAseq.g28727.t1,three_way,77.678,,,,,,,,,,,,,,,,,
OG_09324,0.6640607345444722,OG_09324,FUN_040241-T1,Peve_00018573,Pocillopora_meandrina_HIv1___RNAseq.g7782.t1,three_way,95.93533333333332,FUN_040241-T1,Q7ZVZ7,,,,,75.6,287.0,3.9e-138,492.3,sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1,,,,,,
OG_05417,0.6638882265913506,OG_05417,FUN_024355-T1,Peve_00024184,Pocillopora_meandrina_HIv1___RNAseq.g18691.t1,three_way,67.9895,,,,,,,,,,,,,,,,,
OG_09872,0.6637923676099554,OG_09872,FUN_042910-T1,Peve_00019286,Pocillopora_meandrina_HIv1___RNAseq.g7200.t1,three_way,80.18383333333334,FUN_042910-T1,E7F021,,,,,36.5,249.0,4.5999999999999995e-24,114.8,sp|E7F021|ZD12B_DANRE Palmitoyltransferase ZDHHC12-B OS=Danio rerio OX=7955 GN=zdhhc12b PE=3 SV=1,,,,,,
OG_01883,0.6632984645567322,OG_01883,FUN_007859-T1,Peve_00044447,Pocillopora_meandrina_HIv1___RNAseq.g18297.t1,three_way,66.80633333333333,FUN_007859-T1,Q8R3J5,CHAC1_MOUSE,,Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Blocks Notch protein) (Botch) (Cation transport regulator-like protein 1),Mus musculus (Mouse),48.9,180.0,7.299999999999999e-49,195.3,sp|Q8R3J5|CHAC1_MOUSE Glutathione-specific gamma-glutamylcyclotransferase 1 OS=Mus musculus OX=10090 GN=Chac1 PE=1 SV=2,GO:0005112; GO:0005802; GO:0005829; GO:0006751; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061771; GO:0061928; GO:0070059,glutathione catabolic process [GO:0006751]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to caloric restriction [GO:0061771]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; trans-Golgi network [GO:0005802],glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016829; GO:0030154,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; lyase activity; cell differentiation
OG_01342,0.661698793644006,OG_01342,FUN_005243-T1,Peve_00014457,Pocillopora_meandrina_HIv1___RNAseq.g8139.t1,three_way,80.71866666666666,FUN_005243-T1,Q9Z211,,,,,32.9,246.0,2.2999999999999997e-24,114.0,sp|Q9Z211|PX11A_MOUSE Peroxisomal membrane protein 11A OS=Mus musculus OX=10090 GN=Pex11a PE=1 SV=1,,,,,,
OG_06842,0.6609031852309635,OG_06842,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_06105,0.6608006462948403,OG_06105,FUN_027806-T1,Peve_00036481,Pocillopora_meandrina_HIv1___RNAseq.g13895.t1,three_way,70.82966666666667,,,,,,,,,,,,,,,,,
OG_04469,0.6605676974998038,OG_04469,FUN_020835-T1,Peve_00010927,Pocillopora_meandrina_HIv1___RNAseq.g20757.t2,three_way,70.56066666666666,,,,,,,,,,,,,,,,,
OG_03716,0.6597274891605353,OG_03716,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_09627,0.6589654578281857,OG_09627,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03187,0.658825557556029,OG_03187,FUN_012657-T1,Peve_00022119,Pocillopora_meandrina_HIv1___RNAseq.g22895.t1,three_way,70.13616666666667,FUN_012657-T1,Q9UK58,,,,,56.1,173.0,6.700000000000001e-48,193.0,sp|Q9UK58|CCNL1_HUMAN Cyclin-L1 OS=Homo sapiens OX=9606 GN=CCNL1 PE=1 SV=1,,,,,,
OG_06627,0.6585651270776041,OG_06627,FUN_030057-T1,Peve_00027775,Pocillopora_meandrina_HIv1___RNAseq.g17349.t1,three_way,71.34366666666666,FUN_030057-T1,Q19425,,,,,43.3,536.0,1.2e-109,398.7,sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2,,,,,,
OG_06047,0.6579596290108715,OG_06047,FUN_026715-T1,Peve_00018524,Pocillopora_meandrina_HIv1___TS.g19669.t1,three_way,89.792,,,,,,,,,,,,,,,,,
OG_00526,0.6578526779563978,OG_00526,FUN_001530-T1,Peve_00000625,Pocillopora_meandrina_HIv1___RNAseq.g2045.t2,three_way,82.98033333333333,FUN_001530-T1,Q2KIH7,PH4H_BOVIN,,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),Bos taurus (Bovine),64.8,423.0,7.6e-165,581.6,sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1,GO:0004505; GO:0005506; GO:0006559; GO:0006571,L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571],,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505],GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_05718,0.6576077883498979,OG_05718,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_06341,0.6575815903155366,OG_06341,FUN_028906-T1,Peve_00031963,Pocillopora_meandrina_HIv1___RNAseq.g25670.t1,three_way,85.42666666666668,FUN_028906-T1,O00429,DNM1L_HUMAN,,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),Homo sapiens (Human),60.5,770.0,7.5e-242,838.2,sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,GO:0000266; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0160040; GO:1900063; GO:1901524; GO:1903578,calcium ion transport [GO:0006816]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion organization [GO:0007005]; mitocytosis [GO:0160040]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; regulation of peroxisome organization [GO:1900063]; rhythmic process [GO:0048511],brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625],GO:0003013; GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0061024; GO:0065003; GO:0098772,circulatory system process; catalytic activity; GTPase activity; mitochondrion; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_01486,0.6564894557966601,OG_01486,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_09217,0.654913579098344,OG_09217,FUN_039937-T1,Peve_00007733,Pocillopora_meandrina_HIv1___RNAseq.g15743.t1,three_way,79.05833333333334,FUN_039937-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,451.0,1.1e-66,255.8,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02535,0.6546912456341968,OG_02535,FUN_010614-T1,Peve_00013367,Pocillopora_meandrina_HIv1___RNAseq.g21488.t1,three_way,71.218,FUN_010614-T1,A7SWH1,PESC_NEMVE,,Pescadillo homolog,Nematostella vectensis (Starlet sea anemone),65.3,444.0,5.3e-170,599.0,sp|A7SWH1|PESC_NEMVE Pescadillo homolog OS=Nematostella vectensis OX=45351 GN=v1g194255 PE=3 SV=1,GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]",ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723],GO:0003723; GO:0005654,RNA binding; nucleoplasm
OG_01957,0.6546523800577432,OG_01957,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_05347,0.6546466414526324,OG_05347,FUN_024110-T1,Peve_00000187,Pocillopora_meandrina_HIv1___RNAseq.g19190.t1,three_way,60.88066666666666,FUN_024110-T1,P30874,SSR2_HUMAN,,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1),Homo sapiens (Human),23.1,337.0,2e-13,78.6,sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1,GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007187; GO:0007193; GO:0007218; GO:0008285; GO:0030165; GO:0042923; GO:0043005; GO:0071385; GO:0071392,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]",cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994],GO:0005654; GO:0005829; GO:0005886; GO:0060089,nucleoplasm; cytosol; plasma membrane; molecular transducer activity
OG_08096,0.653858989968134,OG_08096,FUN_035837-T1,Peve_00032517,Pocillopora_meandrina_HIv1___RNAseq.g11959.t1,three_way,60.47533333333333,FUN_035837-T1,Q16820,,,,,34.7,380.0,1.9e-53,213.0,sp|Q16820|MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens OX=9606 GN=MEP1B PE=1 SV=3,,,,,,
OG_10051,0.6532251857472035,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_09530,0.653123433999788,OG_09530,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_09146,0.6525597708371556,OG_09146,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_02050,0.6524695862984059,OG_02050,FUN_008260-T1,Peve_00042074,Pocillopora_meandrina_HIv1___RNAseq.g17965.t1,three_way,81.01316666666668,FUN_008260-T1,P59325,,,,,52.8,390.0,5e-105,382.9,sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1,,,,,,
OG_10147,0.6523178763833178,OG_10147,FUN_043537-T1,Peve_00016669,Pocillopora_meandrina_HIv1___RNAseq.g24410.t1,three_way,56.086666666666666,,,,,,,,,,,,,,,,,
OG_00838,0.6521251340899133,OG_00838,FUN_004088-T1,Peve_00024024,Pocillopora_meandrina_HIv1___RNAseq.29948_t,three_way,59.1695,FUN_004088-T1,Q0KIA2,,,,,44.8,232.0,3.5e-49,197.6,sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1,,,,,,
OG_00147,0.6518643185176705,OG_00147,FUN_000592-T1,Peve_00025298,Pocillopora_meandrina_HIv1___RNAseq.g29290.t1,three_way,64.05,,,,,,,,,,,,,,,,,
OG_05565,0.6517675288943166,OG_05565,FUN_024794-T1,Peve_00007040,Pocillopora_meandrina_HIv1___RNAseq.2280_t,three_way,39.91566666666667,FUN_024794-T1,P79121,,,,,26.6,177.0,1.8e-13,77.8,sp|P79121|TIMP3_BOVIN Metalloproteinase inhibitor 3 OS=Bos taurus OX=9913 GN=TIMP3 PE=2 SV=1,,,,,,
OG_04371,0.6515397229070193,OG_04371,FUN_018030-T1,Peve_00017616,Pocillopora_meandrina_HIv1___RNAseq.g25339.t1,three_way,71.04333333333334,FUN_018030-T1,P59054,CSRN1_MOUSE,,Cysteine/serine-rich nuclear protein 1 (CSRNP-1) (Axin-1 up-regulated gene 1 protein) (TGF-beta-induced apoptosis protein 3) (TAIP-3),Mus musculus (Mouse),35.6,222.0,4.2e-30,132.9,sp|P59054|CSRN1_MOUSE Cysteine/serine-rich nuclear protein 1 OS=Mus musculus OX=10090 GN=Csrnp1 PE=2 SV=1,GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006915; GO:0009791; GO:0043565; GO:0045944; GO:0048008; GO:0048705; GO:0060021; GO:0060325,apoptotic process [GO:0006915]; face morphogenesis [GO:0060325]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; transcription regulator activity
OG_01813,0.6508971490436156,OG_01813,FUN_007669-T1,Peve_00014361,Pocillopora_meandrina_HIv1___RNAseq.g5891.t1,three_way,42.031666666666666,,,,,,,,,,,,,,,,,
OG_08540,0.6503307633519617,OG_08540,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_09216,0.6502501029627256,OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_02517,0.6502225355644613,OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_01403,0.6493195949070214,OG_01403,FUN_005467-T1,Peve_00002034,Pocillopora_meandrina_HIv1___TS.g362.t1,three_way,65.028,FUN_005467-T1,Q25197,,,,,37.8,1370.0,2.5e-238,827.4,sp|Q25197|HTK7_HYDVU Putative insulin-like peptide receptor OS=Hydra vulgaris OX=6087 GN=HTK7 PE=2 SV=1,,,,,,
OG_09855,0.6492393403227202,OG_09855,FUN_042848-T1,Peve_00023277,Pocillopora_meandrina_HIv1___RNAseq.g7251.t2,three_way,92.89133333333334,FUN_042848-T1,Q9Z1N5,,,,,85.5,429.0,4.2000000000000003e-213,741.9,sp|Q9Z1N5|DX39B_MOUSE Spliceosome RNA helicase Ddx39b OS=Mus musculus OX=10090 GN=Ddx39b PE=1 SV=1,,,,,,
OG_10174,0.6491266156230169,OG_10174,FUN_043583-T1,Peve_00045199,Pocillopora_meandrina_HIv1___RNAseq.g6989.t1,three_way,62.69716666666667,FUN_043583-T1,Q68F67,,,,,45.0,467.0,4.1e-113,410.6,sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1,,,,,,
OG_03673,0.6482236454292152,OG_03673,FUN_014924-T1,Peve_00006268,Pocillopora_meandrina_HIv1___RNAseq.g21081.t1,three_way,64.52166666666666,FUN_014924-T1,Q6PAJ1,BCR_MOUSE,,Breakpoint cluster region protein (EC 2.7.11.1),Mus musculus (Mouse),38.2,798.0,1.9999999999999997e-142,508.8,sp|Q6PAJ1|BCR_MOUSE Breakpoint cluster region protein OS=Mus musculus OX=10090 GN=Bcr PE=1 SV=3,GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006909; GO:0007264; GO:0007420; GO:0014069; GO:0016477; GO:0030036; GO:0030216; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051649; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378,actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; establishment of localization in cell [GO:0051649]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of cell cycle [GO:0051726]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003013; GO:0003014; GO:0003824; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0098772; GO:0140096,"immune system process; circulatory system process; renal system process; catalytic activity; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07933,0.6481450405747216,OG_07933,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_02622,0.6480115473751863,OG_02622,FUN_010769-T1,Peve_00004500,Pocillopora_meandrina_HIv1___RNAseq.g21287.t1,three_way,72.27866666666667,FUN_010769-T1,F1MV99,,,,,25.5,286.0,3.5e-11,70.9,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_05755,0.6473188918627295,OG_05755,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_07134,0.646699099693753,OG_07134,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_06626,0.6464642335673423,OG_06626,FUN_030056-T1,Peve_00040199,Pocillopora_meandrina_HIv1___RNAseq.g17348.t1,three_way,57.199666666666666,,,,,,,,,,,,,,,,,
OG_09845,0.6453605939120931,OG_09845,FUN_042830-T1,Peve_00041826,Pocillopora_meandrina_HIv1___RNAseq.g7271.t1,three_way,92.688,FUN_042830-T1,P62915,TF2B_MOUSE,,Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor),Mus musculus (Mouse),79.1,316.0,4.3e-135,482.3,sp|P62915|TF2B_MOUSE Transcription initiation factor IIB OS=Mus musculus OX=10090 GN=Gtf2b PE=1 SV=1,GO:0000776; GO:0000793; GO:0000979; GO:0000993; GO:0001174; GO:0003677; GO:0004402; GO:0005634; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0010467; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032153; GO:0032993; GO:0042585; GO:0046966; GO:0051123; GO:0051177; GO:0051225; GO:0051276; GO:1990114; GO:1990841,chromosome organization [GO:0051276]; gene expression [GO:0010467]; meiotic sister chromatid cohesion [GO:0051177]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083],cell division site [GO:0032153]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; germinal vesicle [GO:0042585]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor TFIID complex [GO:0005669],acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006351; GO:0007010; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; chromosome; DNA-templated transcription; cytoskeleton organization; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_06604,0.6453497775396763,OG_06604,FUN_029731-T1,Peve_00020200,Pocillopora_meandrina_HIv1___RNAseq.g16841.t1,three_way,41.393,,,,,,,,,,,,,,,,,
OG_06500,0.6449146597380945,OG_06500,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.0999999999999997e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07645,0.6444256833460993,OG_07645,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_09286,0.644084265043851,OG_09286,FUN_040107-T1,Peve_00037281,Pocillopora_meandrina_HIv1___RNAseq.g8724.t1,three_way,86.47783333333334,FUN_040107-T1,Q0VCX2,BIP_BOVIN,,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),Bos taurus (Bovine),83.2,637.0,9.8e-294,1010.4,sp|Q0VCX2|BIP_BOVIN Endoplasmic reticulum chaperone BiP OS=Bos taurus OX=9913 GN=HSPA5 PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006886; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0098772; GO:0140657,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; protein folding; intracellular protein transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_07621,0.6435100437804194,OG_07621,FUN_034366-T1,Peve_00036160,Pocillopora_meandrina_HIv1___RNAseq.g26129.t1,three_way,55.84466666666667,,,,,,,,,,,,,,,,,
OG_00802,0.6433464373323252,OG_00802,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_08716,0.6432028861643787,OG_08716,FUN_037968-T1,Peve_00012657,Pocillopora_meandrina_HIv1___RNAseq.g26237.t1,three_way,76.11933333333333,FUN_037968-T1,Q16658,FSCN1_HUMAN,,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),Homo sapiens (Human),40.2,488.0,2.5e-97,357.5,sp|Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091,actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0034330; GO:0043226; GO:0048870; GO:0060090,RNA binding; cytosol; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_09573,0.6429647404520473,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_02734,0.6428976166351671,OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_07013,0.6425975423256377,OG_07013,FUN_032166-T1,Peve_00038634,Pocillopora_meandrina_HIv1___RNAseq.g5319.t2,three_way,83.15083333333334,FUN_032166-T1,Q6DFF9,,,,,47.4,610.0,1.9e-158,560.8,sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1,,,,,,
OG_01630,0.6424764791018239,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_04843,0.6408450663324914,OG_04843,FUN_022852-T1,Peve_00028878,Pocillopora_meandrina_HIv1___RNAseq.g3393.t1,three_way,64.0195,FUN_022852-T1,Q5ZJS6,,,,,34.9,129.0,1.5e-07,57.4,sp|Q5ZJS6|PAIP2_CHICK Polyadenylate-binding protein-interacting protein 2 OS=Gallus gallus OX=9031 GN=PAIP2 PE=2 SV=1,,,,,,
OG_07718,0.6407971760203459,OG_07718,FUN_034873-T1,Peve_00005762,Pocillopora_meandrina_HIv1___RNAseq.g27162.t1,three_way,90.15966666666668,FUN_034873-T1,A1L3F5,,,,,44.8,724.0,1.6e-163,577.8,sp|A1L3F5|CMIP_XENLA C-Maf-inducing protein OS=Xenopus laevis OX=8355 GN=cmip PE=2 SV=2,,,,,,
OG_05951,0.6405370637320801,OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09963,0.640529161646386,OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_00225,0.6405121203654076,OG_00225,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_06330,0.6404339696245387,OG_06330,FUN_028886-T1,Peve_00044601,Pocillopora_meandrina_HIv1___RNAseq.g12807.t1,three_way,57.31466666666667,,,,,,,,,,,,,,,,,
OG_01190,0.6402687253100856,OG_01190,FUN_004844-T1,Peve_00019431,Pocillopora_meandrina_HIv1___RNAseq.g8621.t1,three_way,65.215,,,,,,,,,,,,,,,,,
OG_08151,0.6402532094025991,OG_08151,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_02083,0.638951951004184,OG_02083,FUN_008306-T1,Peve_00015428,Pocillopora_meandrina_HIv1___TS.g24507.t2,three_way,73.73883333333333,FUN_008306-T1,Q9CQE8,,,,,50.2,245.0,1.6e-63,244.2,"sp|Q9CQE8|RTRAF_MOUSE RNA transcription, translation and transport factor protein OS=Mus musculus OX=10090 GN=RTRAF PE=1 SV=1",,,,,,
OG_09835,0.6387085678057066,OG_09835,FUN_042814-T1,Peve_00021878,Pocillopora_meandrina_HIv1___RNAseq.g7429.t1,three_way,82.54266666666666,FUN_042814-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),66.0,1113.0,0.0,1439.5,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_00179,0.638633058149389,OG_00179,FUN_000872-T1,Peve_00002057,Pocillopora_meandrina_HIv1___RNAseq.g1815.t1,three_way,56.59033333333333,FUN_000872-T1,Q08288,LYAR_MOUSE,,Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264),Mus musculus (Mouse),40.4,406.0,2.3e-39,164.5,sp|Q08288|LYAR_MOUSE Cell growth-regulating nucleolar protein OS=Mus musculus OX=10090 GN=Lyar PE=1 SV=2,GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416,erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0048856; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_07749,0.6381113574025811,OG_07749,FUN_034938-T1,Peve_00036685,Pocillopora_meandrina_HIv1___RNAseq.g27832.t1,three_way,69.10716666666667,FUN_034938-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),35.0,246.0,3.5000000000000005e-22,107.1,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_03914,0.6373071782397339,OG_03914,FUN_015998-T1,Peve_00023991,Pocillopora_meandrina_HIv1___RNAseq.g21377.t2,three_way,83.981,FUN_015998-T1,Q00944,,,,,41.0,1143.0,8.4e-229,795.4,sp|Q00944|FAK1_CHICK Focal adhesion kinase 1 OS=Gallus gallus OX=9031 GN=PTK2 PE=1 SV=2,,,,,,
OG_05241,0.6372470507291599,OG_05241,FUN_023682-T1,Peve_00014139,Pocillopora_meandrina_HIv1___RNAseq.g17753.t1,three_way,78.52883333333334,FUN_023682-T1,A7SK48,EIF3A_NEMVE,,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10),Nematostella vectensis (Starlet sea anemone),73.3,786.0,8.7e-296,1018.1,sp|A7SK48|EIF3A_NEMVE Eukaryotic translation initiation factor 3 subunit A OS=Nematostella vectensis OX=45351 GN=v1g190699 PE=3 SV=2,GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541,formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]",mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_04801,0.6366897719876746,OG_04801,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_06880,0.6365505699736483,OG_06880,FUN_031900-T1,Peve_00037707,Pocillopora_meandrina_HIv1___RNAseq.21387_t,three_way,70.62066666666666,FUN_031900-T1,Q00168,,,,,39.0,264.0,1.4e-53,211.5,sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster OX=7227 GN=CaMKII PE=1 SV=1,,,,,,
OG_05169,0.6364801217426054,OG_05169,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_01465,0.636371580364491,OG_01465,FUN_006001-T1,Peve_00036061,Pocillopora_meandrina_HIv1___RNAseq.g19928.t1,three_way,87.754,FUN_006001-T1,P38024,,,,,60.3,330.0,1.3e-116,421.0,sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1,,,,,,
OG_03018,0.63620025366306,OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,69.3,215.0,1.0000000000000001e-71,272.7,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_03018,0.63620025366306,OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,73.3,45.0,2.1e-08,62.4,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_01456,0.6358988538309489,OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.500000000000001e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_02331,0.6358868758395207,OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_01612,0.6354513732797004,OG_01612,FUN_006692-T1,Peve_00029050,Pocillopora_meandrina_HIv1___RNAseq.g19966.t1,three_way,46.55916666666666,,,,,,,,,,,,,,,,,
OG_08945,0.6351539375445964,OG_08945,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07346,0.6341580308941674,OG_07346,FUN_033753-T1,Peve_00004935,Pocillopora_meandrina_HIv1___RNAseq.g28751.t1,three_way,71.35733333333333,FUN_033753-T1,Q8MPM1,,,,,51.9,362.0,3.4e-99,363.2,sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1,,,,,,
OG_02084,0.6337674440567285,OG_02084,FUN_008307-T1,Peve_00015429,Pocillopora_meandrina_HIv1___RNAseq.g5789.t1,three_way,71.01916666666666,FUN_008307-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),40.9,252.0,4.3e-47,189.9,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_00323,0.6330884703450903,OG_00323,FUN_001142-T1,Peve_00029340,Pocillopora_meandrina_HIv1___RNAseq.g29332.t1,three_way,72.95883333333333,FUN_001142-T1,Q91827,,,,,38.8,178.0,1.4999999999999998e-24,114.4,sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_05875,0.6330763003908763,OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_08937,0.632987929898063,OG_08937,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_01464,0.6325375006700219,OG_01464,FUN_006000-T1,Peve_00036040,Pocillopora_meandrina_HIv1___RNAseq.3462_t,three_way,85.708,FUN_006000-T1,Q8CIH9,PUR1_MOUSE,,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),Mus musculus (Mouse),60.8,533.0,4.7e-179,629.0,sp|Q8CIH9|PUR1_MOUSE Amidophosphoribosyltransferase OS=Mus musculus OX=10090 GN=Ppat PE=1 SV=1,GO:0004044; GO:0006177; GO:0006189; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113],,"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02907,0.6321652929445782,OG_02907,FUN_011984-T1,Peve_00000523,Pocillopora_meandrina_HIv1___TS.g16589.t1,three_way,64.19166666666666,FUN_011984-T1,Q8JHI3,AR13B_DANRE,,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,208.0,2.4999999999999997e-62,241.1,sp|Q8JHI3|AR13B_DANRE ADP-ribosylation factor-like protein 13B OS=Danio rerio OX=7955 GN=arl13b PE=1 SV=1,GO:0003924; GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515,cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005929; GO:0016787; GO:0043226; GO:0044782; GO:0048870,catalytic activity; GTPase activity; cilium; hydrolase activity; organelle; cilium organization; cell motility
OG_04727,0.6315057435340913,OG_04727,FUN_022593-T1,Peve_00020267,Pocillopora_meandrina_HIv1___RNAseq.g4428.t2,three_way,75.349,,,,,,,,,,,,,,,,,
OG_08251,0.6311904297285782,OG_08251,FUN_036160-T1,Peve_00039232,Pocillopora_meandrina_HIv1___RNAseq.g27495.t1,three_way,53.35233333333333,FUN_036160-T1,Q1LZE9,,,,,33.4,317.0,2.7e-34,147.9,sp|Q1LZE9|PRS23_BOVIN Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1,,,,,,
OG_03080,0.6310798715627199,OG_03080,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_01161,0.6308577207487814,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_10057,0.6300672697105943,OG_10057,FUN_043351-T1,Peve_00022832,Pocillopora_meandrina_HIv1___TS.g20682.t1,three_way,75.10366666666667,FUN_043351-T1,Q9UJX6,,,,,44.4,762.0,8.299999999999997e-175,615.5,sp|Q9UJX6|ANC2_HUMAN Anaphase-promoting complex subunit 2 OS=Homo sapiens OX=9606 GN=ANAPC2 PE=1 SV=1,,,,,,
OG_08254,0.6298366121418832,OG_08254,FUN_036164-T1,Peve_00027211,Pocillopora_meandrina_HIv1___RNAseq.g27499.t1,three_way,89.75383333333333,FUN_036164-T1,Q5RC80,RBM39_PONAB,,RNA-binding protein 39 (RNA-binding motif protein 39),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),58.2,385.0,3.1e-117,423.7,sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1,GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]",centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; RS domain binding [GO:0050733],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_01326,0.6291473217259348,OG_01326,FUN_005202-T1,Peve_00031640,Pocillopora_meandrina_HIv1___TS.g19875.t2,three_way,66.72316666666667,FUN_005202-T1,Q21974,UNC8_CAEEL,,Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8),Caenorhabditis elegans,31.3,393.0,2.7999999999999998e-39,164.9,sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1,GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025,locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00520,0.6287860927190525,OG_00520,FUN_001519-T1,Peve_00042520,Pocillopora_meandrina_HIv1___TS.g4541.t1,three_way,73.94266666666667,FUN_001519-T1,Q6QDP7,CR3L2_RAT,,Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (SCI-related protein Ra69) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2],Rattus norvegicus (Rat),38.3,334.0,6.8e-34,146.7,sp|Q6QDP7|CR3L2_RAT Cyclic AMP-responsive element-binding protein 3-like protein 2 OS=Rattus norvegicus OX=10116 GN=Creb3l2 PE=2 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0006986; GO:0010628; GO:0010976; GO:0034976; GO:0035497; GO:0045893; GO:0045944; GO:0051216; GO:0097038,cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038],"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005783; GO:0006355; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06776,0.6281937131248083,OG_06776,FUN_031642-T1,Peve_00032678,Pocillopora_meandrina_HIv1___RNAseq.g5693.t1,three_way,79.11933333333333,FUN_031642-T1,Q16975,,,,,57.8,742.0,1.7000000000000001e-248,860.1,sp|Q16975|KPC2_APLCA Calcium-independent protein kinase C OS=Aplysia californica OX=6500 GN=PRKC2 PE=1 SV=1,,,,,,
OG_08647,0.6275224213910273,OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_04932,0.6274138017703108,OG_04932,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_01455,0.6269502945182673,OG_01455,FUN_005913-T1,Peve_00008487,Pocillopora_meandrina_HIv1___RNAseq.g19569.t1,three_way,86.37333333333333,FUN_005913-T1,Q922V4,,,,,67.2,497.0,3.8999999999999996e-90,333.6,sp|Q922V4|PLRG1_MOUSE Pleiotropic regulator 1 OS=Mus musculus OX=10090 GN=Plrg1 PE=1 SV=1,,,,,,
OG_09563,0.6261574229101665,OG_09563,FUN_041673-T1,Peve_00031771,Pocillopora_meandrina_HIv1___RNAseq.g14000.t1,three_way,72.09633333333333,,,,,,,,,,,,,,,,,
OG_07720,0.6261434074975095,OG_07720,FUN_034875-T1,Peve_00005784,Pocillopora_meandrina_HIv1___RNAseq.g27164.t1b,three_way,85.19866666666667,FUN_034875-T1,Q8QZR1,ATTY_MOUSE,,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),Mus musculus (Mouse),53.7,408.0,7.9e-140,498.4,sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1,GO:0004838; GO:0005739; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine-2-oxoglutarate transaminase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_08167,0.6254613825982234,OG_08167,FUN_035969-T1,Peve_00045085,Pocillopora_meandrina_HIv1___RNAseq.g12339.t1,three_way,87.10833333333333,FUN_035969-T1,Q6GR45,,,,,81.2,245.0,5.7e-114,411.8,sp|Q6GR45|IF6_XENLA Eukaryotic translation initiation factor 6 OS=Xenopus laevis OX=8355 GN=eif6 PE=2 SV=1,,,,,,
OG_01705,0.625251499354308,OG_01705,FUN_006950-T1,Peve_00035084,Pocillopora_meandrina_HIv1___RNAseq.g20153.t1,three_way,71.223,FUN_006950-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),35.3,1239.0,4.6e-206,720.7,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_03195,0.6249967738794027,OG_03195,FUN_012674-T1,Peve_00008658,Pocillopora_meandrina_HIv1___RNAseq.g22883.t2,three_way,87.56833333333333,FUN_012674-T1,Q6NRQ7,,,,,60.9,138.0,3e-43,176.0,sp|Q6NRQ7|SSU72_XENLA RNA polymerase II subunit A C-terminal domain phosphatase SSU72 OS=Xenopus laevis OX=8355 GN=ssu72 PE=2 SV=1,,,,,,
OG_09597,0.6242029498830822,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_04782,0.6237971746758423,OG_04782,FUN_022693-T1,Peve_00045100,Pocillopora_meandrina_HIv1___RNAseq.g4832.t1,three_way,44.72983333333333,,,,,,,,,,,,,,,,,
OG_07906,0.6235828019196149,OG_07906,FUN_035349-T1,Peve_00032934,Pocillopora_meandrina_HIv1___RNAseq.g12261.t1,three_way,88.37633333333333,FUN_035349-T1,P11387,TOP1_HUMAN,,DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I),Homo sapiens (Human),67.5,511.0,6.8e-202,704.9,sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,GO:0000932; GO:0000978; GO:0001650; GO:0001651; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0008301; GO:0009266; GO:0009303; GO:0009410; GO:0010332; GO:0012501; GO:0018105; GO:0019904; GO:0031100; GO:0031490; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0044877; GO:0051591; GO:0071373; GO:0097100,animal organ regeneration [GO:0031100]; cellular response to luteinizing hormone stimulus [GO:0071373]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; programmed cell death [GO:0012501]; response to cAMP [GO:0051591]; response to gamma radiation [GO:0010332]; response to temperature stimulus [GO:0009266]; response to xenobiotic stimulus [GO:0009410]; rRNA transcription [GO:0009303],chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993],"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0006351; GO:0007059; GO:0012501; GO:0016740; GO:0016853; GO:0043226; GO:0048856; GO:0140096; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA replication; chromatin organization; DNA-templated transcription; chromosome segregation; programmed cell death; transferase activity; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_00737,0.6231331645704258,OG_00737,FUN_002719-T1,Peve_00025047,Pocillopora_meandrina_HIv1___RNAseq.g14939.t2,three_way,87.38666666666667,FUN_002719-T1,Q8IWF6,,,,,56.7,557.0,5.699999999999999e-181,635.6,sp|Q8IWF6|DEN6A_HUMAN Protein DENND6A OS=Homo sapiens OX=9606 GN=DENND6A PE=1 SV=1,,,,,,
OG_03445,0.6229724364107168,OG_03445,FUN_014509-T1,Peve_00031996,Pocillopora_meandrina_HIv1___RNAseq.g22632.t1,three_way,69.32416666666667,FUN_014509-T1,Q5F3V0,SMYD4_CHICK,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Gallus gallus (Chicken),28.4,401.0,4.9999999999999996e-26,121.3,sp|Q5F3V0|SMYD4_CHICK Protein-lysine N-methyltransferase SMYD4 OS=Gallus gallus OX=9031 GN=SMYD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259; GO:0042826,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],histone deacetylase binding [GO:0042826]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_05711,0.6228512378039127,OG_05711,FUN_025595-T1,Peve_00037558,Pocillopora_meandrina_HIv1___RNAseq.g13622.t1,three_way,49.812666666666665,FUN_025595-T1,Q07912,ACK1_HUMAN,,Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2),Homo sapiens (Human),46.8,438.0,1.4e-106,389.4,sp|Q07912|ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens OX=9606 GN=TNK2 PE=1 SV=3,GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005095; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007166; GO:0007264; GO:0016020; GO:0016310; GO:0030136; GO:0030659; GO:0031625; GO:0042802; GO:0043231; GO:0046872; GO:0048471; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:0106310; GO:2000369,cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase-mediated signal transduction [GO:0007264],adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699],GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04733,0.6222869040946647,OG_04733,FUN_022602-T1,Peve_00012234,Pocillopora_meandrina_HIv1___RNAseq.g4421.t1,three_way,70.62083333333334,FUN_022602-T1,Q91VY9,,,,,38.8,477.0,4.4e-81,303.1,sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1,,,,,,
OG_01250,0.6221481471296824,OG_01250,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_06615,0.6216067094594427,OG_06615,FUN_029771-T1,Peve_00042908,Pocillopora_meandrina_HIv1___RNAseq.g5152.t1,three_way,51.961666666666666,,,,,,,,,,,,,,,,,
OG_04507,0.6214432164003441,OG_04507,FUN_022031-T1,Peve_00036254,Pocillopora_meandrina_HIv1___RNAseq.g3190.t1,three_way,65.41766666666666,FUN_022031-T1,Q86A72,,,,,24.7,178.0,1.5e-07,60.1,sp|Q86A72|Y4781_DICDI Recoverin family protein DDB_G0274781 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0274781 PE=3 SV=1,,,,,,
OG_07641,0.6212969845662097,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_01868,0.6205794705852297,OG_01868,FUN_007834-T1,Peve_00003993,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1b,three_way,72.9755,FUN_007834-T1,Q3UFK8,,,,,35.4,378.0,1.6e-61,238.4,sp|Q3UFK8|FRMD8_MOUSE FERM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Frmd8 PE=1 SV=2,,,,,,
OG_01040,0.6204363055345186,OG_01040,FUN_004477-T1,Peve_00033228,Pocillopora_meandrina_HIv1___RNAseq.g4945.t1,three_way,66.27733333333333,FUN_004477-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),27.2,949.0,1.1e-65,253.4,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_01059,0.6203594127220253,OG_01059,FUN_004514-T1,Peve_00044065,Pocillopora_meandrina_HIv1___RNAseq.g11652.t1,three_way,77.31266666666667,FUN_004514-T1,P54731,FAF1_MOUSE,,FAS-associated factor 1,Mus musculus (Mouse),40.6,672.0,1.3e-112,408.7,sp|P54731|FAF1_MOUSE FAS-associated factor 1 OS=Mus musculus OX=10090 GN=Faf1 PE=1 SV=2,GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0019901; GO:0019904; GO:0030155; GO:0031072; GO:0031625; GO:0034098; GO:0036337; GO:0042176; GO:0043124; GO:0043130; GO:0045732; GO:0045740; GO:0048471; GO:0051059; GO:1902043; GO:1990917,apoptotic process [GO:0006915]; Fas signaling pathway [GO:0036337]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0012501; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; programmed cell death; organelle
OG_09363,0.6201148297123318,OG_09363,FUN_040478-T1,Peve_00015419,Pocillopora_meandrina_HIv1___RNAseq.g6523.t1,three_way,71.109,FUN_040478-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),36.8,277.0,4.1e-47,191.0,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08639,0.6194777916344874,OG_08639,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03826,0.6193270802160931,OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_03093,0.6186459871200913,OG_03093,FUN_012378-T1,Peve_00042531,Pocillopora_meandrina_HIv1___RNAseq.g23353.t1,three_way,64.31700000000001,FUN_012378-T1,Q9JKK0,,,,,34.0,194.0,7.4e-20,99.0,sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1,,,,,,
OG_05413,0.6184802785382796,OG_05413,FUN_024350-T1,Peve_00021948,Pocillopora_meandrina_HIv1___RNAseq.g18672.t1,three_way,54.338166666666666,FUN_024350-T1,Q01804,OTUD4_HUMAN,,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),Homo sapiens (Human),46.7,285.0,7.4e-66,254.2,sp|Q01804|OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0006508; GO:0034122; GO:0035871; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:0140374; GO:1903093; GO:2000660,antiviral innate immune response [GO:0140374]; DNA alkylation repair [GO:0006307]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of protein K48-linked deubiquitination [GO:1903093],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_02198,0.6175675167299189,OG_02198,FUN_008562-T1,Peve_00044733,Pocillopora_meandrina_HIv1___TS.g25491.t1,three_way,80.36,,,,,,,,,,,,,,,,,
OG_03032,0.6173574486605499,OG_03032,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_07078,0.6172811741017523,OG_07078,FUN_032315-T1,Peve_00002571,Pocillopora_meandrina_HIv1___TS.g12729.t1,three_way,79.40783333333333,FUN_032315-T1,O14730,RIOK3_HUMAN,,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog),Homo sapiens (Human),56.2,470.0,6.699999999999999e-141,502.3,sp|O14730|RIOK3_HUMAN Serine/threonine-protein kinase RIO3 OS=Homo sapiens OX=9606 GN=RIOK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786,cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005829; GO:0007059; GO:0016740; GO:0098542; GO:0140096,"immune system process; catalytic activity; cytosol; chromosome segregation; transferase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10107,0.6171551571716241,OG_10107,FUN_043455-T1,Peve_00031074,Pocillopora_meandrina_HIv1___RNAseq.g7903.t1,three_way,72.78833333333333,,,,,,,,,,,,,,,,,
OG_02560,0.6170731339729322,OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_04247,0.616289166825432,OG_04247,FUN_017773-T1,Peve_00016058,Pocillopora_meandrina_HIv1___RNAseq.g448.t1,three_way,76.1215,FUN_017773-T1,P48746,,,,,41.1,915.0,2.4000000000000002e-182,641.0,sp|P48746|B3A2_RABIT Anion exchange protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC4A2 PE=1 SV=1,,,,,,
OG_05508,0.6158750842950992,OG_05508,FUN_024589-T1,Peve_00007645,Pocillopora_meandrina_HIv1___RNAseq.g19110.t1,three_way,77.43599999999999,FUN_024589-T1,Q96EY1,DNJA3_HUMAN,,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",Homo sapiens (Human),42.7,424.0,7.7e-85,315.8,"sp|Q96EY1|DNJA3_HUMAN DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043231; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297,activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005739; GO:0005829; GO:0006260; GO:0006355; GO:0006457; GO:0007005; GO:0012501; GO:0030154; GO:0034330; GO:0043226; GO:0098772,immune system process; nucleus; mitochondrion; cytosol; DNA replication; regulation of DNA-templated transcription; protein folding; mitochondrion organization; programmed cell death; cell differentiation; cell junction organization; organelle; molecular function regulator activity
OG_00829,0.615471822582426,OG_00829,FUN_004060-T1,Peve_00028225,Pocillopora_meandrina_HIv1___RNAseq.g17246.t2,three_way,51.38283333333333,FUN_004060-T1,O97827,,,,,33.2,554.0,1.4000000000000001e-74,282.3,sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1,,,,,,
OG_02338,0.6146744449459078,OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02681,0.6142469450377829,OG_02681,FUN_010931-T1,Peve_00005964,Pocillopora_meandrina_HIv1___RNAseq.g20986.t1,three_way,70.11850000000001,FUN_010931-T1,Q9DBE9,SPB1_MOUSE,,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),Mus musculus (Mouse),47.7,830.0,1.7e-162,574.7,sp|Q9DBE9|SPB1_MOUSE pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Mus musculus OX=10090 GN=Ftsj3 PE=1 SV=1,GO:0001510; GO:0005654; GO:0005694; GO:0005730; GO:0008649; GO:0030688; GO:0062105,RNA methylation [GO:0001510],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA methyltransferase activity [GO:0008649],GO:0003824; GO:0005654; GO:0005694; GO:0005730; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleoplasm; chromosome; nucleolus; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06844,0.6138082717674005,OG_06844,FUN_031784-T1,Peve_00010429,Pocillopora_meandrina_HIv1___TS.g24287.t1,three_way,83.68866666666666,FUN_031784-T1,Q9ULT8,HECD1_HUMAN,,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),Homo sapiens (Human),52.0,2736.0,0.0,2536.5,sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4,GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630,aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281],,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04729,0.6136170836675724,OG_04729,FUN_022596-T1,Peve_00020269,Pocillopora_meandrina_HIv1___RNAseq.g4426.t1,three_way,59.531,FUN_022596-T1,Q91559,,,,,29.8,352.0,2.9000000000000002e-30,134.4,sp|Q91559|5HT7R_XENLA 5-hydroxytryptamine receptor 7 OS=Xenopus laevis OX=8355 GN=htr7 PE=2 SV=1,,,,,,
OG_09075,0.6133841329904822,OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_02807,0.6133350642891333,OG_02807,FUN_011778-T1,Peve_00006120,Pocillopora_meandrina_HIv1___RNAseq.g23294.t1,three_way,92.68933333333334,FUN_011778-T1,Q80Y75,DJB13_MOUSE,,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),Mus musculus (Mouse),63.5,315.0,1.6e-116,420.6,sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0097729; GO:0120212; GO:1904158,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],unfolded protein binding [GO:0051082],GO:0005576; GO:0005929; GO:0006457; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; protein folding; microtubule-based movement; reproductive process; organelle; cell motility
OG_00687,0.6127297794454115,OG_00687,FUN_002358-T1,Peve_00014905,Pocillopora_meandrina_HIv1___RNAseq.g42.t1,three_way,69.67566666666666,FUN_002358-T1,Q19297,,,,,43.6,94.0,8.4e-17,88.2,sp|Q19297|YZ73_CAEEL Uncharacterized monothiol glutaredoxin F10D7.3 OS=Caenorhabditis elegans OX=6239 GN=F10D7.3 PE=3 SV=2,,,,,,
OG_00491,0.6126147599834327,OG_00491,FUN_001461-T1,Peve_00027130,Pocillopora_meandrina_HIv1___TS.g4468.t1,three_way,90.859,FUN_001461-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),57.9,242.0,6.200000000000001e-73,275.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_01354,0.6112502812283507,OG_01354,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_02066,0.6107021978206517,OG_02066,FUN_008280-T1,Peve_00001965,Pocillopora_meandrina_HIv1___RNAseq.g17988.t1,three_way,85.35566666666666,FUN_008280-T1,A7RP64,PNO1_NEMVE,,RNA-binding protein pno1,Nematostella vectensis (Starlet sea anemone),74.9,235.0,7.3e-98,358.2,sp|A7RP64|PNO1_NEMVE RNA-binding protein pno1 OS=Nematostella vectensis OX=45351 GN=pno1 PE=3 SV=1,GO:0003723; GO:0005634; GO:0005730; GO:0032040; GO:0042274,ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0043226,RNA binding; nucleus; nucleolus; organelle
OG_08934,0.6105183897080092,OG_08934,FUN_038396-T1,Peve_00000044,Pocillopora_meandrina_HIv1___RNAseq.g28268.t1,three_way,67.62233333333333,FUN_038396-T1,P52189,KCNJ4_MOUSE,,"Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",Mus musculus (Mouse),44.0,357.0,2.899999999999999e-75,283.9,sp|P52189|KCNJ4_MOUSE Inward rectifier potassium channel 4 OS=Mus musculus OX=10090 GN=Kcnj4 PE=1 SV=1,GO:0005242; GO:0030659; GO:0034702; GO:0045211; GO:0098978,,cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],inward rectifier potassium channel activity [GO:0005242],GO:0005215,transporter activity
OG_03845,0.6099349255315234,OG_03845,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_09815,0.6095957748718275,OG_09815,FUN_042643-T1,Peve_00030042,Pocillopora_meandrina_HIv1___TS.g7635.t1,three_way,52.61466666666667,,,,,,,,,,,,,,,,,
OG_08423,0.6095346915256316,OG_08423,FUN_037082-T1,Peve_00004722,Pocillopora_meandrina_HIv1___RNAseq.g11121.t1,three_way,46.04966666666667,FUN_037082-T1,Q7T2Z5,UNC5C_CHICK,,Netrin receptor UNC5C (Protein unc-5 homolog 3) (cUNC-5H3) (Protein unc-5 homolog C),Gallus gallus (Chicken),24.0,1007.0,2.7e-64,248.8,sp|Q7T2Z5|UNC5C_CHICK Netrin receptor UNC5C OS=Gallus gallus OX=9031 GN=UNC5C PE=2 SV=1,GO:0005042; GO:0005886; GO:0007411; GO:0009986; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0045202; GO:1990791,axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791],cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202],netrin receptor activity [GO:0005042],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_02905,0.6095199819555895,OG_02905,FUN_011975-T1,Peve_00000996,Pocillopora_meandrina_HIv1___RNAseq.g23721.t1,three_way,79.435,,,,,,,,,,,,,,,,,
OG_02000,0.6086671558427164,OG_02000,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08781,0.6083563561789687,OG_08781,FUN_038067-T1,Peve_00010945,Pocillopora_meandrina_HIv1___RNAseq.g787.t1,three_way,64.63766666666666,,,,,,,,,,,,,,,,,
OG_04252,0.6076501704772252,OG_04252,FUN_017782-T1,Peve_00029910,Pocillopora_meandrina_HIv1___TS.g23048.t1,three_way,68.84083333333334,FUN_017782-T1,P77952,,,,,33.3,129.0,1.6e-06,55.8,sp|P77952|GLSA_STRGR L-glutamine:scyllo-inosose aminotransferase OS=Streptomyces griseus OX=1911 GN=stsC PE=1 SV=1,,,,,,
OG_07251,0.6075464157480931,OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_04360,0.606996501485089,OG_04360,FUN_018011-T1,Peve_00000403,Pocillopora_meandrina_HIv1___RNAseq.g25254.t1,three_way,62.35866666666666,,,,,,,,,,,,,,,,,
OG_04155,0.6069665606436464,OG_04155,FUN_016622-T1,Peve_00011211,Pocillopora_meandrina_HIv1___RNAseq.g9609.t1,three_way,83.40233333333333,FUN_016622-T1,P36975,,,,,51.5,202.0,4.2e-49,196.1,sp|P36975|SNP25_DROME Synaptosomal-associated protein 25 OS=Drosophila melanogaster OX=7227 GN=Snap25 PE=2 SV=1,,,,,,
OG_08155,0.6069519905926787,OG_08155,FUN_035933-T1,Peve_00036622,Pocillopora_meandrina_HIv1___RNAseq.g12069.t1,three_way,85.512,FUN_035933-T1,Q8HXG8,BCDO2_MACFA,,"Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (Beta-carotene dioxygenase 2)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.6,368.0,2.7e-56,220.7,"sp|Q8HXG8|BCDO2_MACFA Carotenoid-cleaving dioxygenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=BCO2 PE=2 SV=2",GO:0003834; GO:0005739; GO:0010437; GO:0016119; GO:0016121; GO:0016124; GO:0016702; GO:0042574; GO:0046872; GO:0062172; GO:0102076; GO:1901176; GO:1901826,carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; retinal metabolic process [GO:0042574]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826],mitochondrion [GO:0005739],"9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_08990,0.606358563136919,OG_08990,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_02699,0.6062463577580626,OG_02699,FUN_010968-T1,Peve_00035956,Pocillopora_meandrina_HIv1___RNAseq.g21969.t2,three_way,64.66499999999999,FUN_010968-T1,Q98TZ8,,,,,34.2,161.0,1.2e-22,107.8,sp|Q98TZ8|FLOT2_DANRE Flotillin-2a OS=Danio rerio OX=7955 GN=flot2a PE=2 SV=2,,,,,,
OG_00799,0.6061990724467301,OG_00799,FUN_003992-T1,Peve_00038456,Pocillopora_meandrina_HIv1___RNAseq.g17199.t1,three_way,69.46000000000001,FUN_003992-T1,Q0GGW5,STK11_CHICK,,Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1),Gallus gallus (Chicken),45.7,234.0,4.6999999999999995e-49,196.4,sp|Q0GGW5|STK11_CHICK Serine/threonine-protein kinase STK11 OS=Gallus gallus OX=9031 GN=STK11 PE=2 SV=1,GO:0000287; GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006974; GO:0007165; GO:0009267; GO:0009410; GO:0010212; GO:0016020; GO:0019901; GO:0030010; GO:0030111; GO:0030295; GO:0030308; GO:0032147; GO:0042593; GO:0046777; GO:0072332; GO:0090090; GO:0106310; GO:1901610,activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; positive regulation of vesicle transport along microtubule [GO:1901610]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; vasculature development [GO:0001944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0007163; GO:0016740; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; cytosol; establishment or maintenance of cell polarity; transferase activity; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00836,0.6060282861510929,OG_00836,FUN_004086-T1,Peve_00024027,Pocillopora_meandrina_HIv1___RNAseq.g12611.t1,three_way,91.55833333333334,FUN_004086-T1,Q9UNQ2,,,,,71.2,313.0,3.5e-129,462.6,sp|Q9UNQ2|DIM1_HUMAN Dimethyladenosine transferase OS=Homo sapiens OX=9606 GN=DIMT1 PE=1 SV=1,,,,,,
OG_04345,0.6056407265777692,OG_04345,FUN_017967-T1,Peve_00000394,Pocillopora_meandrina_HIv1___RNAseq.g25247.t1,three_way,83.32000000000001,FUN_017967-T1,Q0IID7,DUS10_BOVIN,,Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48),Bos taurus (Bovine),40.2,323.0,1.2e-64,248.4,sp|Q0IID7|DUS10_BOVIN Dual specificity protein phosphatase 10 OS=Bos taurus OX=9913 GN=DUSP10 PE=2 SV=1,GO:0002819; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042,negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_10052,0.6054094640298329,OG_10052,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_03343,0.6052822935255752,OG_03343,FUN_013573-T1,Peve_00026650,Pocillopora_meandrina_HIv1___RNAseq.g13522.t1,three_way,62.46266666666667,FUN_013573-T1,Q9NXK6,,,,,31.4,328.0,2.7000000000000004e-32,141.0,sp|Q9NXK6|PAQR5_HUMAN Membrane progestin receptor gamma OS=Homo sapiens OX=9606 GN=PAQR5 PE=1 SV=2,,,,,,
OG_01390,0.6051772679398738,OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_04915,0.605175187881645,OG_04915,FUN_022969-T1,Peve_00011904,Pocillopora_meandrina_HIv1___RNAseq.g3761.t1,three_way,71.649,FUN_022969-T1,P17124,,,,,30.7,332.0,2.2e-29,131.3,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_06197,0.605169572076418,OG_06197,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_02650,0.6043501369252299,OG_02650,FUN_010832-T1,Peve_00017537,Pocillopora_meandrina_HIv1___RNAseq.g20916.t1,three_way,73.97983333333333,FUN_010832-T1,Q13118,KLF10_HUMAN,,Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1),Homo sapiens (Human),62.6,179.0,2.5e-12,74.7,sp|Q13118|KLF10_HUMAN Krueppel-like factor 10 OS=Homo sapiens OX=9606 GN=KLF10 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008270; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837,bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019],chromatin [GO:0000785]; nucleus [GO:0005634],"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0023052; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; signaling; organelle; anatomical structure development; transcription regulator activity
OG_03975,0.6031517257010109,OG_03975,FUN_016129-T1,Peve_00013443,Pocillopora_meandrina_HIv1___TS.g26226.t1,three_way,44.653,,,,,,,,,,,,,,,,,
OG_05896,0.6027921697354356,OG_05896,FUN_026072-T1,Peve_00010389,Pocillopora_meandrina_HIv1___RNAseq.g10563.t1c,three_way,70.632,FUN_026072-T1,O19998,,,,,50.7,207.0,4.7e-52,207.6,sp|O19998|HO_RHOVL Heme oxygenase OS=Rhodella violacea OX=2801 GN=pbsA PE=3 SV=1,,,,,,
OG_08354,0.6027112758652142,OG_08354,FUN_036898-T1,Peve_00018372,Pocillopora_meandrina_HIv1___RNAseq.g10780.t1,three_way,90.75833333333333,FUN_036898-T1,Q6XUZ5,,,,,79.5,409.0,2.4e-189,662.9,sp|Q6XUZ5|IDHC_SHEEP Isocitrate dehydrogenase [NADP] cytoplasmic OS=Ovis aries OX=9940 GN=IDH1 PE=2 SV=1,,,,,,
OG_06069,0.6026310589818483,OG_06069,FUN_026917-T1,Peve_00013239,Pocillopora_meandrina_HIv1___RNAseq.g9415.t2,three_way,55.821,FUN_026917-T1,A2VD33,,,,,42.9,825.0,2.5e-193,677.2,sp|A2VD33|MOCOS_DANRE Molybdenum cofactor sulfurase OS=Danio rerio OX=7955 GN=mocos PE=2 SV=2,,,,,,
OG_00163,0.6017537947496376,OG_00163,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_03145,0.601441854387083,OG_03145,FUN_012531-T1,Peve_00013910,Pocillopora_meandrina_HIv1___RNAseq.g23956.t1c,three_way,73.822,FUN_012531-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),71.5,583.0,2.8e-132,473.8,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_04141,0.6007574550027206,OG_04141,FUN_016596-T1,Peve_00033776,Pocillopora_meandrina_HIv1___RNAseq.g481.t1,three_way,74.769,FUN_016596-T1,O46385,,,,,34.0,1119.0,3.3e-163,578.6,sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2,,,,,,
OG_00540,0.600489376415272,OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_02488,0.5997212740353487,OG_02488,FUN_009820-T1,Peve_00042914,Pocillopora_meandrina_HIv1___RNAseq.g24547.t1,three_way,81.36066666666666,FUN_009820-T1,Q6NZ09,,,,,50.5,380.0,2.1e-54,214.5,sp|Q6NZ09|ADRM1_DANRE Proteasomal ubiquitin receptor ADRM1 OS=Danio rerio OX=7955 GN=adrm1b PE=1 SV=1,,,,,,
OG_01505,0.599474946468923,OG_01505,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_08988,0.5990906761216879,OG_08988,FUN_038508-T1,Peve_00041683,Pocillopora_meandrina_HIv1___RNAseq.g28175.t1,three_way,84.98566666666667,FUN_038508-T1,P10644,KAP0_HUMAN,,cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1),Homo sapiens (Human),70.1,374.0,1.1e-140,501.1,sp|P10644|KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,GO:0001707; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005952; GO:0006357; GO:0007189; GO:0008603; GO:0010629; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0045214; GO:0046007; GO:0060038; GO:0071377; GO:0097546; GO:0098978; GO:0120212; GO:0141162,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; positive regulation of insulin secretion [GO:0032024]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm head-tail coupling apparatus [GO:0120212],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0031410; GO:0043226; GO:0098772,endosome; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_04083,0.5990853905946423,OG_04083,FUN_016419-T1,Peve_00023004,Pocillopora_meandrina_HIv1___RNAseq.g9801.t1,three_way,61.829,,,,,,,,,,,,,,,,,
OG_05622,0.5987276008896243,OG_05622,FUN_025315-T1,Peve_00027083,Pocillopora_meandrina_HIv1___RNAseq.g13448.t1,three_way,79.72466666666666,FUN_025315-T1,P30038,AL4A1_HUMAN,,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",Homo sapiens (Human),55.4,552.0,1.2e-183,644.4,"sp|P30038|AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802,4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_08173,0.598470958130363,OG_08173,FUN_035981-T1,Peve_00045083,Pocillopora_meandrina_HIv1___RNAseq.g12342.t1,three_way,87.08966666666667,FUN_035981-T1,Q9QYJ0,,,,,57.3,410.0,3.3e-127,456.4,sp|Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A member 2 OS=Mus musculus OX=10090 GN=Dnaja2 PE=1 SV=1,,,,,,
OG_02321,0.5983997976357888,OG_02321,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_02142,0.5983963998457178,OG_02142,FUN_008448-T1,Peve_00025570,Pocillopora_meandrina_HIv1___RNAseq.21564_t,three_way,64.99516666666666,FUN_008448-T1,Q9H4B6,SAV1_HUMAN,,Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45),Homo sapiens (Human),56.9,181.0,1.4999999999999998e-24,115.9,sp|Q9H4B6|SAV1_HUMAN Protein salvador homolog 1 OS=Homo sapiens OX=9606 GN=SAV1 PE=1 SV=2,GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0030216; GO:0035329; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0050673; GO:0050680; GO:0050821; GO:0060038; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:0097283; GO:0140537; GO:1902174; GO:2000036,cardiac muscle cell proliferation [GO:0060038]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte apoptotic process [GO:0097283]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of keratinocyte apoptotic process [GO:1902174]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; ventricular septum morphogenesis [GO:0060412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; transcription regulator activator activity [GO:0140537],GO:0005634; GO:0005829; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; cytosol; programmed cell death; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07344,0.59825616685219,OG_07344,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_03919,0.5981611970612045,OG_03919,FUN_016017-T1,Peve_00004545,Pocillopora_meandrina_HIv1___TS.g26118.t2,three_way,74.83916666666667,FUN_016017-T1,Q9QZB0,RGS17_MOUSE,,Regulator of G-protein signaling 17 (RGS17) (Regulator of Gz-selective protein signaling 2),Mus musculus (Mouse),49.4,89.0,2.6e-18,93.6,sp|Q9QZB0|RGS17_MOUSE Regulator of G-protein signaling 17 OS=Mus musculus OX=10090 GN=Rgs17 PE=1 SV=1,GO:0001975; GO:0005096; GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0016020; GO:0043005; GO:0045202,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to amphetamine [GO:0001975],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202],GTPase activator activity [GO:0005096],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_04022,0.5981583363981948,OG_04022,FUN_016327-T1,Peve_00032378,Pocillopora_meandrina_HIv1___RNAseq.g9682.t1,three_way,50.593,,,,,,,,,,,,,,,,,
OG_02475,0.597757153723811,OG_02475,FUN_009736-T1,Peve_00033566,Pocillopora_meandrina_HIv1___RNAseq.g29063.t1,three_way,57.04183333333333,FUN_009736-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,32.1,764.0,9.100000000000001e-104,380.6,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_08901,0.5976536800781166,OG_08901,FUN_038315-T1,Peve_00035853,Pocillopora_meandrina_HIv1___RNAseq.g1120.t1,three_way,66.31266666666666,FUN_038315-T1,Q8NDV7,,,,,34.4,224.0,3.4e-17,93.2,sp|Q8NDV7|TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=2,,,,,,
OG_01060,0.5975030312140311,OG_01060,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_01009,0.5972025657811594,OG_01009,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_08861,0.5971222714552373,OG_08861,FUN_038247-T1,Peve_00007988,Pocillopora_meandrina_HIv1___RNAseq.g923.t1,three_way,78.74566666666666,FUN_038247-T1,P15170,ERF3A_HUMAN,,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Homo sapiens (Human),71.9,427.0,3.8e-190,666.0,sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444; GO:0022626,"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0005840; GO:0016071; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; cytosol; ribosome; mRNA metabolic process; hydrolase activity; organelle
OG_00703,0.5971211109609791,OG_00703,FUN_002453-T1,Peve_00023668,Pocillopora_meandrina_HIv1___RNAseq.g14891.t1,three_way,78.35433333333334,,,,,,,,,,,,,,,,,
OG_02355,0.5969314702240117,OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_08433,0.5958482301805528,OG_08433,FUN_037167-T1,Peve_00003254,Pocillopora_meandrina_HIv1___RNAseq.g11080.t1,three_way,59.40383333333333,,,,,,,,,,,,,,,,,
OG_05531,0.595824318826727,OG_05531,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_01905,0.595487695507856,OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_09670,0.5952854923798817,OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.8999999999999995e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_06301,0.5945555851651888,OG_06301,FUN_028506-T1,Peve_00029711,Pocillopora_meandrina_HIv1___RNAseq.g15898.t1,three_way,64.91666666666667,,,,,,,,,,,,,,,,,
OG_01584,0.5942467055486511,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03031,0.5939137390505979,OG_03031,FUN_012265-T1,Peve_00036383,Pocillopora_meandrina_HIv1___RNAseq.9171_t,three_way,76.63199999999999,FUN_012265-T1,Q86SQ9,DHDDS_HUMAN,,Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m),Homo sapiens (Human),62.4,274.0,2.3e-95,350.5,sp|Q86SQ9|DHDDS_HUMAN Dehydrodolichyl diphosphate synthase complex subunit DHDDS OS=Homo sapiens OX=9606 GN=DHDDS PE=1 SV=3,GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0019408; GO:0045547; GO:0046872; GO:1904423,dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094],dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity [GO:0045547]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06891,0.5938255790065808,OG_06891,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_03971,0.5937206207992658,OG_03971,FUN_016125-T1,Peve_00013452,Pocillopora_meandrina_HIv1___RNAseq.g21531.t1,three_way,80.723,FUN_016125-T1,Q8VI36,PAXI_MOUSE,,Paxillin,Mus musculus (Mouse),52.0,471.0,3.8e-133,476.5,sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1,GO:0005078; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1900026,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027],BH4 domain binding [GO:0051435]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; signaling receptor complex adaptor activity [GO:0030159],GO:0005856; GO:0007010; GO:0007155; GO:0034330; GO:0043226; GO:0048870; GO:0060090,cytoskeleton; cytoskeleton organization; cell adhesion; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_06663,0.593365521802276,OG_06663,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_05026,0.5932737291641174,OG_05026,FUN_023189-T1,Peve_00009992,Pocillopora_meandrina_HIv1___TS.g25367.t1,three_way,58.125,FUN_023189-T1,O43490,,,,,27.2,751.0,1.8e-53,212.6,sp|O43490|PROM1_HUMAN Prominin-1 OS=Homo sapiens OX=9606 GN=PROM1 PE=1 SV=1,,,,,,
OG_03436,0.5932006605548241,OG_03436,FUN_014494-T1,Peve_00024062,Pocillopora_meandrina_HIv1___RNAseq.g22515.t1,three_way,81.14283333333333,FUN_014494-T1,Q2KHP8,,,,,71.8,429.0,2.0000000000000005e-187,656.8,sp|Q2KHP8|TYW1_XENLA S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Xenopus laevis OX=8355 GN=tyw1 PE=2 SV=1,,,,,,
OG_02935,0.5930028448701171,OG_02935,FUN_012040-T1,Peve_00016079,Pocillopora_meandrina_HIv1___RNAseq.g24061.t1,three_way,58.10066666666667,,,,,,,,,,,,,,,,,
OG_06199,0.5929996504527794,OG_06199,FUN_028133-T1,Peve_00004264,Pocillopora_meandrina_HIv1___RNAseq.g15555.t1,three_way,47.007000000000005,FUN_028133-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),22.6,495.0,5.8e-18,94.4,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_07916,0.5929928062389436,OG_07916,FUN_035397-T1,Peve_00005178,Pocillopora_meandrina_HIv1___RNAseq.g12210.t1,three_way,59.64666666666667,,,,,,,,,,,,,,,,,
OG_02160,0.5929152453779575,OG_02160,FUN_008496-T1,Peve_00010569,Pocillopora_meandrina_HIv1___RNAseq.g5883.t1,three_way,57.5785,FUN_008496-T1,P47748,,,,,27.1,303.0,4.6e-17,90.5,sp|P47748|OPRX_CAVPO Nociceptin receptor OS=Cavia porcellus OX=10141 GN=OPRL1 PE=2 SV=1,,,,,,
OG_05950,0.5928079684975216,OG_05950,FUN_026200-T1,Peve_00044664,Pocillopora_meandrina_HIv1___RNAseq.g3045.t1,three_way,58.144,FUN_026200-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),47.4,342.0,3.6e-107,392.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09544,0.5923670526830066,OG_09544,FUN_041639-T1,Peve_00007388,Pocillopora_meandrina_HIv1___RNAseq.g14209.t1,three_way,52.72933333333334,,,,,,,,,,,,,,,,,
OG_02366,0.5919410195503755,OG_02366,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.5999999999999999e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_00403,0.5915713268031729,OG_00403,FUN_001290-T1,Peve_00037014,Pocillopora_meandrina_HIv1___TS.g4708.t1b,three_way,90.79066666666668,FUN_001290-T1,P10860,DHE3_RAT,,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) (Memory-related gene 2 protein) (MRG-2)",Rattus norvegicus (Rat),65.2,500.0,6.2e-198,691.8,"sp|P10860|DHE3_RAT Glutamate dehydrogenase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Glud1 PE=1 SV=2",GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350,cerebellum development [GO:0021549]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005783; GO:0006520; GO:0016491; GO:0043226; GO:0048856; GO:0050877,catalytic activity; mitochondrion; endoplasmic reticulum; amino acid metabolic process; oxidoreductase activity; organelle; anatomical structure development; nervous system process
OG_04311,0.5911216424067174,OG_04311,FUN_017899-T1,Peve_00000241,Pocillopora_meandrina_HIv1___RNAseq.g341.t1,three_way,85.13083333333333,FUN_017899-T1,Q8ND07,,,,,40.7,477.0,4.6e-76,287.0,sp|Q8ND07|BBOF1_HUMAN Basal body-orientation factor 1 OS=Homo sapiens OX=9606 GN=BBOF1 PE=1 SV=3,,,,,,
OG_04225,0.5909936772390646,OG_04225,FUN_016992-T1,Peve_00025272,Pocillopora_meandrina_HIv1___RNAseq.g9893.t1,three_way,59.312333333333335,FUN_016992-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.0,318.0,1.2999999999999998e-24,115.5,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_04072,0.5909688749365956,OG_04072,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_01495,0.5903377025045541,OG_01495,FUN_006218-T1,Peve_00020212,Pocillopora_meandrina_HIv1___RNAseq.g20436.t1,three_way,60.865,,,,,,,,,,,,,,,,,
OG_03121,0.5901145900525665,OG_03121,FUN_012475-T1,Peve_00004003,Pocillopora_meandrina_HIv1___RNAseq.g23989.t1,three_way,76.35766666666667,FUN_012475-T1,Q9D6D8,,,,,49.7,286.0,2.5e-79,297.0,sp|Q9D6D8|PPIL6_MOUSE Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 OS=Mus musculus OX=10090 GN=Ppil6 PE=1 SV=2,,,,,,
OG_07381,0.5893559393760184,OG_07381,FUN_033803-T1,Peve_00009714,Pocillopora_meandrina_HIv1___RNAseq.g26324.t1,three_way,73.78666666666666,FUN_033803-T1,P01108,,,,,27.5,415.0,2.2e-16,88.2,sp|P01108|MYC_MOUSE Myc proto-oncogene protein OS=Mus musculus OX=10090 GN=Myc PE=1 SV=2,,,,,,
OG_10186,0.5887223806566987,OG_10186,FUN_043601-T1,Peve_00040384,Pocillopora_meandrina_HIv1___RNAseq.g6949.t1,three_way,45.54,FUN_043601-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),28.0,1276.0,2.1e-133,478.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_05149,0.5885562058212764,OG_05149,FUN_023431-T1,Peve_00019220,Pocillopora_meandrina_HIv1___RNAseq.g563.t1,three_way,61.802166666666665,FUN_023431-T1,O13076,,,,,23.0,309.0,6e-08,60.1,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_07435,0.5882383512949815,OG_07435,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_01762,0.5880277098914299,OG_01762,FUN_007117-T1,Peve_00043801,Pocillopora_meandrina_HIv1___RNAseq.g18998.t1,three_way,71.51549999999999,FUN_007117-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),30.2,129.0,4.2e-10,67.0,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08247,0.5879804039965376,OG_08247,FUN_036155-T1,Peve_00006921,Pocillopora_meandrina_HIv1___RNAseq.g27468.t1,three_way,65.3335,FUN_036155-T1,P23944,ADA1D_RAT,,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (RA42),Rattus norvegicus (Rat),34.2,339.0,1.7e-33,145.2,sp|P23944|ADA1D_RAT Alpha-1D adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1d PE=2 SV=2,GO:0001986; GO:0001994; GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0008217; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001986]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217],plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802],GO:0003013; GO:0005886; GO:0023052; GO:0060089,circulatory system process; plasma membrane; signaling; molecular transducer activity
OG_02090,0.5878146938348304,OG_02090,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05812,0.587047019798726,OG_05812,FUN_025814-T1,Peve_00002523,Pocillopora_meandrina_HIv1___RNAseq.g9336.t1,three_way,66.91966666666667,FUN_025814-T1,O15520,FGF10_HUMAN,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Homo sapiens (Human),32.0,122.0,1.2e-12,74.7,sp|O15520|FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens OX=9606 GN=FGF10 PE=1 SV=1,GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009880; GO:0009986; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0022008; GO:0030036; GO:0030334; GO:0030538; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0043616; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_07364,0.5868117567817812,OG_07364,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_03079,0.5860658676825882,OG_03079,FUN_012351-T1,Peve_00042524,Pocillopora_meandrina_HIv1___RNAseq.g23280.t1,three_way,33.19883333333333,,,,,,,,,,,,,,,,,
OG_06001,0.5857402524309101,OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_04154,0.58508982756189,OG_04154,FUN_016621-T1,Peve_00005682,Pocillopora_meandrina_HIv1___RNAseq.g9611.t1,three_way,71.54566666666666,FUN_016621-T1,Q99615,DNJC7_HUMAN,,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),Homo sapiens (Human),55.3,414.0,1.4999999999999998e-127,458.0,sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2,GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034,chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072],GO:0005654; GO:0005829; GO:0005856; GO:0006457; GO:0043226; GO:0098772,nucleoplasm; cytosol; cytoskeleton; protein folding; organelle; molecular function regulator activity
OG_03321,0.5850896271135031,OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_06329,0.5847842419407386,OG_06329,FUN_028877-T1,Peve_00044602,Pocillopora_meandrina_HIv1___RNAseq.g12808.t1,three_way,91.02266666666668,FUN_028877-T1,Q28FE4,,,,,80.5,113.0,2.1e-56,219.9,sp|Q28FE4|MORN5_XENTR MORN repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=morn5 PE=2 SV=1,,,,,,
OG_03139,0.584020849917235,OG_03139,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_00618,0.5836489090050061,OG_00618,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05907,0.583575751287265,OG_05907,FUN_026096-T1,Peve_00013339,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1b,three_way,84.50033333333333,FUN_026096-T1,P19891,,,,,60.1,564.0,4.6e-196,685.6,sp|P19891|ASNS_CRIGR Asparagine synthetase [glutamine-hydrolyzing] OS=Cricetulus griseus OX=10029 GN=ASNS PE=2 SV=2,,,,,,
OG_03965,0.5831225146997868,OG_03965,FUN_016114-T1,Peve_00013353,Pocillopora_meandrina_HIv1___RNAseq.g21557.t1,three_way,59.141666666666666,FUN_016114-T1,B8F7S3,,,,,51.5,66.0,2.1e-13,78.2,sp|B8F7S3|DNAJ_GLAP5 Chaperone protein DnaJ OS=Glaesserella parasuis serovar 5 (strain SH0165) OX=557723 GN=dnaJ PE=3 SV=1,,,,,,
OG_04838,0.5830535234331198,OG_04838,FUN_022837-T1,Peve_00028887,Pocillopora_meandrina_HIv1___RNAseq.g3399.t1,three_way,45.176,,,,,,,,,,,,,,,,,
OG_04587,0.5828314149411133,OG_04587,FUN_022259-T1,Peve_00043995,Pocillopora_meandrina_HIv1___RNAseq.g4721.t1,three_way,56.8915,,,,,,,,,,,,,,,,,
OG_02511,0.582586952862481,OG_02511,FUN_010518-T1,Peve_00003566,Pocillopora_meandrina_HIv1___RNAseq.g12949.t1,three_way,56.06633333333333,FUN_010518-T1,Q5BKC9,NGEF_RAT,,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),Rattus norvegicus (Rat),35.8,573.0,2.1e-92,342.4,sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2,GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806,cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794],ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0048856; GO:0098772,cell differentiation; anatomical structure development; molecular function regulator activity
OG_05643,0.5825590549885978,OG_05643,FUN_025361-T1,Peve_00040526,Pocillopora_meandrina_HIv1___RNAseq.14643_t,three_way,74.309,FUN_025361-T1,P10160,,,,,69.3,153.0,2.4e-57,223.0,sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2,,,,,,
OG_04571,0.5824997093778906,OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.999999999999999e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_08709,0.5824301377793064,OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_06925,0.5823479715253977,OG_06925,FUN_032015-T1,Peve_00041126,Pocillopora_meandrina_HIv1___RNAseq.g30271.t1,three_way,95.74166666666667,FUN_032015-T1,Q9BXW4,,,,,72.9,118.0,2.5e-41,169.5,sp|Q9BXW4|MLP3C_HUMAN Microtubule-associated protein 1 light chain 3 gamma OS=Homo sapiens OX=9606 GN=MAP1LC3C PE=1 SV=1,,,,,,
OG_08952,0.5818488519446706,OG_08952,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_01091,0.5813651712051783,OG_01091,FUN_004584-T1,Peve_00012393,Pocillopora_meandrina_HIv1___RNAseq.g6602.t1,three_way,49.74033333333333,,,,,,,,,,,,,,,,,
OG_08975,0.581059867693753,OG_08975,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_00696,0.580981490348192,OG_00696,FUN_002425-T1,Peve_00034031,Pocillopora_meandrina_HIv1___RNAseq.g14843.t1,three_way,39.469,,,,,,,,,,,,,,,,,
OG_02611,0.5807858789969402,OG_02611,FUN_010745-T1,Peve_00038409,Pocillopora_meandrina_HIv1___TS.g25690.t1,three_way,79.04633333333334,FUN_010745-T1,O75153,,,,,47.6,1302.0,0.0,1138.6,sp|O75153|CLU_HUMAN Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,,,,,,
OG_05375,0.5801600041389626,OG_05375,FUN_024188-T1,Peve_00013618,Pocillopora_meandrina_HIv1___RNAseq.g18884.t1,three_way,43.766,,,,,,,,,,,,,,,,,
OG_03980,0.5799392603463058,OG_03980,FUN_016138-T1,Peve_00022583,Pocillopora_meandrina_HIv1___RNAseq.g22031.t2,three_way,68.26350000000001,FUN_016138-T1,Q9ER33,CNGA3_RAT,,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),Rattus norvegicus (Rat),42.4,224.0,1.1999999999999999e-41,172.2,sp|Q9ER33|CNGA3_RAT Cyclic nucleotide-gated channel alpha-3 OS=Rattus norvegicus OX=10116 GN=Cnga3 PE=1 SV=1,GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0006814; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0046549; GO:0051591; GO:0051899; GO:0060041; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495,inorganic cation import across plasma membrane [GO:0098659]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; sodium ion transport [GO:0006814],axon initial segment [GO:0043194]; cone photoreceptor outer segment [GO:0120199]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495],cadherin binding [GO:0045296]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; myosin binding [GO:0017022]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0008092; GO:0048856; GO:0055085,transporter activity; plasma membrane; cytoskeletal protein binding; anatomical structure development; transmembrane transport
OG_06800,0.5797898376738475,OG_06800,FUN_031688-T1,Peve_00008190,Pocillopora_meandrina_HIv1___RNAseq.g5768.t1,three_way,65.605,FUN_031688-T1,Q15582,BGH3_HUMAN,,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP),Homo sapiens (Human),27.7,629.0,1.4999999999999999e-53,212.6,sp|Q15582|BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens OX=9606 GN=TGFBI PE=1 SV=1,GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023; GO:0070062,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0007155; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; extracellular region; extracellular space; plasma membrane; cell adhesion; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05401,0.579491967575242,OG_05401,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_02951,0.5791800457162245,OG_02951,FUN_012070-T1,Peve_00025863,Pocillopora_meandrina_HIv1___TS.g16508.t1,three_way,72.754,,,,,,,,,,,,,,,,,
OG_07302,0.5790303188713384,OG_07302,FUN_033688-T1,Peve_00010874,Pocillopora_meandrina_HIv1___TS.g18604.t2,three_way,85.6255,,,,,,,,,,,,,,,,,
OG_08400,0.5787563110231522,OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_04033,0.5783967088465102,OG_04033,FUN_016341-T1,Peve_00044577,Pocillopora_meandrina_HIv1___RNAseq.g9731.t1,three_way,85.63799999999999,FUN_016341-T1,Q5ZKX6,UBE2F_CHICK,,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),Gallus gallus (Chicken),60.9,184.0,1.2e-62,241.1,sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654; GO:0061663,protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07943,0.5776688401480932,OG_07943,FUN_035457-T1,Peve_00012137,Pocillopora_meandrina_HIv1___TS.g14393.t2,three_way,86.11866666666667,FUN_035457-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),55.7,474.0,5.5e-114,412.9,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_05925,0.5772840103800959,OG_05925,FUN_026148-T1,Peve_00014875,Pocillopora_meandrina_HIv1___RNAseq.g3232.t1,three_way,87.95866666666667,FUN_026148-T1,Q64261,CDK6_MOUSE,,Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),Mus musculus (Mouse),68.0,222.0,6.7e-85,315.1,sp|Q64261|CDK6_MOUSE Cyclin-dependent kinase 6 OS=Mus musculus OX=10090 GN=Cdk6 PE=1 SV=2,GO:0000082; GO:0000122; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0007219; GO:0009615; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000773,cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_08289,0.5772494545851373,OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_07038,0.5772308885107853,OG_07038,FUN_032233-T1,Peve_00012061,Pocillopora_meandrina_HIv1___RNAseq.g24837.t1,three_way,53.79233333333333,,,,,,,,,,,,,,,,,
OG_01712,0.5769932023991855,OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_00314,0.5767946267914702,OG_00314,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_03516,0.576436270107023,OG_03516,FUN_014627-T1,Peve_00002415,Pocillopora_meandrina_HIv1___TS.g27554.t1,three_way,87.76583333333333,FUN_014627-T1,Q5ZML3,,,,,65.0,200.0,3.2e-57,223.4,sp|Q5ZML3|SRSF1_CHICK Serine/arginine-rich splicing factor 1 OS=Gallus gallus OX=9031 GN=SRSF1 PE=1 SV=3,,,,,,
OG_07733,0.5762738911906796,OG_07733,FUN_034894-T1,Peve_00030258,Pocillopora_meandrina_HIv1___RNAseq.g27804.t1,three_way,78.94566666666667,FUN_034894-T1,Q62737,CY24A_RAT,,Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox),Rattus norvegicus (Rat),52.1,140.0,2.100000000000001e-33,143.7,sp|Q62737|CY24A_RAT Cytochrome b-245 light chain OS=Rattus norvegicus OX=10116 GN=Cyba PE=1 SV=3,GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0034137; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0071260; GO:0071333; GO:0071356; GO:0071480; GO:0072593; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904628; GO:1904845,cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175],GO:0002376; GO:0003012; GO:0003824; GO:0005768; GO:0005886; GO:0006954; GO:0016491; GO:0031410; GO:0043226; GO:0050886; GO:0065003; GO:0098542,immune system process; muscle system process; catalytic activity; endosome; plasma membrane; inflammatory response; oxidoreductase activity; cytoplasmic vesicle; organelle; endocrine process; protein-containing complex assembly; defense response to other organism
OG_05267,0.5760479288204607,OG_05267,FUN_023801-T1,Peve_00035150,Pocillopora_meandrina_HIv1___RNAseq.g17839.t1,three_way,70.28433333333334,FUN_023801-T1,F1R4Y7,,,,,28.7,421.0,1.3e-35,152.5,sp|F1R4Y7|CEP83_DANRE Centrosomal protein of 83 kDa OS=Danio rerio OX=7955 GN=cep83 PE=3 SV=2,,,,,,
OG_05785,0.5749333537525012,OG_05785,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_02243,0.5747546239205785,OG_02243,FUN_008660-T1,Peve_00002968,Pocillopora_meandrina_HIv1___RNAseq.g14873.t1,three_way,90.71133333333331,FUN_008660-T1,H9BW96,,,,,88.4,207.0,3.8e-101,369.0,sp|H9BW96|RAB7_EPICO Ras-related protein rab7 OS=Epinephelus coioides OX=94232 GN=rab7 PE=1 SV=1,,,,,,
OG_05054,0.5738145061912917,OG_05054,FUN_023250-T1,Peve_00019253,Pocillopora_meandrina_HIv1___RNAseq.g17400.t1,three_way,95.03433333333334,FUN_023250-T1,Q9GR88,,,,,85.8,431.0,4.2e-216,751.9,sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1,,,,,,
OG_07978,0.5738144185950991,OG_07978,FUN_035600-T1,Peve_00027480,Pocillopora_meandrina_HIv1___RNAseq.g28038.t1,three_way,84.73833333333333,FUN_035600-T1,Q9T043,,,,,54.9,133.0,1.4e-32,140.6,sp|Q9T043|RL142_ARATH Large ribosomal subunit protein eL14y OS=Arabidopsis thaliana OX=3702 GN=RPL14B PE=1 SV=1,,,,,,
OG_09694,0.5733690735322069,OG_09694,FUN_041923-T1,Peve_00007865,Pocillopora_meandrina_HIv1___RNAseq.g15625.t1,three_way,75.917,FUN_041923-T1,D6C652,YAP1A_XENLA,,Transcriptional coactivator YAP1-A (Yes-associated protein 1-A) (xYAP) (Protein yorkie homolog-A) (Yes-associated protein YAP65 homolog A),Xenopus laevis (African clawed frog),28.5,456.0,6.000000000000001e-28,126.7,sp|D6C652|YAP1A_XENLA Transcriptional coactivator YAP1-A OS=Xenopus laevis OX=8355 GN=yap1-a PE=1 SV=1,GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944,hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005886; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_03458,0.5731026644798934,OG_03458,FUN_014534-T1,Peve_00040836,Pocillopora_meandrina_HIv1___RNAseq.g22608.t1,three_way,82.51333333333334,FUN_014534-T1,Q5ZLG0,,,,,64.0,655.0,3.2999999999999996e-257,889.0,sp|Q5ZLG0|AACS_CHICK Acetoacetyl-CoA synthetase OS=Gallus gallus OX=9031 GN=AACS PE=2 SV=1,,,,,,
OG_00585,0.5730493603733233,OG_00585,FUN_001658-T1,Peve_00038361,Pocillopora_meandrina_HIv1___RNAseq.g29403.t1,three_way,89.375,FUN_001658-T1,Q5RBE5,,,,,70.9,323.0,2.9e-134,479.6,sp|Q5RBE5|FCL_PONAB GDP-L-fucose synthase OS=Pongo abelii OX=9601 GN=GFUS PE=2 SV=1,,,,,,
OG_07642,0.5730005173467367,OG_07642,FUN_034421-T1,Peve_00038701,Pocillopora_meandrina_HIv1___RNAseq.g28564.t1,three_way,82.62766666666667,FUN_034421-T1,Q3MHQ7,,,,,47.0,230.0,2.9e-47,190.3,sp|Q3MHQ7|TM86A_BOVIN Lysoplasmalogenase TMEM86A OS=Bos taurus OX=9913 GN=TMEM86A PE=2 SV=1,,,,,,
OG_09644,0.5727131713124566,OG_09644,FUN_041839-T1,Peve_00009639,Pocillopora_meandrina_HIv1___RNAseq.g15081.t1,three_way,63.03933333333333,FUN_041839-T1,Q9UKB3,,,,,38.9,144.0,6e-25,115.5,sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1,,,,,,
OG_00145,0.5724316841000274,OG_00145,FUN_000588-T1,Peve_00025320,Pocillopora_meandrina_HIv1___RNAseq.g29293.t3,three_way,87.40333333333334,FUN_000588-T1,P28347,TEAD1_HUMAN,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Homo sapiens (Human),65.6,450.0,3.6000000000000002e-146,519.6,sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837,embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_04670,0.5695170724587877,OG_04670,FUN_022428-T1,Peve_00037611,Pocillopora_meandrina_HIv1___RNAseq.g4345.t1,three_way,59.46366666666667,FUN_022428-T1,Q9VCX3,,,,,31.2,253.0,4.2e-31,136.7,sp|Q9VCX3|RM45_DROME Large ribosomal subunit protein mL45 OS=Drosophila melanogaster OX=7227 GN=mRpL45 PE=2 SV=1,,,,,,
OG_09183,0.5693294094767756,OG_09183,FUN_039863-T1,Peve_00020822,Pocillopora_meandrina_HIv1___RNAseq.g7280.t1,three_way,68.19433333333333,FUN_039863-T1,B5XF11,KDM8_SALSA,,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),Salmo salar (Atlantic salmon),47.1,401.0,1.6e-104,381.3,sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1,GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0140680,circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_09250,0.5691909487824679,OG_09250,FUN_040040-T1,Peve_00040427,Pocillopora_meandrina_HIv1___RNAseq.g8459.t1,three_way,75.77216666666668,FUN_040040-T1,Q9BRS2,RIOK1_HUMAN,,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.1.-) (RIO kinase 1),Homo sapiens (Human),55.6,459.0,1.2e-133,478.4,sp|Q9BRS2|RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02451,0.568898627623039,OG_02451,FUN_009528-T1,Peve_00014183,Pocillopora_meandrina_HIv1___RNAseq.g24497.t1,three_way,84.42966666666666,,,,,,,,,,,,,,,,,
OG_01872,0.5685988222609961,OG_01872,FUN_007839-T1,Peve_00019308,Pocillopora_meandrina_HIv1___TS.g21414.t1,three_way,62.15633333333333,FUN_007839-T1,Q61830,,,,,29.1,299.0,1.1e-23,112.8,sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2,,,,,,
OG_05193,0.5685390228320261,OG_05193,FUN_023559-T1,Peve_00037259,Pocillopora_meandrina_HIv1___RNAseq.g518.t1,three_way,85.97,FUN_023559-T1,Q3T000,YKT6_BOVIN,,Synaptobrevin homolog YKT6 (EC 2.3.1.-),Bos taurus (Bovine),62.6,187.0,1.7e-59,230.7,sp|Q3T000|YKT6_BOVIN Synaptobrevin homolog YKT6 OS=Bos taurus OX=9913 GN=YKT6 PE=2 SV=1,GO:0000139; GO:0005484; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484],GO:0003824; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03312,0.5678947926933977,OG_03312,FUN_013390-T1,Peve_00030638,Pocillopora_meandrina_HIv1___RNAseq.g22976.t1,three_way,70.00083333333333,FUN_013390-T1,Q26613,,,,,37.5,651.0,5.9e-132,473.8,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_03230,0.5678786574324395,OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_08411,0.5674962135191446,OG_08411,FUN_037062-T1,Peve_00018396,Pocillopora_meandrina_HIv1___RNAseq.g26779.t1,three_way,65.08266666666667,FUN_037062-T1,O95628,CNOT4_HUMAN,,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),Homo sapiens (Human),48.8,441.0,2.6e-103,377.9,sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3,GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634],RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03574,0.5668937548020989,OG_03574,FUN_014728-T1,Peve_00009505,Pocillopora_meandrina_HIv1___RNAseq.g22491.t1,three_way,50.2435,,,,,,,,,,,,,,,,,
OG_02119,0.5663864533859425,OG_02119,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_00319,0.5663182830210273,OG_00319,FUN_001137-T1,Peve_00029385,Pocillopora_meandrina_HIv1___RNAseq.g29339.t1,three_way,81.55166666666666,FUN_001137-T1,Q9Y345,,,,,44.3,625.0,1.2e-152,541.6,sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3,,,,,,
OG_04627,0.5660530491102307,OG_04627,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_00455,0.5652932149095893,OG_00455,FUN_001384-T1,Peve_00019346,Pocillopora_meandrina_HIv1___TS.g4636.t2,three_way,67.6845,,,,,,,,,,,,,,,,,
OG_06077,0.5649539547187528,OG_06077,FUN_026988-T1,Peve_00012934,Pocillopora_meandrina_HIv1___RNAseq.g4369.t1,three_way,61.893,,,,,,,,,,,,,,,,,
OG_04261,0.564773292816255,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,0.564773292816255,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_10207,0.5644203015316956,OG_10207,FUN_043642-T1,Peve_00041942,Pocillopora_meandrina_HIv1___RNAseq.g7410.t1,three_way,83.61566666666667,,,,,,,,,,,,,,,,,
OG_01574,0.5642677890023629,OG_01574,FUN_006578-T1,Peve_00018194,Pocillopora_meandrina_HIv1___RNAseq.g20266.t1,three_way,88.35233333333333,FUN_006578-T1,P49139,,,,,62.1,346.0,1.4000000000000001e-126,454.1,sp|P49139|MAPK2_RABIT MAP kinase-activated protein kinase 2 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=MAPKAPK2 PE=1 SV=2,,,,,,
OG_07669,0.5642052837381656,OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_05287,0.5639362835927548,OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_04237,0.5631753104581622,OG_04237,FUN_017758-T1,Peve_00040794,Pocillopora_meandrina_HIv1___RNAseq.g432.t3,three_way,65.21266666666666,FUN_017758-T1,Q9I8C7,,,,,33.0,485.0,1e-67,259.2,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_04111,0.5630742872013311,OG_04111,FUN_016484-T1,Peve_00005880,Pocillopora_meandrina_HIv1___RNAseq.g99.t1,three_way,81.93266666666666,FUN_016484-T1,Q9IA79,,,,,53.2,231.0,4.7e-65,249.2,sp|Q9IA79|BI1_PAROL Probable Bax inhibitor 1 OS=Paralichthys olivaceus OX=8255 GN=tmbim6 PE=2 SV=1,,,,,,
OG_06609,0.5630408788930417,OG_06609,FUN_029759-T1,Peve_00019499,Pocillopora_meandrina_HIv1___RNAseq.g17321.t1,three_way,95.305,FUN_029759-T1,Q9QYK7,RNF11_MOUSE,,RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669),Mus musculus (Mouse),62.2,156.0,3.2e-45,182.6,sp|Q9QYK7|RNF11_MOUSE RING finger protein 11 OS=Mus musculus OX=10090 GN=Rnf11 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0008270; GO:0051865; GO:0055037; GO:0061630,protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_04435,0.5628974872932169,OG_04435,FUN_018802-T1,Peve_00013887,Pocillopora_meandrina_HIv1___RNAseq.g9880.t1,three_way,68.601,,,,,,,,,,,,,,,,,
OG_04633,0.5626251991538889,OG_04633,FUN_022346-T1,Peve_00018538,Pocillopora_meandrina_HIv1___RNAseq.g4661.t1,three_way,98.06033333333332,FUN_022346-T1,Q3T057,RL23_BOVIN,,Large ribosomal subunit protein uL14 (60S ribosomal protein L23),Bos taurus (Bovine),92.1,139.0,2.0999999999999997e-68,259.6,sp|Q3T057|RL23_BOVIN Large ribosomal subunit protein uL14 OS=Bos taurus OX=9913 GN=RPL23 PE=2 SV=2,GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0045202; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1990948; GO:2000059,cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005198; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0098772,RNA binding; structural molecule activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_04221,0.5624946399178868,OG_04221,FUN_016981-T1,Peve_00025289,Pocillopora_meandrina_HIv1___RNAseq.g9901.t1,three_way,58.73716666666667,FUN_016981-T1,P70585,,,,,28.4,278.0,1.3e-21,105.9,sp|P70585|GPR19_RAT Probable G-protein coupled receptor 19 OS=Rattus norvegicus OX=10116 GN=Gpr19 PE=2 SV=2,,,,,,
OG_04370,0.5623253614064162,OG_04370,FUN_018029-T1,Peve_00017615,Pocillopora_meandrina_HIv1___RNAseq.g25340.t1,three_way,59.88433333333333,FUN_018029-T1,Q9ULJ8,,,,,25.1,1213.0,1.4999999999999999e-40,170.2,sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2,,,,,,
OG_00581,0.5622937501758591,OG_00581,FUN_001654-T1,Peve_00038365,Pocillopora_meandrina_HIv1___RNAseq.g29407.t1,three_way,87.83066666666666,FUN_001654-T1,Q4R7Y4,GBLP_MACFA,,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),83.1,313.0,2.1e-132,473.4,sp|Q4R7Y4|GBLP_MACFA Small ribosomal subunit protein RACK1 OS=Macaca fascicularis OX=9541 GN=GNB2L1 PE=2 SV=3,GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006915; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0045182; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:1990904; GO:2000114; GO:2000543,apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; translation regulator activity [GO:0045182],GO:0005634; GO:0005840; GO:0012501; GO:0043226; GO:0045182; GO:0098772,nucleus; ribosome; programmed cell death; organelle; translation regulator activity; molecular function regulator activity
OG_05670,0.562230444585984,OG_05670,FUN_025463-T1,Peve_00043840,Pocillopora_meandrina_HIv1___RNAseq.g13243.t1,three_way,97.54233333333332,FUN_025463-T1,Q5E9F9,PRS7_BOVIN,,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Bos taurus (Bovine),92.2,434.0,7.399999999999999e-234,810.8,sp|Q5E9F9|PRS7_BOVIN 26S proteasome regulatory subunit 7 OS=Bos taurus OX=9913 GN=PSMC2 PE=2 SV=3,GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140657,catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; protein catabolic process; organelle; ATP-dependent activity
OG_05639,0.5620935708316547,OG_05639,FUN_025343-T1,Peve_00027051,Pocillopora_meandrina_HIv1___RNAseq.g13379.t1,three_way,83.50133333333333,FUN_025343-T1,P13732,,,,,66.7,93.0,9.900000000000001e-30,130.6,sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1,,,,,,
OG_07355,0.5620643179970436,OG_07355,FUN_033763-T1,Peve_00009255,Pocillopora_meandrina_HIv1___RNAseq.g28734.t1,three_way,65.53633333333333,FUN_033763-T1,Q6NRZ1,,,,,29.8,1444.0,1.4e-132,476.1,sp|Q6NRZ1|BLT3B_XENLA Bridge-like lipid transfer protein family member 3B OS=Xenopus laevis OX=8355 GN=bltp3b PE=2 SV=1,,,,,,
OG_06691,0.5620495730850286,OG_06691,FUN_031236-T1,Peve_00043063,Pocillopora_meandrina_HIv1___RNAseq.g5195.t1,three_way,57.85166666666667,FUN_031236-T1,Q8NA75,,,,,33.1,278.0,1.8999999999999998e-39,164.9,sp|Q8NA75|DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 OS=Homo sapiens OX=9606 GN=DCAF4L2 PE=1 SV=1,,,,,,
OG_01678,0.5614680693777793,OG_01678,FUN_006886-T1,Peve_00009910,Pocillopora_meandrina_HIv1___RNAseq.g19832.t3,three_way,80.65033333333334,FUN_006886-T1,A2CI35,,,,,46.3,934.0,7.7e-244,845.1,sp|A2CI35|DUSTY_STRPU Dual serine/threonine and tyrosine protein kinase OS=Strongylocentrotus purpuratus OX=7668 GN=DSTYK PE=2 SV=1,,,,,,
OG_04244,0.5612946534506535,OG_04244,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_08033,0.561288994161246,OG_08033,FUN_035693-T1,Peve_00041290,Pocillopora_meandrina_HIv1___RNAseq.g11812.t1,three_way,82.895,FUN_035693-T1,Q6NYL5,ALAT2_DANRE,,Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),Danio rerio (Zebrafish) (Brachydanio rerio),57.9,487.0,4.2000000000000006e-164,579.3,sp|Q6NYL5|ALAT2_DANRE Alanine aminotransferase 2-like OS=Danio rerio OX=7955 GN=gpt2l PE=2 SV=2,GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_03941,0.561200376473738,OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_06809,0.5611881883647173,OG_06809,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_04003,0.5609872848519073,OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_05133,0.5608208195980862,OG_05133,FUN_023402-T1,Peve_00038654,Pocillopora_meandrina_HIv1___RNAseq.g17559.t1,three_way,90.449,FUN_023402-T1,Q3ZCH0,HSPA9_BOVIN,,"Stress-70 protein, mitochondrial (EC 3.6.4.10) (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)",Bos taurus (Bovine),78.8,660.0,3.6e-295,1015.4,"sp|Q3ZCH0|HSPA9_BOVIN Stress-70 protein, mitochondrial OS=Bos taurus OX=9913 GN=HSPA9 PE=2 SV=1",GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0036444; GO:0042026; GO:0042645; GO:0043065; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0140662; GO:1902037; GO:1903707,calcium import into the mitochondrion [GO:0036444]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of apoptotic process [GO:0043065]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005730; GO:0005739; GO:0006457; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0044183; GO:0055085; GO:0140657,catalytic activity; nucleolus; mitochondrion; protein folding; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; protein folding chaperone; transmembrane transport; ATP-dependent activity
OG_00033,0.5605460980871971,OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_00584,0.5605332967984309,OG_00584,FUN_001657-T1,Peve_00038362,Pocillopora_meandrina_HIv1___RNAseq.g29404.t1,three_way,76.9125,FUN_001657-T1,Q5ZK05,,,,,53.3,276.0,1e-67,258.5,sp|Q5ZK05|TOLIP_CHICK Toll-interacting protein OS=Gallus gallus OX=9031 GN=TOLLIP PE=2 SV=1,,,,,,
OG_05852,0.5602810178931888,OG_05852,FUN_025925-T1,Peve_00034317,Pocillopora_meandrina_HIv1___RNAseq.g10524.t1,three_way,79.89450000000001,FUN_025925-T1,A6IPG1,,,,,66.2,225.0,7.6e-65,248.4,sp|A6IPG1|EF1B_RAT Elongation factor 1-beta OS=Rattus norvegicus OX=10116 GN=Eef1b2 PE=1 SV=1,,,,,,
OG_03708,0.5599443484035009,OG_03708,FUN_014981-T1,Peve_00039942,Pocillopora_meandrina_HIv1___TS.g25894.t1,three_way,81.89766666666667,FUN_014981-T1,Q8CCN5,BCAS3_MOUSE,,BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3 homolog) (K20D4) (Protein rudhira),Mus musculus (Mouse),47.1,768.0,1.1e-178,628.6,sp|Q8CCN5|BCAS3_MOUSE BCAS3 microtubule associated cell migration factor OS=Mus musculus OX=10090 GN=Bcas3 PE=1 SV=2,GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0031252; GO:0032956; GO:0035091; GO:0043085; GO:0045111; GO:0045944; GO:0048487; GO:0071391; GO:0071944,angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956],cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407],beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; phosphatidylinositol binding [GO:0035091],GO:0005634; GO:0005856; GO:0006355; GO:0006914; GO:0008092; GO:0008289; GO:0023052; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; autophagy; cytoskeletal protein binding; lipid binding; signaling; organelle
OG_00071,0.5597944780298156,OG_00071,FUN_000393-T1,Peve_00033591,Pocillopora_meandrina_HIv1___RNAseq.g2528.t1,three_way,82.34016666666666,FUN_000393-T1,P08429,,,,,65.9,349.0,9.9e-131,468.0,sp|P08429|RL4A_XENLA Large ribosomal subunit protein uL4A OS=Xenopus laevis OX=8355 GN=rpl4-a PE=2 SV=2,,,,,,
OG_03805,0.5593753474793087,OG_03805,FUN_015192-T1,Peve_00013032,Pocillopora_meandrina_HIv1___RNAseq.g22303.t1,three_way,69.30916666666666,FUN_015192-T1,Q8WY54,PPM1E_HUMAN,,Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA),Homo sapiens (Human),52.3,367.0,7.700000000000001e-98,359.0,sp|Q8WY54|PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens OX=9606 GN=PPM1E PE=1 SV=3,GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006469; GO:0007165; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071222; GO:0071466,cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02649,0.5589252324727157,OG_02649,FUN_010831-T1,Peve_00017536,Pocillopora_meandrina_HIv1___RNAseq.g20914.t1,three_way,75.07333333333334,FUN_010831-T1,P09057,DCOR_RAT,,Ornithine decarboxylase (ODC) (EC 4.1.1.17),Rattus norvegicus (Rat),53.1,409.0,6.7e-132,472.2,sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1,GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471,"cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016829; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; lyase activity; anatomical structure development
OG_01646,0.5588483441632798,OG_01646,FUN_006798-T1,Peve_00019182,Pocillopora_meandrina_HIv1___RNAseq.g20494.t1,three_way,82.02783333333333,FUN_006798-T1,Q32NR4,,,,,44.1,256.0,4.7000000000000004e-57,223.8,sp|Q32NR4|TTC29_XENLA Tetratricopeptide repeat protein 29 OS=Xenopus laevis OX=8355 GN=ttc29 PE=2 SV=1,,,,,,
OG_08816,0.5584047871626876,OG_08816,FUN_038143-T1,Peve_00026425,Pocillopora_meandrina_HIv1___RNAseq.g754.t1,three_way,89.606,FUN_038143-T1,Q96AX2,RAB37_HUMAN,,Ras-related protein Rab-37 (EC 3.6.5.2),Homo sapiens (Human),68.2,201.0,5.6e-78,292.0,sp|Q96AX2|RAB37_HUMAN Ras-related protein Rab-37 OS=Homo sapiens OX=9606 GN=RAB37 PE=1 SV=3,GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0005886; GO:0010508; GO:0015031; GO:0017157; GO:0032391; GO:0035577; GO:0035579; GO:0042478,positive regulation of autophagy [GO:0010508]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of eye photoreceptor cell development [GO:0042478],azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00102,0.5580957216468387,OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_06086,0.5580066526039186,OG_06086,FUN_027084-T1,Peve_00013218,Pocillopora_meandrina_HIv1___RNAseq.g2808.t1,three_way,82.44433333333333,FUN_027084-T1,Q3ZBR6,,,,,77.6,49.0,1.5e-13,77.0,sp|Q3ZBR6|SEM1_BOVIN 26S proteasome complex subunit SEM1 OS=Bos taurus OX=9913 GN=SEM1 PE=3 SV=1,,,,,,
OG_04671,0.5576412843494613,OG_04671,FUN_022429-T1,Peve_00037610,Pocillopora_meandrina_HIv1___TS.g21752.t1,three_way,84.66583333333334,FUN_022429-T1,Q5ZLT7,,,,,58.7,421.0,3.5e-135,483.0,sp|Q5ZLT7|5MP2_CHICK eIF5-mimic protein 2 OS=Gallus gallus OX=9031 GN=BZW1 PE=2 SV=1,,,,,,
OG_08323,0.5575148160741491,OG_08323,FUN_036750-T1,Peve_00036101,Pocillopora_meandrina_HIv1___RNAseq.g12086.t1,three_way,56.69133333333333,FUN_036750-T1,Q4R537,,,,,38.1,433.0,1.6000000000000001e-71,271.6,sp|Q4R537|NOB1_MACFA RNA-binding protein NOB1 OS=Macaca fascicularis OX=9541 GN=NOB1 PE=2 SV=1,,,,,,
OG_03447,0.5574581919742059,OG_03447,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_08313,0.5573687909530863,OG_08313,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_00204,0.5570437095716864,OG_00204,FUN_000920-T1,Peve_00044963,Pocillopora_meandrina_HIv1___TS.g6665.t2,three_way,57.738166666666665,,,,,,,,,,,,,,,,,
OG_02011,0.5565182877731629,OG_02011,FUN_008183-T1,Peve_00018748,Pocillopora_meandrina_HIv1___RNAseq.g29991.t1,three_way,78.25766666666667,FUN_008183-T1,K4CJJ1,,,,,26.0,481.0,5.5e-26,120.6,"sp|K4CJJ1|NCED2_SOLLC 9-cis-epoxycarotenoid dioxygenase NCED2, chloroplastic OS=Solanum lycopersicum OX=4081 GN=NCED2 PE=2 SV=1",,,,,,
OG_09293,0.5558879113361043,OG_09293,FUN_040138-T1,Peve_00038115,Pocillopora_meandrina_HIv1___RNAseq.g8515.t1,three_way,76.93733333333334,FUN_040138-T1,Q5NVI9,DNJA1_PONAB,,DnaJ homolog subfamily A member 1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),56.7,404.0,5.1e-128,459.1,sp|Q5NVI9|DNJA1_PONAB DnaJ homolog subfamily A member 1 OS=Pongo abelii OX=9601 GN=DNAJA1 PE=2 SV=1,GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585,negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0043226; GO:0098772,nucleus; mitochondrion; endoplasmic reticulum; protein folding; organelle; molecular function regulator activity
OG_01240,0.5558260326446424,OG_01240,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_09543,0.5557282062863768,OG_09543,FUN_041638-T1,Peve_00040173,Pocillopora_meandrina_HIv1___RNAseq.g14218.t1,three_way,75.633,FUN_041638-T1,Q6P4S6,SIK3_MOUSE,,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),Mus musculus (Mouse),44.5,643.0,6.7e-122,440.3,sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus OX=10090 GN=Sik3 PE=1 SV=4,GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0048705; GO:0060351; GO:0106310; GO:1904263; GO:1904515,cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; limb morphogenesis [GO:0035108]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],cytoplasm [GO:0005737],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04907,0.5557210763717862,OG_04907,FUN_022957-T1,Peve_00001411,Pocillopora_meandrina_HIv1___RNAseq.g3772.t1,three_way,78.32566666666666,FUN_022957-T1,Q28BS5,,,,,41.9,148.0,1.9e-25,117.9,sp|Q28BS5|FOXF1_XENTR Forkhead box protein F1 OS=Xenopus tropicalis OX=8364 GN=foxf1 PE=2 SV=1,,,,,,
OG_06383,0.5554401110457516,OG_06383,FUN_029007-T1,Peve_00025770,Pocillopora_meandrina_HIv1___RNAseq.g25642.t1,three_way,63.09433333333333,FUN_029007-T1,Q8N4T0,CBPA6_HUMAN,,Carboxypeptidase A6 (EC 3.4.17.-),Homo sapiens (Human),33.4,404.0,1.7e-60,235.0,sp|Q8N4T0|CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens OX=9606 GN=CPA6 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270,proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_05553,0.555123744118456,OG_05553,FUN_024761-T1,Peve_00025825,Pocillopora_meandrina_HIv1___RNAseq.g18823.t1,three_way,89.74166666666666,FUN_024761-T1,P49459,UBE2A_HUMAN,,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),Homo sapiens (Human),94.0,149.0,1.8e-78,293.1,sp|P49459|UBE2A_HUMAN Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens OX=9606 GN=UBE2A PE=1 SV=2,GO:0000086; GO:0000209; GO:0000785; GO:0004842; GO:0005524; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006281; GO:0006301; GO:0006338; GO:0006511; GO:0009411; GO:0031625; GO:0033503; GO:0043130; GO:0043161; GO:0061631; GO:0070936; GO:0070979; GO:1901526,chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of mitophagy [GO:1901526]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; lysosome; endosome; vacuole; cytosol; DNA repair; chromatin organization; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_04880,0.5550302397879603,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_02375,0.5549648866089752,OG_02375,FUN_008985-T1,Peve_00034872,Pocillopora_meandrina_HIv1___RNAseq.g3902.t1,three_way,86.08683333333333,FUN_008985-T1,O35491,CLK2_MOUSE,,Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2),Mus musculus (Mouse),68.3,338.0,2.4e-142,506.9,sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus OX=10090 GN=Clk2 PE=1 SV=2,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0006468; GO:0010212; GO:0016607; GO:0032526; GO:0043484; GO:0045721; GO:0046777; GO:0106310,negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01981,0.5549528450428356,OG_01981,FUN_008088-T1,Peve_00033650,Pocillopora_meandrina_HIv1___RNAseq.g30114.t1,three_way,54.91016666666667,FUN_008088-T1,B3EWY9,,,,,96.6,1521.0,0.0,2828.9,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02823,0.554645176163865,OG_02823,FUN_011811-T1,Peve_00020920,Pocillopora_meandrina_HIv1___RNAseq.g23236.t1,three_way,76.99633333333334,FUN_011811-T1,Q8SZA8,,,,,54.0,126.0,2.3e-29,130.2,"sp|Q8SZA8|ADXH2_DROME Adrenodoxin-like protein 2, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx2 PE=2 SV=1",,,,,,
OG_01949,0.554524208158328,OG_01949,FUN_008006-T1,Peve_00011919,Pocillopora_meandrina_HIv1___RNAseq.g30330.t1,three_way,59.504,FUN_008006-T1,P31684,,,,,42.4,535.0,1.4999999999999999e-116,422.5,sp|P31684|4CL1_SOLTU 4-coumarate--CoA ligase 1 OS=Solanum tuberosum OX=4113 GN=4CL1 PE=3 SV=1,,,,,,
OG_05690,0.554338604354343,OG_05690,FUN_025541-T1,Peve_00032959,Pocillopora_meandrina_HIv1___RNAseq.g13799.t1,three_way,49.872166666666665,,,,,,,,,,,,,,,,,
OG_02267,0.5543364422466547,OG_02267,FUN_008716-T1,Peve_00034975,Pocillopora_meandrina_HIv1___RNAseq.g74.t1,three_way,91.29516666666667,FUN_008716-T1,P16036,,,,,73.7,354.0,1.1e-145,517.7,sp|P16036|S25A3_RAT Solute carrier family 25 member 3 OS=Rattus norvegicus OX=10116 GN=Slc25a3 PE=1 SV=1,,,,,,
OG_06430,0.554270557627047,OG_06430,FUN_029123-T1,Peve_00016284,Pocillopora_meandrina_HIv1___RNAseq.g25776.t1,three_way,95.471,FUN_029123-T1,P62833,RAP1A_BOVIN,,Ras-related protein Rap-1A (EC 3.6.5.2) (GTP-binding protein smg p21A),Bos taurus (Bovine),89.1,184.0,7.299999999999999e-90,331.3,sp|P62833|RAP1A_BOVIN Ras-related protein Rap-1A OS=Bos taurus OX=9913 GN=RAP1A PE=1 SV=1,GO:0003924; GO:0003925; GO:0005085; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0007399; GO:0010976; GO:0016079; GO:0019003; GO:0030054; GO:0031267; GO:0032045; GO:0032486; GO:0038180; GO:0043005; GO:0043547; GO:0044877; GO:0045860; GO:0048471; GO:0061028; GO:0070161; GO:0070374; GO:0071320; GO:0072659; GO:0097225; GO:0098696; GO:0098793; GO:0098978; GO:1901888; GO:1990090; GO:2000301; GO:2001214,cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; synaptic vesicle exocytosis [GO:0016079],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sperm midpiece [GO:0097225],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane; molecular function regulator activity
OG_05177,0.5541821799308144,OG_05177,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_00390,0.5540060505989209,OG_00390,FUN_001246-T1,Peve_00037027,Pocillopora_meandrina_HIv1___RNAseq.g2298.t1,three_way,69.81466666666667,FUN_001246-T1,Q7LL04,,,,,34.3,297.0,3.9e-30,133.7,sp|Q7LL04|YQK1_SCHPO UPF0676 protein C1494.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1494.01 PE=3 SV=2,,,,,,
OG_04220,0.5539753779053445,OG_04220,FUN_016979-T1,Peve_00025290,Pocillopora_meandrina_HIv1___RNAseq.g9902.t2,three_way,75.31333333333333,FUN_016979-T1,G3UYX5,,,,,20.5,1227.0,1.4e-16,90.5,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_02762,0.5534521939362661,OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_07477,0.5534289568651929,OG_07477,FUN_033999-T1,Peve_00044495,Pocillopora_meandrina_HIv1___RNAseq.g9828.t1,three_way,84.30799999999999,FUN_033999-T1,Q9F234,,,,,29.2,854.0,2.3e-86,322.0,sp|Q9F234|AGL2_BACTQ Alpha-glucosidase 2 OS=Bacillus thermoamyloliquefaciens OX=1425 PE=3 SV=1,,,,,,
OG_03674,0.5534242078324291,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_03697,0.5533025154259612,OG_03697,FUN_014966-T1,Peve_00006260,Pocillopora_meandrina_HIv1___RNAseq.g21130.t1c,three_way,72.1375,FUN_014966-T1,Q96FN5,,,,,39.6,493.0,3.2e-84,314.7,sp|Q96FN5|KIF12_HUMAN Kinesin-like protein KIF12 OS=Homo sapiens OX=9606 GN=KIF12 PE=1 SV=3,,,,,,
OG_06713,0.5531545711233276,OG_06713,FUN_031306-T1,Peve_00026515,Pocillopora_meandrina_HIv1___RNAseq.11376_t,three_way,53.790333333333336,,,,,,,,,,,,,,,,,
OG_09721,0.5527018046901507,OG_09721,FUN_041967-T1,Peve_00033991,Pocillopora_meandrina_HIv1___RNAseq.g15917.t1,three_way,83.85133333333333,FUN_041967-T1,Q03123,,,,,46.5,260.0,5.2e-54,212.6,sp|Q03123|T2FB_XENLA General transcription factor IIF subunit 2 OS=Xenopus laevis OX=8355 GN=gtf2f2 PE=2 SV=1,,,,,,
OG_05774,0.5519872836150717,OG_05774,FUN_025737-T1,Peve_00008541,Pocillopora_meandrina_HIv1___RNAseq.g10429.t1,three_way,55.18066666666667,FUN_025737-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),33.6,125.0,8.9e-12,73.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_01760,0.5514065437106518,OG_01760,FUN_007115-T1,Peve_00017834,Pocillopora_meandrina_HIv1___TS.g28404.t1,three_way,70.838,FUN_007115-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),30.5,1384.0,1.1000000000000001e-164,582.8,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_05797,0.5512495627114441,OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_09540,0.5511195373441994,OG_09540,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02476,0.5510182272098274,OG_02476,FUN_009764-T1,Peve_00002102,Pocillopora_meandrina_HIv1___RNAseq.g24565.t1b,three_way,82.993,FUN_009764-T1,Q9USM7,,,,,42.9,168.0,3e-25,116.7,sp|Q9USM7|TIM23_SCHPO Mitochondrial import inner membrane translocase subunit tim23 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=tim23 PE=3 SV=1,,,,,,
OG_06743,0.5509014626059692,OG_06743,FUN_031549-T1,Peve_00022771,Pocillopora_meandrina_HIv1___RNAseq.g5142.t1,three_way,79.50266666666667,FUN_031549-T1,Q5F480,ITPK1_CHICK,,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",Gallus gallus (Chicken),42.8,320.0,4.6e-77,289.7,sp|Q5F480|ITPK1_CHICK Inositol-tetrakisphosphate 1-kinase OS=Gallus gallus OX=9031 GN=ITPK1 PE=2 SV=1,GO:0000287; GO:0000825; GO:0005524; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266,inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266],,"ATP binding [GO:0005524]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0012501; GO:0016740; GO:0016853,catalytic activity; programmed cell death; transferase activity; isomerase activity
OG_02104,0.5507099200836288,OG_02104,FUN_008383-T1,Peve_00005318,Pocillopora_meandrina_HIv1___TS.g24875.t1b,three_way,94.05366666666669,FUN_008383-T1,Q15436,SC23A_HUMAN,,Protein transport protein Sec23A (hSec23A) (SEC23-related protein A),Homo sapiens (Human),74.7,775.0,0.0,1215.3,sp|Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,GO:0000139; GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005783; GO:0005829; GO:0006886; GO:0043226; GO:0072659; GO:0098772,endoplasmic reticulum; cytosol; intracellular protein transport; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_05672,0.5506978566727994,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_02541,0.5504162685081047,OG_02541,FUN_010624-T1,Peve_00004472,Pocillopora_meandrina_HIv1___TS.g26046.t2,three_way,68.38433333333333,FUN_010624-T1,Q6NSQ7,,,,,44.8,415.0,2.5000000000000003e-78,294.3,sp|Q6NSQ7|LTV1_MOUSE Protein LTV1 homolog OS=Mus musculus OX=10090 GN=Ltv1 PE=1 SV=2,,,,,,
OG_08335,0.5502865152096966,OG_08335,FUN_036831-T1,Peve_00006966,Pocillopora_meandrina_HIv1___RNAseq.g10632.t1,three_way,76.47966666666666,FUN_036831-T1,O95470,SGPL1_HUMAN,,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),Homo sapiens (Human),52.1,94.0,7.9e-25,114.4,sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3,GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190,androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117],GO:0003824; GO:0005783; GO:0006629; GO:0016829; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870,catalytic activity; endoplasmic reticulum; lipid metabolic process; lyase activity; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility
OG_09093,0.550193742694669,OG_09093,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.699999999999999e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_09791,0.5501132705703826,OG_09791,FUN_042593-T1,Peve_00008128,Pocillopora_meandrina_HIv1___RNAseq.g16867.t1,three_way,79.72,FUN_042593-T1,Q80TC6,,,,,50.6,1158.0,2.7e-309,1062.8,sp|Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Zswim5 PE=2 SV=2,,,,,,
OG_04165,0.5499020538878205,OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_03722,0.5498906218852729,OG_03722,FUN_015007-T1,Peve_00034683,Pocillopora_meandrina_HIv1___RNAseq.g21247.t1,three_way,90.045,FUN_015007-T1,A6NIH7,U119B_HUMAN,,Protein unc-119 homolog B,Homo sapiens (Human),68.4,193.0,2.3000000000000002e-74,280.0,sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271,cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytosol; cilium; lipid binding; organelle; cilium organization; anatomical structure development
OG_08517,0.5498730302055052,OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.1999999999999995e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_02793,0.5497258013255204,OG_02793,FUN_011755-T1,Peve_00015652,Pocillopora_meandrina_HIv1___RNAseq.g23894.t1,three_way,85.19933333333333,FUN_011755-T1,Q6NXD2,CHM2B_DANRE,,Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b),Danio rerio (Zebrafish) (Brachydanio rerio),43.1,153.0,2.3e-07,57.4,sp|Q6NXD2|CHM2B_DANRE Charged multivesicular body protein 2b OS=Danio rerio OX=7955 GN=chmp2b PE=2 SV=1,GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324,endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01700,0.5496556323683054,OG_01700,FUN_006943-T1,Peve_00014293,Pocillopora_meandrina_HIv1___RNAseq.g20147.t1,three_way,84.57433333333333,FUN_006943-T1,Q5RCK6,SYT10_PONAB,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.1,257.0,5.3999999999999985e-25,116.7,sp|Q5RCK6|SYT10_PONAB Synaptotagmin-10 OS=Pongo abelii OX=9601 GN=SYT10 PE=2 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978,calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process
OG_07474,0.5492569086297663,OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02006,0.5490235387659664,OG_02006,FUN_008121-T1,Peve_00022347,Pocillopora_meandrina_HIv1___RNAseq.g17884.t1,three_way,60.455666666666666,FUN_008121-T1,Q5TCY1,TTBK1_HUMAN,,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),Homo sapiens (Human),65.9,308.0,9.2e-116,419.9,sp|Q5TCY1|TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens OX=9606 GN=TTBK1 PE=1 SV=2,GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980,learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_09646,0.5480009340261317,OG_09646,FUN_041841-T1,Peve_00009641,Pocillopora_meandrina_HIv1___RNAseq.g15079.t1,three_way,63.284666666666666,,,,,,,,,,,,,,,,,
OG_04464,0.5479233769338744,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05430,0.547537833261783,OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_06689,0.5475062592644235,OG_06689,FUN_031221-T1,Peve_00043066,Pocillopora_meandrina_HIv1___RNAseq.g5197.t1,three_way,64.83466666666666,FUN_031221-T1,P51901,,,,,29.0,635.0,6.1e-63,245.0,sp|P51901|ANXA6_CHICK Annexin A6 OS=Gallus gallus OX=9031 GN=ANXA6 PE=2 SV=1,,,,,,
OG_04746,0.547336716622568,OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03291,0.5472985023211581,OG_03291,FUN_013350-T1,Peve_00041996,Pocillopora_meandrina_HIv1___TS.g2168.t1a,three_way,66.735,FUN_013350-T1,Q8CBF3,EPHB1_MOUSE,,Ephrin type-B receptor 1 (EC 2.7.10.1),Mus musculus (Mouse),38.3,975.0,3.2e-176,620.5,sp|Q8CBF3|EPHB1_MOUSE Ephrin type-B receptor 1 OS=Mus musculus OX=10090 GN=Ephb1 PE=1 SV=1,GO:0001525; GO:0001771; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1902723; GO:1902725,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005],GO:0003824; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007163; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04001,0.5471389785529133,OG_04001,FUN_016296-T1,Peve_00043168,Pocillopora_meandrina_HIv1___RNAseq.g503.t1,three_way,73.475,FUN_016296-T1,Q99758,ABCA3_HUMAN,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Homo sapiens (Human),35.3,1952.0,2.1e-296,1020.8,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005615; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; extracellular space; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_05480,0.5468475965943563,OG_05480,FUN_024476-T1,Peve_00002831,Pocillopora_meandrina_HIv1___RNAseq.g18568.t1,three_way,62.83433333333333,FUN_024476-T1,Q6NRD3,SH3R1_XENLA,,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (xPOSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1),Xenopus laevis (African clawed frog),39.7,514.0,1.3e-79,298.9,sp|Q6NRD3|SH3R1_XENLA E3 ubiquitin-protein ligase SH3RF1 OS=Xenopus laevis OX=8355 GN=sh3rf1 PE=1 SV=1,GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564,"negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471],MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0016740; GO:0043226; GO:0048870; GO:0060090; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; transferase activity; organelle; cell motility; molecular adaptor activity; catalytic activity, acting on a protein"
OG_10031,0.5467586724133722,OG_10031,FUN_043286-T1,Peve_00007448,Pocillopora_meandrina_HIv1___RNAseq.g8869.t1,three_way,90.06933333333333,FUN_043286-T1,Q5ZKN1,CDK9_CHICK,,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9),Gallus gallus (Chicken),71.5,375.0,2.3e-151,536.6,sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187,positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]; P-TEFb complex [GO:0070691],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06443,0.5466124402521029,OG_06443,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_00146,0.5465261325508429,OG_00146,FUN_000591-T1,Peve_00025321,Pocillopora_meandrina_HIv1___RNAseq.g29291.t1,three_way,71.13566666666667,,,,,,,,,,,,,,,,,
OG_05138,0.5460990278873481,OG_05138,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_09390,0.5456521229638774,OG_09390,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_02254,0.5454977616176752,OG_02254,FUN_008700-T1,Peve_00025639,Pocillopora_meandrina_HIv1___RNAseq.g12731.t1,three_way,66.20166666666667,,,,,,,,,,,,,,,,,
OG_05567,0.5453079692430134,OG_05567,FUN_024797-T1,Peve_00026090,Pocillopora_meandrina_HIv1___RNAseq.g18789.t1,three_way,78.34133333333334,FUN_024797-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),32.6,482.0,4.4e-71,270.4,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_08879,0.5452957556819995,OG_08879,FUN_038279-T1,Peve_00041709,Pocillopora_meandrina_HIv1___RNAseq.g28314.t1,three_way,89.11583333333333,FUN_038279-T1,Q4G0X9,CCD40_HUMAN,,Coiled-coil domain-containing protein 40,Homo sapiens (Human),30.7,969.0,3.8e-100,367.9,sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2,GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910,axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514],,GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003,extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly
OG_03068,0.5450625472361315,OG_03068,FUN_012338-T1,Peve_00021550,Pocillopora_meandrina_HIv1___RNAseq.g24073.t1,three_way,51.0305,,,,,,,,,,,,,,,,,
OG_06984,0.5449660639715799,OG_06984,FUN_032123-T1,Peve_00040721,Pocillopora_meandrina_HIv1___RNAseq.g5374.t1,three_way,85.32833333333333,FUN_032123-T1,Q8K4B0,MTA1_MOUSE,,Metastasis-associated protein MTA1,Mus musculus (Mouse),52.5,571.0,1e-152,542.3,sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1,GO:0000978; GO:0003682; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:1902499; GO:2000736,"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]",cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581],chromatin binding [GO:0003682]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nuclear envelope; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_03854,0.5449121976726009,OG_03854,FUN_015346-T1,Peve_00017513,Pocillopora_meandrina_HIv1___RNAseq.g21715.t1,three_way,54.33833333333333,,,,,,,,,,,,,,,,,
OG_08922,0.5446959901533119,OG_08922,FUN_038378-T1,Peve_00000075,Pocillopora_meandrina_HIv1___TS.g5619.t2,three_way,74.34866666666667,FUN_038378-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),55.8,190.0,7.6e-51,202.2,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_00129,0.5444147710039741,OG_00129,FUN_000556-T1,Peve_00039813,Pocillopora_meandrina_HIv1___RNAseq.g2463.t1,three_way,76.964,FUN_000556-T1,P47747,,,,,27.6,322.0,1.8e-17,91.7,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_09247,0.5443878734776186,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02893,0.5442606213482079,OG_02893,FUN_011950-T1,Peve_00016916,Pocillopora_meandrina_HIv1___RNAseq.g24086.t1,three_way,85.28399999999999,FUN_011950-T1,Q5XIV0,,,,,62.7,327.0,7.4e-113,408.7,sp|Q5XIV0|TET5C_RAT Terminal nucleotidyltransferase 5C OS=Rattus norvegicus OX=10116 GN=Tent5c PE=2 SV=1,,,,,,
OG_02323,0.544236157229233,OG_02323,FUN_008915-T1,Peve_00033002,Pocillopora_meandrina_HIv1___RNAseq.g3980.t1,three_way,93.944,FUN_008915-T1,P58375,,,,,80.4,112.0,2.2e-45,183.0,sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1,,,,,,
OG_05387,0.5442011542928081,OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_04910,0.5438060274696271,OG_04910,FUN_022960-T1,Peve_00011908,Pocillopora_meandrina_HIv1___RNAseq.g3769.t1a,three_way,65.96483333333333,FUN_022960-T1,P41596,,,,,28.2,358.0,1.7e-21,105.5,sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2,,,,,,
OG_01730,0.5437787937685963,OG_01730,FUN_007024-T1,Peve_00032896,Pocillopora_meandrina_HIv1___RNAseq.g20020.t1,three_way,90.27,FUN_007024-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),66.6,308.0,3.2e-110,399.8,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_07366,0.5434011325005447,OG_07366,FUN_033778-T1,Peve_00025001,Pocillopora_meandrina_HIv1___RNAseq.g26651.t1,three_way,74.63816666666666,FUN_033778-T1,O00327,BMAL1_HUMAN,,Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3),Homo sapiens (Human),43.1,634.0,9.999999999999999e-123,442.2,sp|O00327|BMAL1_HUMAN Basic helix-loop-helix ARNT-like protein 1 OS=Homo sapiens OX=9606 GN=BMAL1 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0097009; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283],aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],"aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_02952,0.5433583166692503,OG_02952,FUN_012072-T1,Peve_00025864,Pocillopora_meandrina_HIv1___RNAseq.g23632.t1,three_way,87.756,FUN_012072-T1,Q32L77,CFA95_BOVIN,,Cilia- and flagella-associated protein 95,Bos taurus (Bovine),41.5,200.0,4.3e-36,152.9,sp|Q32L77|CFA95_BOVIN Cilia- and flagella-associated protein 95 OS=Bos taurus OX=9913 GN=CFAP95 PE=1 SV=1,GO:0005737; GO:0005879; GO:0005886; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126],,GO:0005886; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,plasma membrane; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_08271,0.5432440266207074,OG_08271,FUN_036183-T1,Peve_00015587,Pocillopora_meandrina_HIv1___RNAseq.g27377.t1,three_way,72.55316666666667,FUN_036183-T1,Q8R422,CD109_MOUSE,,CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109),Mus musculus (Mouse),33.9,1471.0,4.4000000000000005e-193,677.2,sp|Q8R422|CD109_MOUSE CD109 antigen OS=Mus musculus OX=10090 GN=Cd109 PE=1 SV=1,GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_08692,0.5431858515504396,OG_08692,FUN_037936-T1,Peve_00015639,Pocillopora_meandrina_HIv1___RNAseq.g26203.t1,three_way,85.81533333333333,FUN_037936-T1,Q3MHZ2,,,,,40.0,210.0,1.6999999999999999e-35,151.0,sp|Q3MHZ2|SPSB3_BOVIN SPRY domain-containing SOCS box protein 3 OS=Bos taurus OX=9913 GN=SPSB3 PE=2 SV=1,,,,,,
OG_03629,0.5431673910374087,OG_03629,FUN_014846-T1,Peve_00038813,Pocillopora_meandrina_HIv1___RNAseq.g22386.t2,three_way,83.38516666666666,FUN_014846-T1,P97526,NF1_RAT,,Neurofibromin (Neurofibromatosis-related protein NF-1),Rattus norvegicus (Rat),46.1,2783.0,0.0,2161.0,sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1,GO:0000165; GO:0001525; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001935; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006606; GO:0006915; GO:0007154; GO:0007265; GO:0007269; GO:0007405; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008283; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014009; GO:0014010; GO:0014037; GO:0014044; GO:0016477; GO:0016525; GO:0016601; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030316; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033024; GO:0033027; GO:0033028; GO:0033034; GO:0034605; GO:0035021; GO:0036135; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048144; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048708; GO:0048709; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0051402; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070662; GO:0070667; GO:0071549; GO:0071887; GO:0072089; GO:0097192; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1904707; GO:1904738; GO:1904753; GO:1990090; GO:1990874; GO:2000108; GO:2000647; GO:2001241,"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glial cell proliferation [GO:0014009]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid cell apoptotic process [GO:0033028]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]",axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545],GO:0002376; GO:0005634; GO:0005730; GO:0005886; GO:0006886; GO:0006913; GO:0007010; GO:0008092; GO:0008289; GO:0012501; GO:0030154; GO:0030198; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,immune system process; nucleus; nucleolus; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; cytoskeletal protein binding; lipid binding; programmed cell death; cell differentiation; extracellular matrix organization; wound healing; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_02800,0.543103009839845,OG_02800,FUN_011771-T1,Peve_00034384,Pocillopora_meandrina_HIv1___RNAseq.g23368.t2,three_way,81.78533333333334,FUN_011771-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),62.6,171.0,4.5e-53,209.9,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_01154,0.5429329379900919,OG_01154,FUN_004755-T1,Peve_00031387,Pocillopora_meandrina_HIv1___RNAseq.g6700.t1,three_way,84.58933333333333,,,,,,,,,,,,,,,,,
OG_08275,0.542506022219023,OG_08275,FUN_036192-T1,Peve_00011127,Pocillopora_meandrina_HIv1___RNAseq.g27369.t1,three_way,85.32933333333334,FUN_036192-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,536.0,3.7e-101,370.9,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09081,0.5422973810040903,OG_09081,FUN_038811-T1,Peve_00007216,Pocillopora_meandrina_HIv1___RNAseq.g28537.t1,three_way,90.37766666666668,FUN_038811-T1,Q92503,S14L1_HUMAN,,SEC14-like protein 1,Homo sapiens (Human),56.3,712.0,6.1e-230,798.5,sp|Q92503|S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens OX=9606 GN=SEC14L1 PE=1 SV=2,GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039532; GO:0039536; GO:0039552; GO:0045087; GO:0140311,choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of RIG-I signaling pathway [GO:0039536],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654],protein sequestering activity [GO:0140311]; RIG-I binding [GO:0039552],GO:0002376; GO:0005654; GO:0005794; GO:0005829; GO:0043226; GO:0098542; GO:0140313,immune system process; nucleoplasm; Golgi apparatus; cytosol; organelle; defense response to other organism; molecular sequestering activity
OG_06372,0.5422608587092317,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06103,0.5421436906499958,OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_02623,0.5421221208517719,OG_02623,FUN_010772-T1,Peve_00004496,Pocillopora_meandrina_HIv1___RNAseq.g21195.t1,three_way,63.85333333333333,FUN_010772-T1,Q8HZN9,,,,,24.3,276.0,1.8e-09,65.1,sp|Q8HZN9|BKRB1_PIG B1 bradykinin receptor OS=Sus scrofa OX=9823 GN=BDKRB1 PE=3 SV=1,,,,,,
OG_10007,0.5420977150065452,OG_10007,FUN_043242-T1,Peve_00001436,Pocillopora_meandrina_HIv1___RNAseq.g6708.t1,three_way,59.496500000000005,FUN_043242-T1,Q6YHK3,CD109_HUMAN,,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),Homo sapiens (Human),25.8,1416.0,2.8e-104,382.1,sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2,GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular region; extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_03335,0.5420045989737374,OG_03335,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_08673,0.5419355710010163,OG_08673,FUN_037909-T1,Peve_00020691,Pocillopora_meandrina_HIv1___RNAseq.g1145.t1,three_way,93.333,FUN_037909-T1,P48149,,,,,84.6,130.0,6.6e-61,234.6,sp|P48149|RS15A_DROME Small ribosomal subunit protein uS8A OS=Drosophila melanogaster OX=7227 GN=RpS15Aa PE=1 SV=2,,,,,,
OG_00607,0.5417312983226089,OG_00607,FUN_001769-T1,Peve_00035580,Pocillopora_meandrina_HIv1___RNAseq.g2678.t1a,three_way,61.7965,,,,,,,,,,,,,,,,,
OG_02708,0.5415959884073414,OG_02708,FUN_010985-T1,Peve_00013387,Pocillopora_meandrina_HIv1___RNAseq.g22008.t1,three_way,72.90966666666667,FUN_010985-T1,Q96JM7,,,,,33.9,840.0,2.0999999999999998e-129,464.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_07673,0.541262897793197,OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_08346,0.541041318272519,OG_08346,FUN_036879-T1,Peve_00006949,Pocillopora_meandrina_HIv1___RNAseq.g10628.t1,three_way,88.30766666666666,FUN_036879-T1,Q27128,PAPSS_URECA,,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],Urechis caupo (Innkeeper worm) (Spoonworm),71.9,597.0,1.0999999999999999e-265,917.1,sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1,GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],GO:0003824; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04816,0.5409934476323293,OG_04816,FUN_022797-T1,Peve_00024723,Pocillopora_meandrina_HIv1___TS.g9662.t2,three_way,93.94933333333334,FUN_022797-T1,P36876,,,,,76.0,441.0,2.8e-204,712.6,sp|P36876|2ABA_RAT Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Rattus norvegicus OX=10116 GN=Ppp2r2a PE=2 SV=1,,,,,,
OG_00756,0.5405909098485915,OG_00756,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_03328,0.5405356163753207,OG_03328,FUN_013419-T1,Peve_00038577,Pocillopora_meandrina_HIv1___RNAseq.g22950.t1,three_way,58.92666666666667,FUN_013419-T1,P54213,,,,,26.5,162.0,5.9e-10,67.4,sp|P54213|CATR_DUNSA Caltractin OS=Dunaliella salina OX=3046 PE=2 SV=1,,,,,,
OG_08487,0.5404334819665023,OG_08487,FUN_037323-T1,Peve_00006230,Pocillopora_meandrina_HIv1___RNAseq.g10700.t1,three_way,56.69433333333333,FUN_037323-T1,B3LYS5,,,,,43.9,123.0,2e-18,94.7,sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2,,,,,,
OG_08859,0.5403486086398197,OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_05594,0.5402256700479336,OG_05594,FUN_025108-T1,Peve_00038376,Pocillopora_meandrina_HIv1___RNAseq.g19430.t1,three_way,83.12366666666667,FUN_025108-T1,P41252,SYIC_HUMAN,,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",Homo sapiens (Human),62.5,1157.0,0.0,1500.3,"sp|P41252|SYIC_HUMAN Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2",GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062,isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_00373,0.5401020869138176,OG_00373,FUN_001215-T1,Peve_00009931,Pocillopora_meandrina_HIv1___RNAseq.g29508.t1,three_way,74.34766666666667,FUN_001215-T1,O08684,,,,,42.6,975.0,8.6e-222,771.9,sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1,,,,,,
OG_01295,0.5398818511983494,OG_01295,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_08846,0.5394351268073795,OG_08846,FUN_038204-T1,Peve_00006771,Pocillopora_meandrina_HIv1___RNAseq.g930.t1,three_way,91.27933333333333,FUN_038204-T1,P26368,U2AF2_HUMAN,,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),Homo sapiens (Human),67.7,387.0,2.5e-142,506.9,sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,GO:0000243; GO:0000245; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701; GO:0140678,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; spliceosomal complex assembly [GO:0000245]",commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701],C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; molecular function inhibitor activity [GO:0140678]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003; GO:0098772,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02088,0.5393162733254581,OG_02088,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_02394,0.539173029475795,OG_02394,FUN_009022-T1,Peve_00044352,Pocillopora_meandrina_HIv1___RNAseq.g3941.t1,three_way,75.0855,FUN_009022-T1,Q1AAU6,ASAP1_RAT,,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",Rattus norvegicus (Rat),38.6,1193.0,7.400000000000001e-201,702.6,"sp|Q1AAU6|ASAP1_RAT Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Asap1 PE=1 SV=2",GO:0000139; GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0008270; GO:0032588; GO:0043197; GO:0060271; GO:0061000; GO:0061512; GO:0098978; GO:0099175; GO:1903527,cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; podosome [GO:0002102]; trans-Golgi network membrane [GO:0032588],"GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; zinc ion binding [GO:0008270]",GO:0008289; GO:0043226; GO:0044782; GO:0098772,lipid binding; organelle; cilium organization; molecular function regulator activity
OG_00343,0.5390593873517847,OG_00343,FUN_001168-T1,Peve_00015997,Pocillopora_meandrina_HIv1___RNAseq.g29153.t1,three_way,86.27633333333334,FUN_001168-T1,A4IJ21,,,,,52.2,255.0,2.3e-13,78.6,sp|A4IJ21|MNS1_XENTR Meiosis-specific nuclear structural protein 1 OS=Xenopus tropicalis OX=8364 GN=mns1 PE=2 SV=1,,,,,,
OG_07622,0.538825808004325,OG_07622,FUN_034367-T1,Peve_00036158,Pocillopora_meandrina_HIv1___RNAseq.g26130.t1,three_way,71.85166666666667,FUN_034367-T1,Q6IV56,,,,,34.6,243.0,5.799999999999999e-31,136.0,sp|Q6IV56|RN141_DANRE RING finger protein 141 OS=Danio rerio OX=7955 GN=rnf141 PE=2 SV=2,,,,,,
OG_02862,0.5386657279578393,OG_02862,FUN_011907-T1,Peve_00014640,Pocillopora_meandrina_HIv1___RNAseq.g23364.t1,three_way,57.48433333333333,,,,,,,,,,,,,,,,,
OG_06130,0.5383796568609043,OG_06130,FUN_027934-T1,Peve_00020115,Pocillopora_meandrina_HIv1___RNAseq.g13874.t1,three_way,86.42533333333334,FUN_027934-T1,Q32TG3,,,,,53.9,707.0,2.1e-228,793.5,sp|Q32TG3|EFHC2_CHICK EF-hand domain-containing family member C2 OS=Gallus gallus OX=9031 GN=EFHC2 PE=2 SV=1,,,,,,
OG_07226,0.5379280915099813,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,48.1,270.0,3.4e-62,241.5,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_07226,0.5379280915099813,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,35.9,78.0,3.8e-05,52.0,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_03970,0.5374154129126945,OG_03970,FUN_016124-T1,Peve_00013453,Pocillopora_meandrina_HIv1___RNAseq.g21251.t1a,three_way,41.071333333333335,FUN_016124-T1,Q60774,,,,,30.0,273.0,3.3e-23,110.5,sp|Q60774|TM45A_MOUSE Transmembrane protein 45A OS=Mus musculus OX=10090 GN=Tmem45a PE=2 SV=1,,,,,,
OG_02562,0.536957418500824,OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02048,0.5367954138277639,OG_02048,FUN_008256-T1,Peve_00035501,Pocillopora_meandrina_HIv1___RNAseq.g17961.t1,three_way,85.40433333333334,FUN_008256-T1,Q9Y6V7,DDX49_HUMAN,,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),Homo sapiens (Human),60.0,423.0,1.1999999999999999e-141,504.6,sp|Q9Y6V7|DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0030307; GO:0044357,positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02889,0.5361833106546459,OG_02889,FUN_011944-T1,Peve_00016922,Pocillopora_meandrina_HIv1___RNAseq.g9188.t1,three_way,71.43466666666666,FUN_011944-T1,Q6Q759,SPG17_HUMAN,,Sperm-associated antigen 17 (Projection protein PF6 homolog),Homo sapiens (Human),31.0,2357.0,6.9000000000000005e-174,614.0,sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514],,GO:0005576; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,extracellular region; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_02259,0.5356179758367764,OG_02259,FUN_008706-T1,Peve_00034988,Pocillopora_meandrina_HIv1___RNAseq.g25666.t1,three_way,78.29466666666666,FUN_008706-T1,P55145,MANF_HUMAN,,Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET),Homo sapiens (Human),55.3,170.0,1.0999999999999999e-47,191.0,sp|P55145|MANF_HUMAN Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3,GO:0002014; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0008083; GO:0031175; GO:0033018; GO:0036500; GO:0071542; GO:0120146; GO:1905897,ATF6-mediated unfolded protein response [GO:0036500]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [GO:0002014],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; sarcoplasmic reticulum lumen [GO:0033018],growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146],GO:0003013; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005829; GO:0008289; GO:0030154; GO:0043226; GO:0048018; GO:0098772,circulatory system process; RNA binding; extracellular region; extracellular space; nucleus; endoplasmic reticulum; cytosol; lipid binding; cell differentiation; organelle; receptor ligand activity; molecular function regulator activity
OG_00211,0.53538995380308,OG_00211,FUN_000930-T1,Peve_00009721,Pocillopora_meandrina_HIv1___RNAseq.g29463.t1,three_way,75.37,FUN_000930-T1,A0LJ16,,,,,43.9,269.0,7.6e-61,235.7,sp|A0LJ16|PHNXL_SYNFM Phosphonoacetaldehyde hydrolase-like protein OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=phnX2 PE=3 SV=1,,,,,,
OG_09490,0.5353765869975516,OG_09490,FUN_041526-T1,Peve_00017090,Pocillopora_meandrina_HIv1___RNAseq.g2461.t1,three_way,40.93683333333333,FUN_041526-T1,P78345,RPP38_HUMAN,,Ribonuclease P protein subunit p38 (RNaseP protein p38),Homo sapiens (Human),29.5,251.0,2.5e-13,77.8,sp|P78345|RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2,GO:0000172; GO:0001650; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0030681; GO:0033204,rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682],fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02064,0.5353617704440004,OG_02064,FUN_008278-T1,Peve_00001955,Pocillopora_meandrina_HIv1___RNAseq.g17986.t1,three_way,91.496,FUN_008278-T1,Q5RBG4,KAT5_PONAB,,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.0,470.0,1.1e-174,614.4,sp|Q5RBG4|KAT5_PONAB Histone acetyltransferase KAT5 OS=Pongo abelii OX=9601 GN=KAT5 PE=2 SV=1,GO:0000132; GO:0000724; GO:0000776; GO:0000812; GO:0000922; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006302; GO:0006974; GO:0007286; GO:0008270; GO:0010508; GO:0010867; GO:0018394; GO:0030330; GO:0032777; GO:0035267; GO:0042149; GO:0042753; GO:0043998; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0061733; GO:0062033; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:1902036; GO:1902425; GO:1905168; GO:1905691,"cellular response to glucose starvation [GO:0042149]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; kinetochore [GO:0000776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; spindle pole [GO:0000922]; Swr1 complex [GO:0000812],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0007010; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096; GO:0140110,"immune system process; catalytic activity; nucleus; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein; transcription regulator activity"
OG_06093,0.5353148594880769,OG_06093,FUN_027219-T1,Peve_00018290,Pocillopora_meandrina_HIv1___RNAseq.g15895.t1,three_way,83.92083333333333,FUN_027219-T1,Q95LR0,,,,,55.3,721.0,6.3e-205,715.7,sp|Q95LR0|CFA91_MACFA Cilia- and flagella-associated protein 91 OS=Macaca fascicularis OX=9541 GN=CFAP91 PE=2 SV=3,,,,,,
OG_03086,0.5351485200397038,OG_03086,FUN_012359-T1,Peve_00042556,Pocillopora_meandrina_HIv1___RNAseq.g23272.t1,three_way,74.21950000000001,FUN_012359-T1,Q9UDY4,DNJB4_HUMAN,,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),Homo sapiens (Human),45.7,341.0,5.000000000000001e-81,302.8,sp|Q9UDY4|DNJB4_HUMAN DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1,GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0030018; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018],ATPase activator activity [GO:0001671]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0098772,nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; molecular function regulator activity
OG_07128,0.5343666530770931,OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_09693,0.5336699023217486,OG_09693,FUN_041922-T1,Peve_00007867,Pocillopora_meandrina_HIv1___RNAseq.g15626.t1,three_way,82.96933333333334,FUN_041922-T1,Q5I0R4,,,,,53.6,222.0,4.2e-63,242.7,sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1,,,,,,
OG_04618,0.5335247696833391,OG_04618,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_05759,0.5332114933641083,OG_05759,FUN_025700-T1,Peve_00004692,Pocillopora_meandrina_HIv1___RNAseq.g13829.t1,three_way,50.16833333333334,FUN_025700-T1,P13116,,,,,38.1,97.0,4.7e-06,55.5,sp|P13116|SRC2_XENLA Tyrosine-protein kinase Src-2 OS=Xenopus laevis OX=8355 GN=src-b PE=2 SV=3,,,,,,
OG_05705,0.5329297150705364,OG_05705,FUN_025578-T1,Peve_00022365,Pocillopora_meandrina_HIv1___RNAseq.g13760.t1,three_way,91.371,FUN_025578-T1,Q2TA03,UB2J2_BOVIN,,Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2),Bos taurus (Bovine),60.8,250.0,3.4e-76,286.2,sp|Q2TA03|UB2J2_BOVIN Ubiquitin-conjugating enzyme E2 J2 OS=Bos taurus OX=9913 GN=UBE2J2 PE=2 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0036503; GO:0061631; GO:0085020,ERAD pathway [GO:0036503]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005783; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09902,0.5327887090578013,OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_05742,0.5327815208982827,OG_05742,FUN_025669-T1,Peve_00042197,Pocillopora_meandrina_HIv1___RNAseq.g23058.t1,three_way,85.04666666666667,FUN_025669-T1,Q567I9,,,,,67.1,164.0,1.3e-62,240.7,sp|Q567I9|CB5D1_DANRE Cytochrome b5 domain-containing protein 1 OS=Danio rerio OX=7955 GN=cyb5d1 PE=2 SV=1,,,,,,
OG_06416,0.5325821697228734,OG_06416,FUN_029099-T1,Peve_00038062,Pocillopora_meandrina_HIv1___RNAseq.g25485.t1,three_way,55.33266666666667,FUN_029099-T1,P20105,E74EA_DROME,,Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A),Drosophila melanogaster (Fruit fly),52.4,105.0,3.5e-21,103.6,sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2,GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048102; GO:0048477,"autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0006914; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; autophagy; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08917,0.5325368103709917,OG_08917,FUN_038373-T1,Peve_00000079,Pocillopora_meandrina_HIv1___RNAseq.g1092.t1,three_way,85.541,FUN_038373-T1,Q9UBX3,DIC_HUMAN,,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),Homo sapiens (Human),58.7,286.0,3.6999999999999996e-91,336.3,sp|Q9UBX3|DIC_HUMAN Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 GN=SLC25A10 PE=1 SV=2,GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423; GO:1902358,"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117],GO:0005215; GO:0005634; GO:0005654; GO:0005739; GO:0005975; GO:0006790; GO:0043226; GO:0055085; GO:1901135,transporter activity; nucleus; nucleoplasm; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; organelle; transmembrane transport; carbohydrate derivative metabolic process
OG_09926,0.5325280480698862,OG_09926,FUN_043040-T1,Peve_00026460,Pocillopora_meandrina_HIv1___RNAseq.g7078.t1,three_way,76.39316666666667,FUN_043040-T1,Q5T8I3,,,,,43.2,359.0,2.5e-57,224.2,sp|Q5T8I3|EEIG2_HUMAN EEIG family member 2 OS=Homo sapiens OX=9606 GN=EEIG2 PE=1 SV=2,,,,,,
OG_02768,0.5322856409952449,OG_02768,FUN_011707-T1,Peve_00025137,Pocillopora_meandrina_HIv1___TS.g16696.t1,three_way,79.247,,,,,,,,,,,,,,,,,
OG_00741,0.5322557717692084,OG_00741,FUN_002723-T1,Peve_00025040,Pocillopora_meandrina_HIv1___RNAseq.g14943.t1,three_way,95.002,FUN_002723-T1,Q96HN2,SAHH3_HUMAN,,Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2),Homo sapiens (Human),79.1,470.0,2.7e-219,762.7,sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2 PE=1 SV=1,GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005,one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005],hydrolase activity [GO:0016787],GO:0003824; GO:0005783; GO:0005829; GO:0006790; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; cytosol; sulfur compound metabolic process; hydrolase activity; organelle
OG_00166,0.5321703752014485,OG_00166,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_04392,0.5319289003943081,OG_04392,FUN_018392-T1,Peve_00031705,Pocillopora_meandrina_HIv1___RNAseq.g10095.t1,three_way,82.48366666666666,FUN_018392-T1,F1MMV1,,,,,46.6,573.0,3.8999999999999996e-142,506.5,sp|F1MMV1|EFHB_BOVIN EF-hand domain-containing family member B OS=Bos taurus OX=9913 GN=EFHB PE=1 SV=3,,,,,,
OG_10177,0.5317661111050974,OG_10177,FUN_043586-T1,Peve_00045222,Pocillopora_meandrina_HIv1___RNAseq.g6984.t1,three_way,54.448,,,,,,,,,,,,,,,,,
OG_09567,0.5314624252413809,OG_09567,FUN_041691-T1,Peve_00041081,Pocillopora_meandrina_HIv1___TS.g11766.t1a,three_way,79.19200000000001,FUN_041691-T1,Q9Y0H3,,,,,62.6,139.0,2e-47,189.9,sp|Q9Y0H3|RS19_MYXGL Small ribosomal subunit protein eS19 OS=Myxine glutinosa OX=7769 GN=rps19 PE=2 SV=1,,,,,,
OG_04830,0.5313724613537697,OG_04830,FUN_022824-T1,Peve_00030469,Pocillopora_meandrina_HIv1___RNAseq.g3440.t1,three_way,97.61033333333332,FUN_022824-T1,B2RW38,CFA58_MOUSE,,Cilia- and flagella-associated protein 58,Mus musculus (Mouse),69.4,788.0,3.399999999999999e-177,623.6,sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1,GO:0005737; GO:0005813; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317],centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_05881,0.5313270706119493,OG_05881,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06022,0.5313117277007651,OG_06022,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
OG_09256,0.5309402618668166,OG_09256,FUN_040058-T1,Peve_00018499,Pocillopora_meandrina_HIv1___RNAseq.g7727.t1b,three_way,76.5945,FUN_040058-T1,Q8CFI0,NED4L_MOUSE,,E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),Mus musculus (Mouse),47.7,973.0,1.6e-243,844.0,sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2,GO:0002028; GO:0003085; GO:0005771; GO:0005794; GO:0006511; GO:0006814; GO:0009651; GO:0010765; GO:0010766; GO:0016567; GO:0019871; GO:0030154; GO:0031647; GO:0051649; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1902305; GO:2000810,cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of sodium ion transport [GO:0010765]; protein ubiquitination [GO:0016567]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794],sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03103,0.5308804145094634,OG_03103,FUN_012390-T1,Peve_00022229,Pocillopora_meandrina_HIv1___RNAseq.g23656.t1,three_way,66.252,,,,,,,,,,,,,,,,,
OG_01150,0.5306605618174313,OG_01150,FUN_004749-T1,Peve_00007765,Pocillopora_meandrina_HIv1___RNAseq.g8815.t3,three_way,45.58733333333333,FUN_004749-T1,P27447,,,,,37.6,93.0,4.9e-07,57.8,sp|P27447|YES_XIPHE Tyrosine-protein kinase Yes OS=Xiphophorus hellerii OX=8084 GN=yes PE=2 SV=3,,,,,,
OG_01216,0.5305917319234184,OG_01216,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_08889,0.530537597057056,OG_08889,FUN_038295-T1,Peve_00041732,Pocillopora_meandrina_HIv1___RNAseq.g28299.t1,three_way,78.112,FUN_038295-T1,Q5E9V1,DCNL3_BOVIN,,DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3),Bos taurus (Bovine),59.8,204.0,2.3e-64,247.3,sp|Q5E9V1|DCNL3_BOVIN DCN1-like protein 3 OS=Bos taurus OX=9913 GN=DCUN1D3 PE=2 SV=1,GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436,negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0043226,nucleus; nucleoplasm; cytosol; plasma membrane; organelle
OG_06976,0.5305334728674013,OG_06976,FUN_032111-T1,Peve_00030228,Pocillopora_meandrina_HIv1___RNAseq.g5390.t1,three_way,72.92066666666666,FUN_032111-T1,A6H630,ARMT1_MOUSE,,Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1),Mus musculus (Mouse),46.2,439.0,2.2999999999999997e-105,384.0,sp|A6H630|ARMT1_MOUSE Damage-control phosphatase ARMT1 OS=Mus musculus OX=10090 GN=Armt1 PE=1 SV=1,GO:0006974; GO:0008757; GO:0008983; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026,DNA damage response [GO:0006974]; methylation [GO:0032259],,enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0016740; GO:0016787; GO:0016829; GO:0140096,"catalytic activity; transferase activity; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_02308,0.5302544024489402,OG_02308,FUN_008887-T1,Peve_00000779,Pocillopora_meandrina_HIv1___RNAseq.g4004.t1,three_way,73.50366666666666,FUN_008887-T1,Q0VD32,CRBL2_BOVIN,,cAMP-responsive element-binding protein-like 2,Bos taurus (Bovine),61.9,84.0,8.4e-21,101.7,sp|Q0VD32|CRBL2_BOVIN cAMP-responsive element-binding protein-like 2 OS=Bos taurus OX=9913 GN=CREBL2 PE=1 SV=1,GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821,cell differentiation [GO:0030154]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355],nuclear body [GO:0016604]; nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_09935,0.5300856431887642,OG_09935,FUN_043094-T1,Peve_00038927,Pocillopora_meandrina_HIv1___RNAseq.g7010.t1,three_way,77.438,FUN_043094-T1,Q7XP59,,,,,24.4,475.0,3.8e-18,95.9,sp|Q7XP59|GLR31_ORYSJ Glutamate receptor 3.1 OS=Oryza sativa subsp. japonica OX=39947 GN=GLR3.1 PE=1 SV=1,,,,,,
OG_00880,0.5298667833332865,OG_00880,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_04964,0.5297176402200653,OG_04964,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_05952,0.529697277462366,OG_05952,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_01759,0.5293751579910958,OG_01759,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_07096,0.5293467060886826,OG_07096,FUN_032354-T1,Peve_00026257,Pocillopora_meandrina_HIv1___TS.g25057.t4,three_way,83.02083333333333,,,,,,,,,,,,,,,,,
OG_07649,0.5289916471047192,OG_07649,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_01078,0.5289758184951515,OG_01078,FUN_004566-T1,Peve_00016038,Pocillopora_meandrina_HIv1___RNAseq.g8224.t1,three_way,70.882,FUN_004566-T1,P16393,,,,,46.1,915.0,5.000000000000001e-208,726.1,sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Strongylocentrotus purpuratus OX=7668 GN=HMGCR PE=2 SV=2,,,,,,
OG_00982,0.5287881854965562,OG_00982,FUN_004365-T1,Peve_00008937,Pocillopora_meandrina_HIv1___TS.g7532.t1,three_way,75.77499999999999,FUN_004365-T1,Q6PC91,,,,,64.1,156.0,5.7e-44,178.7,sp|Q6PC91|BT3L4_DANRE Transcription factor BTF3 homolog 4 OS=Danio rerio OX=7955 GN=btf3l4 PE=2 SV=1,,,,,,
OG_09495,0.5283724382967526,OG_09495,FUN_041535-T1,Peve_00039113,Pocillopora_meandrina_HIv1___RNAseq.g15374.t1,three_way,78.69216666666667,FUN_041535-T1,Q5R7X2,,,,,44.6,655.0,4.1e-134,480.7,sp|Q5R7X2|SR140_PONAB U2 snRNP-associated SURP motif-containing protein OS=Pongo abelii OX=9601 GN=U2SURP PE=2 SV=1,,,,,,
OG_07321,0.527996959108207,OG_07321,FUN_033714-T1,Peve_00017869,Pocillopora_meandrina_HIv1___RNAseq.g28832.t1,three_way,41.261,,,,,,,,,,,,,,,,,
OG_09850,0.5279262194150891,OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_07121,0.5278168252903791,OG_07121,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_06209,0.5276115841145091,OG_06209,FUN_028148-T1,Peve_00017303,Pocillopora_meandrina_HIv1___RNAseq.g15549.t1,three_way,81.402,FUN_028148-T1,Q9UI14,PRAF1_HUMAN,,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),Homo sapiens (Human),47.2,125.0,2.5e-26,120.2,sp|Q9UI14|PRAF1_HUMAN Prenylated Rab acceptor protein 1 OS=Homo sapiens OX=9606 GN=RABAC1 PE=1 SV=1,GO:0005794; GO:0005886; GO:0008021; GO:0016020; GO:0042802; GO:0051020; GO:0070064; GO:0098978,,glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064],GO:0005794; GO:0005886; GO:0031410; GO:0043226,Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle
OG_04721,0.5275925536535638,OG_04721,FUN_022578-T1,Peve_00020592,Pocillopora_meandrina_HIv1___RNAseq.g4435.t1,three_way,84.55266666666667,FUN_022578-T1,Q9JLI7,SPAG6_MOUSE,,Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog),Mus musculus (Mouse),87.9,506.0,1.2e-81,305.4,sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716,"cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]",acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm principal piece [GO:0097228],microtubule binding [GO:0008017],GO:0003016; GO:0005576; GO:0005829; GO:0007010; GO:0007018; GO:0007155; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877,respiratory system process; extracellular region; cytosol; cytoskeleton organization; microtubule-based movement; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process
OG_01185,0.527156610286321,OG_01185,FUN_004835-T1,Peve_00019419,Pocillopora_meandrina_HIv1___RNAseq.g8610.t1,three_way,73.24,FUN_004835-T1,Q96PU9,,,,,46.6,238.0,5.4e-51,202.6,sp|Q96PU9|CMA1A_HUMAN Ciliary microtubule associated protein 1A OS=Homo sapiens OX=9606 GN=CIMAP1A PE=1 SV=1,,,,,,
OG_03779,0.5270015782306338,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_08472,0.5269974557269933,OG_08472,FUN_037288-T1,Peve_00013165,Pocillopora_meandrina_HIv1___RNAseq.g10671.t1,three_way,91.804,FUN_037288-T1,Q86YI8,PHF13_HUMAN,,PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1) (SPOC1),Homo sapiens (Human),72.4,76.0,9.5e-29,128.3,sp|Q86YI8|PHF13_HUMAN PHD finger protein 13 OS=Homo sapiens OX=9606 GN=PHF13 PE=1 SV=2,GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006974; GO:0007059; GO:0007076; GO:0008270; GO:0035064; GO:0051301; GO:0062072; GO:0140463,cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; histone H3K9me2/3 reader activity [GO:0062072]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270],GO:0000278; GO:0005634; GO:0005654; GO:0007059; GO:0043226; GO:0060090,mitotic cell cycle; nucleus; nucleoplasm; chromosome segregation; organelle; molecular adaptor activity
OG_08800,0.5267896152235049,OG_08800,FUN_038103-T1,Peve_00025353,Pocillopora_meandrina_HIv1___RNAseq.g837.t1,three_way,71.89616666666667,FUN_038103-T1,Q4R7U0,,,,,32.1,701.0,1.2e-85,319.3,sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1,,,,,,
OG_04934,0.5259759716069885,OG_04934,FUN_023005-T1,Peve_00010020,Pocillopora_meandrina_HIv1___TS.g9991.t1,three_way,69.04316666666666,FUN_023005-T1,Q80YS5,,,,,31.4,468.0,6.6e-10,67.0,sp|Q80YS5|LRC27_MOUSE Leucine-rich repeat-containing protein 27 OS=Mus musculus OX=10090 GN=Lrrc27 PE=2 SV=1,,,,,,
OG_03286,0.5258226056882149,OG_03286,FUN_013326-T1,Peve_00022536,Pocillopora_meandrina_HIv1___RNAseq.g13101.t1,three_way,85.618,FUN_013326-T1,A8JF70,ODA1_CHLRE,,Outer dynein arm protein 1 (Docking complex component 2),Chlamydomonas reinhardtii (Chlamydomonas smithii),32.0,500.0,5.699999999999999e-53,210.3,sp|A8JF70|ODA1_CHLRE Outer dynein arm protein 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ODA1 PE=1 SV=1,GO:0036157; GO:0036158; GO:0060294,cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],outer dynein arm [GO:0036157],,GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_04219,0.5257458367116413,OG_04219,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04908,0.5256215355894662,OG_04908,FUN_022958-T1,Peve_00030518,Pocillopora_meandrina_HIv1___RNAseq.g3771.t1,three_way,66.259,,,,,,,,,,,,,,,,,
OG_05438,0.5253073567147428,OG_05438,FUN_024391-T1,Peve_00005020,Pocillopora_meandrina_HIv1___RNAseq.g18622.t2,three_way,84.50533333333333,FUN_024391-T1,Q90YH9,,,,,43.8,418.0,1.2e-97,358.2,sp|Q90YH9|TES_CHICK Testin OS=Gallus gallus OX=9031 GN=TES PE=2 SV=1,,,,,,
OG_04840,0.5252074629427046,OG_04840,FUN_022844-T1,Peve_00028885,Pocillopora_meandrina_HIv1___TS.g9571.t1,three_way,74.77733333333333,,,,,,,,,,,,,,,,,
OG_09392,0.5249464545363819,OG_09392,FUN_040688-T1,Peve_00033378,Pocillopora_meandrina_HIv1___RNAseq.g6441.t1,three_way,70.6605,FUN_040688-T1,Q9DBN9,DDX59_MOUSE,,Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5),Mus musculus (Mouse),45.4,654.0,5.9e-150,532.7,sp|Q9DBN9|DDX59_MOUSE Probable ATP-dependent RNA helicase DDX59 OS=Mus musculus OX=10090 GN=Ddx59 PE=1 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008270; GO:0016887,,cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05803,0.5246745335104914,OG_05803,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_04359,0.5244422030089381,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_08165,0.5244345354918436,OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_00248,0.5242035050832428,OG_00248,FUN_001011-T1,Peve_00041060,Pocillopora_meandrina_HIv1___RNAseq.g29164.t1,three_way,70.763,FUN_001011-T1,Q6ZUX7,LHPL2_HUMAN,,LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein),Homo sapiens (Human),43.1,232.0,6.4e-43,175.6,sp|Q6ZUX7|LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2,GO:0005886; GO:0007338; GO:0016020; GO:0031092; GO:0046545; GO:0046546; GO:1905516,development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338],membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092],,GO:0005886; GO:0022414,plasma membrane; reproductive process
OG_06491,0.5241889013893316,OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_09598,0.5241196870273347,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_00125,0.5241114771838224,OG_00125,FUN_000549-T1,Peve_00035147,Pocillopora_meandrina_HIv1___RNAseq.g17849.t1,three_way,56.6745,FUN_000549-T1,Q5FVH4,AKTIP_RAT,,AKT-interacting protein (Fused toes protein homolog),Rattus norvegicus (Rat),37.8,135.0,3.5000000000000005e-22,106.7,sp|Q5FVH4|AKTIP_RAT AKT-interacting protein OS=Rattus norvegicus OX=10116 GN=Aktip PE=1 SV=1,GO:0005634; GO:0005886; GO:0006301; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0030897; GO:0045022; GO:0061631; GO:0070534; GO:0070695; GO:1905719,apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],FHF complex [GO:0070695]; HOPS complex [GO:0030897]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005886; GO:0006281; GO:0007040; GO:0012501; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; DNA repair; lysosome organization; programmed cell death; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08995,0.5239372659399568,OG_08995,FUN_038525-T1,Peve_00041748,Pocillopora_meandrina_HIv1___RNAseq.g28187.t1,three_way,68.14699999999999,,,,,,,,,,,,,,,,,
OG_05374,0.5239289093100751,OG_05374,FUN_024187-T1,Peve_00013614,Pocillopora_meandrina_HIv1___RNAseq.g18887.t1,three_way,88.22666666666666,FUN_024187-T1,Q921G7,ETFD_MOUSE,,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",Mus musculus (Mouse),75.3,595.0,1.8999999999999998e-280,966.1,"sp|Q921G7|ETFD_MOUSE Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Etfdh PE=1 SV=1",GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0033539; GO:0046872; GO:0048039; GO:0051539,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinone binding [GO:0048039]",GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0006629; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; lipid metabolic process; oxidoreductase activity; organelle
OG_10159,0.5238875229091782,OG_10159,FUN_043556-T1,Peve_00022070,Pocillopora_meandrina_HIv1___RNAseq.g8045.t1,three_way,53.502,,,,,,,,,,,,,,,,,
OG_01815,0.5234145363072891,OG_01815,FUN_007678-T1,Peve_00013716,Pocillopora_meandrina_HIv1___RNAseq.g5864.t1,three_way,73.167,FUN_007678-T1,O95433,,,,,47.3,347.0,9.9e-88,325.1,sp|O95433|AHSA1_HUMAN Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Homo sapiens OX=9606 GN=AHSA1 PE=1 SV=1,,,,,,
OG_03205,0.5232998974321712,OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_06217,0.5231459563231898,OG_06217,FUN_028158-T1,Peve_00024808,Pocillopora_meandrina_HIv1___RNAseq.g16501.t1,three_way,79.09966666666666,FUN_028158-T1,Q9Y5P8,,,,,48.1,459.0,2.1e-120,434.1,sp|Q9Y5P8|P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens OX=9606 GN=PPP2R3B PE=1 SV=2,,,,,,
OG_04504,0.5228037454595772,OG_04504,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_05971,0.5225945949054278,OG_05971,FUN_026385-T1,Peve_00010504,Pocillopora_meandrina_HIv1___RNAseq.g2955.t1,three_way,77.00399999999999,FUN_026385-T1,Q27960,NPT2B_BOVIN,,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),Bos taurus (Bovine),56.3,545.0,5.3e-150,532.7,sp|Q27960|NPT2B_BOVIN Sodium-dependent phosphate transport protein 2B OS=Bos taurus OX=9913 GN=SLC34A2 PE=1 SV=1,GO:0005436; GO:0005903; GO:0006817; GO:0016020; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341,intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; vesicle [GO:0031982],phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0043226,transporter activity; organelle
OG_09257,0.5224620583511794,OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4000000000000001e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_08827,0.5212166419250174,OG_08827,FUN_038164-T1,Peve_00025796,Pocillopora_meandrina_HIv1___RNAseq.g1067.t1,three_way,72.954,FUN_038164-T1,Q9CR92,,,,,46.4,248.0,3.3999999999999997e-43,177.6,sp|Q9CR92|CF184_MOUSE Cilia- and flagella-associated protein 184 OS=Mus musculus OX=10090 GN=Cfap184 PE=2 SV=1,,,,,,
OG_01374,0.5209039629986351,OG_01374,FUN_005330-T1,Peve_00003301,Pocillopora_meandrina_HIv1___TS.g19931.t1,three_way,58.007000000000005,FUN_005330-T1,A6QPM3,PRDM6_BOVIN,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6),Bos taurus (Bovine),32.9,313.0,3e-37,157.9,sp|A6QPM3|PRDM6_BOVIN Putative histone-lysine N-methyltransferase PRDM6 OS=Bos taurus OX=9913 GN=PRDM6 PE=2 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_06157,0.5207966959523203,OG_06157,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_03062,0.5206719461008198,OG_03062,FUN_012326-T1,Peve_00023484,Pocillopora_meandrina_HIv1___RNAseq.g23752.t1,three_way,88.28433333333334,FUN_012326-T1,Q64331,MYO6_MOUSE,,Unconventional myosin-VI (Protein twist) (Unconventional myosin-6),Mus musculus (Mouse),58.0,1266.0,0.0,1217.2,sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2,GO:0003774; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0016358; GO:0016459; GO:0030136; GO:0030175; GO:0030424; GO:0032587; GO:0042472; GO:0042491; GO:0043025; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171,cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization [GO:0008104]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416],axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774],GO:0003774; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,cytoskeletal motor activity; nucleus; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_02803,0.5204338679487549,OG_02803,FUN_011774-T1,Peve_00034380,Pocillopora_meandrina_HIv1___RNAseq.g23371.t1,three_way,90.731,FUN_011774-T1,Q503E9,,,,,72.2,532.0,1.8e-88,328.2,sp|Q503E9|IMA6_DANRE Importin subunit alpha-6 OS=Danio rerio OX=7955 GN=kpna5 PE=2 SV=3,,,,,,
OG_02850,0.5204265247085357,OG_02850,FUN_011882-T1,Peve_00018836,Pocillopora_meandrina_HIv1___RNAseq.g23402.t1,three_way,89.64316666666666,FUN_011882-T1,O14602,,,,,84.8,145.0,2.7e-50,199.5,"sp|O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A, Y-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AY PE=1 SV=4",,,,,,
OG_05408,0.5203254788210194,OG_05408,FUN_024342-T1,Peve_00016807,Pocillopora_meandrina_HIv1___RNAseq.g18932.t1,three_way,79.807,FUN_024342-T1,P53348,,,,,53.5,114.0,7.6e-30,131.7,sp|P53348|BTG1_BOVIN Protein BTG1 OS=Bos taurus OX=9913 GN=BTG1 PE=2 SV=2,,,,,,
OG_02284,0.5202962178587288,OG_02284,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_06904,0.5200902899177483,OG_06904,FUN_031950-T1,Peve_00031823,Pocillopora_meandrina_HIv1___RNAseq.g6062.t1,three_way,97.722,FUN_031950-T1,P48601,,,,,94.3,334.0,2e-178,626.3,sp|P48601|PRS4_DROME 26S proteasome regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpt2 PE=1 SV=2,,,,,,
OG_04187,0.5200035822207071,OG_04187,FUN_016708-T1,Peve_00024196,Pocillopora_meandrina_HIv1___RNAseq.g277.t1,three_way,80.69266666666667,FUN_016708-T1,Q1RMM1,,,,,48.7,431.0,1.0999999999999999e-91,338.6,sp|Q1RMM1|ZC3HF_BOVIN Zinc finger CCCH domain-containing protein 15 OS=Bos taurus OX=9913 GN=ZC3H15 PE=2 SV=1,,,,,,
OG_06765,0.5199679335028571,OG_06765,FUN_031597-T1,Peve_00012517,Pocillopora_meandrina_HIv1___RNAseq.g5995.t1,three_way,76.125,,,,,,,,,,,,,,,,,
OG_00683,0.5198888731332161,OG_00683,FUN_002350-T1,Peve_00022329,Pocillopora_meandrina_HIv1___RNAseq.g31.t1,three_way,87.33500000000001,FUN_002350-T1,O76924,,,,,52.7,482.0,2.5000000000000002e-145,516.9,sp|O76924|ARI2_DROME Potential E3 ubiquitin-protein ligase ariadne-2 OS=Drosophila melanogaster OX=7227 GN=ari-2 PE=1 SV=1,,,,,,
OG_08721,0.5197583440923889,OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_09372,0.5190155834802302,OG_09372,FUN_040547-T1,Peve_00015401,Pocillopora_meandrina_HIv1___RNAseq.g6506.t1,three_way,82.78766666666667,FUN_040547-T1,P46940,IQGA1_HUMAN,,Ras GTPase-activating-like protein IQGAP1 (p195),Homo sapiens (Human),54.6,1653.0,0.0,1496.9,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990138; GO:1990904,caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0061024; GO:0098772,nucleus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_01918,0.5187567951068329,OG_01918,FUN_007947-T1,Peve_00021143,Pocillopora_meandrina_HIv1___TS.g21111.t2,three_way,56.5525,,,,,,,,,,,,,,,,,
OG_10056,0.5185691493280223,OG_10056,FUN_043350-T1,Peve_00022831,Pocillopora_meandrina_HIv1___RNAseq.g8959.t1,three_way,62.689,,,,,,,,,,,,,,,,,
OG_08538,0.5184709167508147,OG_08538,FUN_037488-T1,Peve_00020417,Pocillopora_meandrina_HIv1___TS.g22716.t1,three_way,79.14133333333334,FUN_037488-T1,Q08BI9,MCU_DANRE,,"Calcium uniporter protein, mitochondrial",Danio rerio (Zebrafish) (Brachydanio rerio),55.8,283.0,5.2e-86,319.3,"sp|Q08BI9|MCU_DANRE Calcium uniporter protein, mitochondrial OS=Danio rerio OX=7955 GN=mcu PE=1 SV=1",GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0046872; GO:0051259; GO:0051560; GO:0051561; GO:0051649; GO:0060027; GO:1990246,actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246],calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; uniporter activity [GO:0015292],GO:0005215; GO:0048856; GO:0055085; GO:0065003,transporter activity; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_10193,0.5183712760797758,OG_10193,FUN_043617-T1,Peve_00008238,Pocillopora_meandrina_HIv1___RNAseq.g6934.t1,three_way,43.36033333333333,,,,,,,,,,,,,,,,,
OG_02474,0.5178622320038742,OG_02474,FUN_009677-T1,Peve_00024097,Pocillopora_meandrina_HIv1___RNAseq.g24567.t1,three_way,78.88666666666667,FUN_009677-T1,Q54LV8,,,,,59.6,94.0,9.6e-25,114.0,sp|Q54LV8|RL34_DICDI Large ribosomal subunit protein eL34 OS=Dictyostelium discoideum OX=44689 GN=rpl34 PE=3 SV=1,,,,,,
OG_00752,0.5177191897007737,OG_00752,FUN_002810-T1,Peve_00044262,Pocillopora_meandrina_HIv1___RNAseq.g14965.t1,three_way,65.89033333333333,FUN_002810-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.8,2393.0,1e-280,969.5,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_06611,0.517578896054108,OG_06611,FUN_029761-T1,Peve_00019503,Pocillopora_meandrina_HIv1___RNAseq.g17322.t1,three_way,61.18983333333333,FUN_029761-T1,Q8NC51,SERB1_HUMAN,,SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein),Homo sapiens (Human),31.6,152.0,5e-06,53.9,sp|Q8NC51|SERB1_HUMAN SERPINE1 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0017148; GO:0030371; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0061770; GO:0070062; GO:0141014,negative regulation of translation [GO:0017148]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]; ribosome hibernation [GO:0141014],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; translation elongation factor binding [GO:0061770]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; organelle; translation regulator activity
OG_08265,0.5175273189097224,OG_08265,FUN_036177-T1,Peve_00027216,Pocillopora_meandrina_HIv1___RNAseq.g27511.t1,three_way,55.68066666666667,,,,,,,,,,,,,,,,,
OG_09910,0.5174553916966986,OG_09910,FUN_043008-T1,Peve_00017770,Pocillopora_meandrina_HIv1___RNAseq.g7032.t1,three_way,89.62533333333333,FUN_043008-T1,Q9JKK1,STX6_MOUSE,,Syntaxin-6,Mus musculus (Mouse),50.4,232.0,1.3e-55,218.0,sp|Q9JKK1|STX6_MOUSE Syntaxin-6 OS=Mus musculus OX=10090 GN=Stx6 PE=1 SV=1,GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0016020; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038,"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_05366,0.5174003239501219,OG_05366,FUN_024155-T1,Peve_00034622,Pocillopora_meandrina_HIv1___RNAseq.g19853.t1,three_way,62.59933333333333,FUN_024155-T1,Q5U405,TMPSD_MOUSE,,Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease),Mus musculus (Mouse),26.8,272.0,2.7e-21,104.8,sp|Q5U405|TMPSD_MOUSE Transmembrane protease serine 13 OS=Mus musculus OX=10090 GN=Tmprss13 PE=2 SV=2,GO:0004252; GO:0005576; GO:0005737; GO:0005886; GO:0006508; GO:0061436,establishment of skin barrier [GO:0061436]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0048856; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02605,0.5173830771147648,OG_02605,FUN_010733-T1,Peve_00038976,Pocillopora_meandrina_HIv1___RNAseq.g20942.t1,three_way,87.03433333333334,FUN_010733-T1,A7SA47,,,,,70.1,318.0,1.1000000000000001e-125,451.1,sp|A7SA47|EIF3H_NEMVE Eukaryotic translation initiation factor 3 subunit H OS=Nematostella vectensis OX=45351 GN=v1g168210 PE=3 SV=1,,,,,,
OG_01259,0.5169990851984909,OG_01259,FUN_005018-T1,Peve_00015875,Pocillopora_meandrina_HIv1___RNAseq.g8677.t1,three_way,82.69383333333333,FUN_005018-T1,Q6GPM1,,,,,45.6,799.0,4e-132,474.2,sp|Q6GPM1|ZFR_XENLA Zinc finger RNA-binding protein OS=Xenopus laevis OX=8355 GN=zfr PE=2 SV=1,,,,,,
OG_01887,0.5168336879620029,OG_01887,FUN_007866-T1,Peve_00044451,Pocillopora_meandrina_HIv1___RNAseq.g18302.t1,three_way,87.58333333333333,FUN_007866-T1,Q07352,TISB_HUMAN,,"mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1)",Homo sapiens (Human),93.3,30.0,2.2e-11,71.2,sp|Q07352|TISB_HUMAN mRNA decay activator protein ZFP36L1 OS=Homo sapiens OX=9606 GN=ZFP36L1 PE=1 SV=1,GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0006915; GO:0007507; GO:0008270; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0048382; GO:0051028; GO:0060710; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904,"3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; regulation of translation [GO:0006417]; response to wounding [GO:0009611]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904],14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0007155; GO:0012501; GO:0016071; GO:0030154; GO:0043226; GO:0048856,immune system process; DNA binding; RNA binding; nucleus; cytosol; cell adhesion; programmed cell death; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_04246,0.516505904458117,OG_04246,FUN_017768-T1,Peve_00008289,Pocillopora_meandrina_HIv1___RNAseq.g461.t1,three_way,94.55683333333332,FUN_017768-T1,P51665,PSMD7_HUMAN,,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),Homo sapiens (Human),79.5,273.0,5.9999999999999985e-127,455.3,sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,extracellular region; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_09753,0.5163435827316907,OG_09753,FUN_042023-T1,Peve_00044157,Pocillopora_meandrina_HIv1___RNAseq.g15167.t1,three_way,91.09866666666666,FUN_042023-T1,Q0V9R4,,,,,42.4,877.0,1.1e-163,578.9,sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1,,,,,,
OG_03580,0.5162897851089561,OG_03580,FUN_014735-T1,Peve_00010434,Pocillopora_meandrina_HIv1___RNAseq.g22482.t1,three_way,69.71300000000001,FUN_014735-T1,O15400,STX7_HUMAN,,Syntaxin-7,Homo sapiens (Human),38.0,221.0,1.3e-21,105.1,sp|O15400|STX7_HUMAN Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4,GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076,intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982],chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0098772,lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_02895,0.5161781123142392,OG_02895,FUN_011952-T1,Peve_00010553,Pocillopora_meandrina_HIv1___RNAseq.g24084.t1,three_way,79.57983333333334,FUN_011952-T1,Q6ZTR5,CFA47_HUMAN,,Cilia- and flagella-associated protein 47,Homo sapiens (Human),33.2,3239.0,0.0,1751.5,sp|Q6ZTR5|CFA47_HUMAN Cilia- and flagella-associated protein 47 OS=Homo sapiens OX=9606 GN=CFAP47 PE=1 SV=5,GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0031514; GO:0060271; GO:0120212,cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212],,GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782,cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization
OG_00264,0.5160582116987327,OG_00264,FUN_001041-T1,Peve_00028475,Pocillopora_meandrina_HIv1___TS.g6804.t1,three_way,83.21833333333333,FUN_001041-T1,Q7Z5V6,SAXO4_HUMAN,,Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32),Homo sapiens (Human),33.2,455.0,1.0999999999999999e-62,242.3,sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1,GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126],phosphatase binding [GO:0019902],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_05654,0.5158747847514856,OG_05654,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_03122,0.5155966958681257,OG_03122,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_00853,0.5154979934012189,OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_08557,0.51532800824089,OG_08557,FUN_037545-T1,Peve_00032229,Pocillopora_meandrina_HIv1___RNAseq.g1633.t2,three_way,65.51433333333333,FUN_037545-T1,P60483,,,,,47.9,382.0,1.2e-98,361.7,"sp|P60483|PTEN_CANLF Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Canis lupus familiaris OX=9615 GN=PTEN PE=2 SV=1",,,,,,
OG_06452,0.515312952557334,OG_06452,FUN_029173-T1,Peve_00015170,Pocillopora_meandrina_HIv1___RNAseq.g25496.t1,three_way,85.54066666666667,FUN_029173-T1,Q3T003,,,,,65.9,176.0,1.4e-69,263.8,sp|Q3T003|RL18A_BOVIN Large ribosomal subunit protein eL20 OS=Bos taurus OX=9913 GN=RPL18A PE=1 SV=1,,,,,,
OG_05798,0.5151257643359084,OG_05798,FUN_025782-T1,Peve_00009656,Pocillopora_meandrina_HIv1___RNAseq.g10389.t1,three_way,90.97166666666666,FUN_025782-T1,Q9U505,,,,,57.1,168.0,8.099999999999997e-35,148.3,"sp|Q9U505|AT5G_MANSE ATP synthase lipid-binding protein, mitochondrial OS=Manduca sexta OX=7130 PE=2 SV=1",,,,,,
OG_07452,0.5147835341408565,OG_07452,FUN_033947-T1,Peve_00039784,Pocillopora_meandrina_HIv1___TS.g19318.t2,three_way,67.47200000000001,FUN_033947-T1,P29775,,,,,48.1,81.0,2.5e-14,81.3,sp|P29775|ETS4_DROME DNA-binding protein D-ETS-4 OS=Drosophila melanogaster OX=7227 GN=Ets98B PE=2 SV=3,,,,,,
OG_02012,0.5146498033118704,OG_02012,FUN_008185-T1,Peve_00018749,Pocillopora_meandrina_HIv1___RNAseq.g29992.t1,three_way,52.86033333333334,FUN_008185-T1,O57382,,,,,29.0,317.0,5.399999999999999e-31,137.5,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_10205,0.5145430572159646,OG_10205,FUN_043638-T1,Peve_00003079,Pocillopora_meandrina_HIv1___RNAseq.g7413.t1,three_way,47.27816666666666,FUN_043638-T1,B3EWY7,,,,,95.8,359.0,2.8e-170,599.4,sp|B3EWY7|ASOMP_ACRMI Acidic skeletal organic matrix protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09069,0.5144640875835133,OG_09069,FUN_038793-T1,Peve_00007204,Pocillopora_meandrina_HIv1___RNAseq.g26398.t1,three_way,68.06166666666667,,,,,,,,,,,,,,,,,
OG_04593,0.514122102979029,OG_04593,FUN_022271-T1,Peve_00007683,Pocillopora_meandrina_HIv1___RNAseq.g4712.t1,three_way,56.11566666666666,FUN_022271-T1,Q5F479,,,,,25.6,679.0,7.7e-41,171.4,sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1,,,,,,
OG_09426,0.5140635778795253,OG_09426,FUN_041310-T1,Peve_00023188,Pocillopora_meandrina_HIv1___TS.g11106.t1,three_way,76.71966666666667,FUN_041310-T1,P50532,,,,,62.6,1213.0,5.000000000000001e-227,789.6,sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1,,,,,,
OG_07343,0.5138192765989179,OG_07343,FUN_033748-T1,Peve_00004932,Pocillopora_meandrina_HIv1___RNAseq.g28754.t1,three_way,36.10916666666667,,,,,,,,,,,,,,,,,
OG_02427,0.5137179530920726,OG_02427,FUN_009353-T1,Peve_00038076,Pocillopora_meandrina_HIv1___TS.g5893.t2,three_way,91.464,FUN_009353-T1,Q99K70,RRAGC_MOUSE,,Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929),Mus musculus (Mouse),72.1,380.0,5.399999999999999e-151,535.4,sp|Q99K70|RRAGC_MOUSE Ras-related GTP-binding protein C OS=Mus musculus OX=10090 GN=Rragc PE=1 SV=1,GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0019003; GO:0032008; GO:0034198; GO:0043200; GO:0043495; GO:0046982; GO:0051020; GO:0060090; GO:0061462; GO:0072657; GO:0140767; GO:1904263; GO:1990877,cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; response to amino acid [GO:0043200],cytoplasm [GO:0005737]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],enzyme-substrate adaptor activity [GO:0140767]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; protein-membrane adaptor activity [GO:0043495],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0060090,catalytic activity; GTPase activity; nucleus; nucleoplasm; lysosome; vacuole; hydrolase activity; organelle; molecular adaptor activity
OG_04401,0.5135210406246742,OG_04401,FUN_018412-T1,Peve_00031696,Pocillopora_meandrina_HIv1___TS.g23694.t2,three_way,59.120666666666665,FUN_018412-T1,P28648,CD63_RAT,,CD63 antigen (Mast cell antigen AD1) (CD antigen CD63),Rattus norvegicus (Rat),36.8,242.0,2.3e-35,150.6,sp|P28648|CD63_RAT CD63 antigen OS=Rattus norvegicus OX=10116 GN=Cd63 PE=1 SV=2,GO:0002092; GO:0005615; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],"cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]",protein-containing complex binding [GO:0044877],GO:0005615; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007155; GO:0030154; GO:0031410; GO:0043226; GO:0048870,extracellular space; nucleoplasm; lysosome; endosome; vacuole; plasma membrane; cell adhesion; cell differentiation; cytoplasmic vesicle; organelle; cell motility
OG_01339,0.5131143665035576,OG_01339,FUN_005238-T1,Peve_00014029,Pocillopora_meandrina_HIv1___RNAseq.g8109.t1,three_way,79.287,,,,,,,,,,,,,,,,,
OG_09805,0.5130149180624215,OG_09805,FUN_042623-T1,Peve_00016196,Pocillopora_meandrina_HIv1___RNAseq.g11512.t1,three_way,79.597,FUN_042623-T1,Q5F3Z7,,,,,46.0,448.0,2.6e-95,350.5,sp|Q5F3Z7|CTSL2_CHICK CTD small phosphatase-like protein 2 OS=Gallus gallus OX=9031 GN=CTDSPL2 PE=2 SV=2,,,,,,
OG_04484,0.5129751760774397,OG_04484,FUN_021473-T1,Peve_00002680,Pocillopora_meandrina_HIv1___RNAseq.g2937.t1,three_way,63.3845,FUN_021473-T1,Q3UHB8,,,,,29.0,335.0,3.1e-11,72.0,sp|Q3UHB8|CC177_MOUSE Coiled-coil domain-containing protein 177 OS=Mus musculus OX=10090 GN=Ccdc177 PE=1 SV=1,,,,,,
OG_03074,0.5129477716259988,OG_03074,FUN_012346-T1,Peve_00012047,Pocillopora_meandrina_HIv1___RNAseq.g24067.t1,three_way,82.01583333333333,FUN_012346-T1,Q7ZVB1,,,,,81.2,197.0,8.7e-44,178.3,sp|Q7ZVB1|CHM1B_DANRE Charged multivesicular body protein 1b OS=Danio rerio OX=7955 GN=chmp1b PE=2 SV=1,,,,,,
OG_05113,0.5127644485723422,OG_05113,FUN_023372-T1,Peve_00005358,Pocillopora_meandrina_HIv1___RNAseq.g17530.t1,three_way,85.00200000000001,FUN_023372-T1,Q14582,,,,,37.6,202.0,1.9e-13,77.4,sp|Q14582|MAD4_HUMAN Max dimerization protein 4 OS=Homo sapiens OX=9606 GN=MXD4 PE=1 SV=2,,,,,,
OG_04260,0.512654227781246,OG_04260,FUN_017806-T1,Peve_00040748,Pocillopora_meandrina_HIv1___RNAseq.g9534.t1,three_way,60.276333333333326,FUN_017806-T1,Q5ZJH7,,,,,46.4,211.0,5.8e-50,199.9,sp|Q5ZJH7|CNPD1_CHICK Protein CNPPD1 OS=Gallus gallus OX=9031 GN=CNPPD1 PE=2 SV=1,,,,,,
OG_06002,0.5126116299286629,OG_06002,FUN_026491-T1,Peve_00032989,Pocillopora_meandrina_HIv1___RNAseq.g4193.t1,three_way,81.38333333333334,FUN_026491-T1,E1B836,ENKUR_BOVIN,,Enkurin,Bos taurus (Bovine),51.8,249.0,8.1e-66,251.9,sp|E1B836|ENKUR_BOVIN Enkurin OS=Bos taurus OX=9913 GN=ENKUR PE=1 SV=2,GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0036126; GO:0061966; GO:0097228; GO:0097728; GO:0160112,establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317],9+0 motile cilium [GO:0097728]; acrosomal vesicle [GO:0001669]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228],calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_09423,0.5125980368768643,OG_09423,FUN_041212-T1,Peve_00021331,Pocillopora_meandrina_HIv1___RNAseq.g16096.t1,three_way,86.64866666666667,FUN_041212-T1,P10114,RAP2A_HUMAN,,Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30),Homo sapiens (Human),76.6,154.0,7.7e-65,248.1,sp|P10114|RAP2A_HUMAN Ras-related protein Rap-2a OS=Homo sapiens OX=9606 GN=RAP2A PE=1 SV=1,GO:0000287; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0008104; GO:0019003; GO:0030033; GO:0030036; GO:0030336; GO:0030496; GO:0031954; GO:0032486; GO:0045184; GO:0046328; GO:0048814; GO:0051963; GO:0055037; GO:0055038; GO:0071466; GO:0072659; GO:0097060; GO:0098685; GO:0099072,actin cytoskeleton organization [GO:0030036]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963],cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0031410; GO:0043226; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_03540,0.5125838660183695,OG_03540,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_05025,0.512530643204415,OG_05025,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_06486,0.5125229121167947,OG_06486,FUN_029260-T1,Peve_00024369,Pocillopora_meandrina_HIv1___RNAseq.g15032.t1,three_way,74.517,FUN_029260-T1,Q13905,,,,,47.8,335.0,2.1000000000000002e-73,279.3,sp|Q13905|RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=RAPGEF1 PE=1 SV=3,,,,,,
OG_06371,0.5123253858313223,OG_06371,FUN_028976-T1,Peve_00016207,Pocillopora_meandrina_HIv1___RNAseq.g25603.t1,three_way,67.631,FUN_028976-T1,Q8IXL7,MSRB3_HUMAN,,Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14),Homo sapiens (Human),57.7,137.0,7.799999999999999e-46,184.9,sp|Q8IXL7|MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens OX=9606 GN=MSRB3 PE=1 SV=2,GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005783; GO:0005829; GO:0016491; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; cytosol; oxidoreductase activity; organelle
OG_00055,0.5122026840661198,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_08933,0.5121110350337741,OG_08933,FUN_038395-T1,Peve_00000045,Pocillopora_meandrina_HIv1___RNAseq.g28267.t1,three_way,81.313,FUN_038395-T1,Q96DY2,,,,,34.0,429.0,5e-53,210.3,sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2,,,,,,
OG_07639,0.5119224185713709,OG_07639,FUN_034399-T1,Peve_00002471,Pocillopora_meandrina_HIv1___RNAseq.g28580.t1,three_way,85.80316666666667,FUN_034399-T1,Q9EPL8,IPO7_MOUSE,,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),Mus musculus (Mouse),55.4,1040.0,2.1e-311,1069.7,sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331,innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0043226; GO:0098542,immune system process; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; organelle; defense response to other organism
OG_03531,0.5118554184122331,OG_03531,FUN_014646-T1,Peve_00025654,Pocillopora_meandrina_HIv1___RNAseq.g22686.t1,three_way,77.64233333333333,FUN_014646-T1,Q9D1L0,,,,,56.7,60.0,7.4e-11,68.6,sp|Q9D1L0|CHCH2_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chchd2 PE=2 SV=1,,,,,,
OG_08795,0.5117084711534473,OG_08795,FUN_038091-T1,Peve_00007109,Pocillopora_meandrina_HIv1___RNAseq.g818.t1,three_way,94.97433333333332,FUN_038091-T1,A6QLG5,RS9_BOVIN,,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Bos taurus (Bovine),90.0,170.0,6.9e-83,308.1,sp|A6QLG5|RS9_BOVIN Small ribosomal subunit protein uS4 OS=Bos taurus OX=9913 GN=RPS9 PE=2 SV=1,GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022627; GO:0032040; GO:0042274; GO:1990904,ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_06281,0.5115075290133592,OG_06281,FUN_028450-T1,Peve_00002378,Pocillopora_meandrina_HIv1___RNAseq.g16191.t1,three_way,41.13883333333333,FUN_028450-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),28.0,168.0,1.3e-08,62.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_03113,0.5113240405513693,OG_03113,FUN_012418-T1,Peve_00026919,Pocillopora_meandrina_HIv1___RNAseq.g23687.t1,three_way,85.58083333333333,FUN_012418-T1,Q4V7D3,MACOI_RAT,,Macoilin (Macoilin-1) (Transmembrane protein 57),Rattus norvegicus (Rat),39.0,715.0,7.6e-111,402.9,sp|Q4V7D3|MACOI_RAT Macoilin OS=Rattus norvegicus OX=10116 GN=Maco1 PE=1 SV=1,GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0043005; GO:0044306; GO:0045202,brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041],axon [GO:0030424]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202],microtubule binding [GO:0008017],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_03938,0.5111131520709126,OG_03938,FUN_016055-T1,Peve_00011789,Pocillopora_meandrina_HIv1___RNAseq.g21631.t1,three_way,71.45683333333334,FUN_016055-T1,Q8IYT8,ULK2_HUMAN,,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),Homo sapiens (Human),34.9,1096.0,7e-132,473.4,sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05804,0.5109406250355386,OG_05804,FUN_025798-T1,Peve_00017924,Pocillopora_meandrina_HIv1___RNAseq.g10383.t1,three_way,63.96233333333333,FUN_025798-T1,P0CB42,ALKB1_MOUSE,,Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-),Mus musculus (Mouse),41.8,275.0,7.2e-58,226.1,sp|P0CB42|ALKB1_MOUSE Nucleic acid dioxygenase ALKBH1 OS=Mus musculus OX=10090 GN=Alkbh1 PE=1 SV=1,GO:0000049; GO:0000791; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005654; GO:0005739; GO:0005783; GO:0006281; GO:0006446; GO:0006448; GO:0008198; GO:0010468; GO:0016706; GO:0030154; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0140078; GO:0141131; GO:0141137; GO:1990983; GO:1990984,"cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; positive regulation of gene expression, epigenetic [GO:0141137]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by tRNA modification [GO:1990983]; RNA repair [GO:0042245]; tRNA wobble cytosine modification [GO:0002101]",endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; broad specificity oxidative DNA demethylase activity [GO:0035516]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N6-methyladenine demethylase activity [GO:0141131]; ferrous iron binding [GO:0008198]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0005783; GO:0006281; GO:0006325; GO:0006399; GO:0016491; GO:0016829; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140097; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; mitochondrion; endoplasmic reticulum; DNA repair; chromatin organization; tRNA metabolic process; oxidoreductase activity; lyase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_03039,0.5108840218101349,OG_03039,FUN_012278-T1,Peve_00010528,Pocillopora_meandrina_HIv1___RNAseq.g23570.t1,three_way,80.52133333333333,FUN_012278-T1,Q9D5W4,,,,,40.4,708.0,7.8e-127,456.1,sp|Q9D5W4|CCD81_MOUSE Coiled-coil domain-containing protein 81 OS=Mus musculus OX=10090 GN=Ccdc81 PE=2 SV=1,,,,,,
OG_06716,0.5107895397992454,OG_06716,FUN_031466-T1,Peve_00026559,Pocillopora_meandrina_HIv1___RNAseq.g5146.t1,three_way,90.51,FUN_031466-T1,Q2KIU7,,,,,53.2,278.0,5.9e-83,308.9,sp|Q2KIU7|RSPH9_BOVIN Radial spoke head protein 9 homolog OS=Bos taurus OX=9913 GN=RSPH9 PE=2 SV=1,,,,,,
OG_05578,0.5107585419545191,OG_05578,FUN_024891-T1,Peve_00008003,Pocillopora_meandrina_HIv1___RNAseq.g19789.t1,three_way,93.80933333333331,FUN_024891-T1,P52046,,,,,32.8,235.0,1.5999999999999999e-24,114.8,sp|P52046|CRT_CLOAB Short-chain-enoyl-CoA hydratase OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=crt PE=1 SV=1,,,,,,
OG_07579,0.5107552578870854,OG_07579,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09043,0.5107299007719225,OG_09043,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_00363,0.5106063371185382,OG_00363,FUN_001198-T1,Peve_00022305,Pocillopora_meandrina_HIv1___RNAseq.g29522.t1,three_way,79.51466666666667,FUN_001198-T1,O94394,,,,,27.7,159.0,2.2e-08,61.6,sp|O94394|YQF1_SCHPO Uncharacterized WD repeat-containing protein C126.01c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC126.01c PE=4 SV=2,,,,,,
OG_02702,0.5104792695578265,OG_02702,FUN_010977-T1,Peve_00013380,Pocillopora_meandrina_HIv1___RNAseq.g22016.t2,three_way,61.6055,FUN_010977-T1,Q8VCM2,NOXO1_MOUSE,,NADPH oxidase organizer 1 (Nox organizer 1) (Sorting nexin-28),Mus musculus (Mouse),34.5,110.0,2e-12,76.3,sp|Q8VCM2|NOXO1_MOUSE NADPH oxidase organizer 1 OS=Mus musculus OX=10090 GN=Noxo1 PE=1 SV=2,GO:0005886; GO:0006801; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0043020,extracellular matrix disassembly [GO:0022617]; superoxide metabolic process [GO:0006801],NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176],GO:0005886; GO:0008289; GO:0030198; GO:0098772,plasma membrane; lipid binding; extracellular matrix organization; molecular function regulator activity
OG_08474,0.5103454797551288,OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_01380,0.51020806560538,OG_01380,FUN_005337-T1,Peve_00035211,Pocillopora_meandrina_HIv1___RNAseq.g8198.t1,three_way,71.58449999999999,FUN_005337-T1,Q0II22,RN126_BOVIN,,E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126),Bos taurus (Bovine),38.8,291.0,3.2e-43,176.8,sp|Q0II22|RN126_BOVIN E3 ubiquitin-protein ligase RNF126 OS=Bos taurus OX=9913 GN=RNF126 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0008270; GO:0016567; GO:0035519; GO:0042059; GO:0042127; GO:0042147; GO:0043161; GO:0043162; GO:0044314; GO:0061630; GO:0070534; GO:0070936; GO:0071629; GO:1905168,"cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08941,0.5099447531721202,OG_08941,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_05385,0.5099367245064957,OG_05385,FUN_024206-T1,Peve_00031875,Pocillopora_meandrina_HIv1___RNAseq.g18903.t1,three_way,91.63933333333333,FUN_024206-T1,P61221,ABCE1_HUMAN,,ATP-binding cassette sub-family E member 1 (EC 3.6.5.-) (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I),Homo sapiens (Human),81.8,598.0,6e-290,997.7,sp|P61221|ABCE1_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1,GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016020; GO:0016887; GO:0017111; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0060702; GO:0072344,negative regulation of endoribonuclease activity [GO:0060702]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]; translational termination [GO:0006415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; endoribonuclease inhibitor activity [GO:0060698]; GTPase activity [GO:0003924]; iron ion binding [GO:0005506]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]",GO:0003824; GO:0003924; GO:0005739; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; mitochondrion; cytosol; ribosome; hydrolase activity; organelle; molecular function regulator activity
OG_07419,0.5098171380723596,OG_07419,FUN_033880-T1,Peve_00043309,Pocillopora_meandrina_HIv1___RNAseq.g28401.t1,three_way,84.31566666666667,FUN_033880-T1,Q66II8,,,,,67.6,225.0,2.1e-77,290.8,sp|Q66II8|RU17_XENTR U1 small nuclear ribonucleoprotein 70 kDa OS=Xenopus tropicalis OX=8364 GN=snrnp70 PE=2 SV=1,,,,,,
OG_09310,0.5093658399675632,OG_09310,FUN_040209-T1,Peve_00038127,Pocillopora_meandrina_HIv1___RNAseq.g7741.t1b,three_way,71.60266666666666,FUN_040209-T1,Q70E20,,,,,53.0,251.0,2.2e-72,275.8,"sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2",,,,,,
OG_05876,0.509356948576455,OG_05876,FUN_026025-T1,Peve_00026725,Pocillopora_meandrina_HIv1___RNAseq.g10478.t1,three_way,86.32866666666666,FUN_026025-T1,Q8N0X2,SPG16_HUMAN,,Sperm-associated antigen 16 protein (Pf20 protein homolog),Homo sapiens (Human),40.9,362.0,5.5e-70,266.9,sp|Q8N0X2|SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens OX=9606 GN=SPAG16 PE=1 SV=2,GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716,axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288],axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],,GO:0003016; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0050877,respiratory system process; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; nervous system process
OG_08491,0.509140631738764,OG_08491,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_01518,0.5091062528124823,OG_01518,FUN_006261-T1,Peve_00015046,Pocillopora_meandrina_HIv1___RNAseq.g20376.t1,three_way,47.83533333333333,,,,,,,,,,,,,,,,,
OG_01750,0.5088555731178257,OG_01750,FUN_007084-T1,Peve_00019890,Pocillopora_meandrina_HIv1___RNAseq.g20077.t2,three_way,43.15733333333333,FUN_007084-T1,Q99PF6,,,,,38.2,173.0,8.5e-17,90.9,sp|Q99PF6|GAB1_MESAU GRB2-associated-binding protein 1 OS=Mesocricetus auratus OX=10036 GN=GAB1 PE=2 SV=1,,,,,,
OG_00811,0.508731546036609,OG_00811,FUN_004011-T1,Peve_00044901,Pocillopora_meandrina_HIv1___RNAseq.g24674.t1,three_way,43.192,,,,,,,,,,,,,,,,,
OG_09952,0.5086340488668553,OG_09952,FUN_043119-T1,Peve_00025023,Pocillopora_meandrina_HIv1___RNAseq.g7886.t1,three_way,82.92333333333333,FUN_043119-T1,Q3ZBN8,,,,,62.8,113.0,6e-34,144.8,sp|Q3ZBN8|TIM14_BOVIN Mitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3,,,,,,
OG_07521,0.5084895107415023,OG_07521,FUN_034091-T1,Peve_00037069,Pocillopora_meandrina_HIv1___RNAseq.g26062.t1,three_way,83.5495,FUN_034091-T1,Q9VWG3,,,,,62.3,154.0,1.1e-44,181.0,sp|Q9VWG3|RS10B_DROME Small ribosomal subunit protein eS10B OS=Drosophila melanogaster OX=7227 GN=RpS10b PE=1 SV=2,,,,,,
OG_08481,0.5082557645472745,OG_08481,FUN_037310-T1,Peve_00011736,Pocillopora_meandrina_HIv1___RNAseq.g10709.t1,three_way,72.46583333333334,FUN_037310-T1,Q08CX1,,,,,28.3,853.0,6.6e-61,237.3,sp|Q08CX1|RASEF_XENTR Ras and EF-hand domain-containing protein OS=Xenopus tropicalis OX=8364 GN=rasef PE=2 SV=1,,,,,,
OG_02059,0.5081920144362911,OG_02059,FUN_008273-T1,Peve_00001960,Pocillopora_meandrina_HIv1___RNAseq.g17981.t1,three_way,91.13633333333333,FUN_008273-T1,Q96M32,KAD7_HUMAN,,Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7),Homo sapiens (Human),53.6,705.0,2.1999999999999998e-187,657.1,sp|Q96M32|KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens OX=9606 GN=AK7 PE=1 SV=3,GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0030030; GO:0031514,cell projection organization [GO:0030030],cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514],(d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005829; GO:0005929; GO:0016740; GO:0043226,catalytic activity; cytosol; cilium; transferase activity; organelle
OG_10033,0.5080795507992074,OG_10033,FUN_043290-T1,Peve_00016457,Pocillopora_meandrina_HIv1___RNAseq.g8864.t1,three_way,76.351,FUN_043290-T1,Q6GN42,CTL4_XENLA,,Choline transporter-like protein 4 (Solute carrier family 44 member 4),Xenopus laevis (African clawed frog),41.9,704.0,1e-147,525.4,sp|Q6GN42|CTL4_XENLA Choline transporter-like protein 4 OS=Xenopus laevis OX=8355 GN=slc44a4 PE=2 SV=1,GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422,acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422],GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_05708,0.5079820279817551,OG_05708,FUN_025581-T1,Peve_00010643,Pocillopora_meandrina_HIv1___RNAseq.g13741.t1,three_way,99.04733333333331,FUN_025581-T1,P62147,,,,,99.1,117.0,7.6e-29,128.3,sp|P62147|CALM1_BRAFL Calmodulin-1 OS=Branchiostoma floridae OX=7739 PE=2 SV=2,,,,,,
OG_03972,0.5078509921175242,OG_03972,FUN_016126-T1,Peve_00013450,Pocillopora_meandrina_HIv1___RNAseq.g21529.t1,three_way,54.19866666666667,,,,,,,,,,,,,,,,,
OG_03269,0.5074302049881183,OG_03269,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_02945,0.5073974761056426,OG_02945,FUN_012059-T1,Peve_00004100,Pocillopora_meandrina_HIv1___RNAseq.g23640.t1,three_way,57.582,,,,,,,,,,,,,,,,,
OG_09554,0.5073260642516211,OG_09554,FUN_041657-T1,Peve_00033087,Pocillopora_meandrina_HIv1___RNAseq.g13861.t2,three_way,47.284333333333336,,,,,,,,,,,,,,,,,
OG_01413,0.5070909316903659,OG_01413,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_04107,0.507075788287027,OG_04107,FUN_016472-T1,Peve_00015305,Pocillopora_meandrina_HIv1___TS.g6873.t1,three_way,61.89483333333333,FUN_016472-T1,A4IJ06,GRP1_XENTR,,RAS guanyl-releasing protein 1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.0,234.0,1.6e-47,191.4,sp|A4IJ06|GRP1_XENTR RAS guanyl-releasing protein 1 OS=Xenopus tropicalis OX=8364 GN=rasgrp1 PE=2 SV=1,GO:0000139; GO:0005085; GO:0005509; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0008270; GO:0030154,cell differentiation [GO:0030154]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0005829; GO:0005886; GO:0030154; GO:0098772,cytosol; plasma membrane; cell differentiation; molecular function regulator activity
OG_08969,0.5068564116756081,OG_08969,FUN_038474-T1,Peve_00039890,Pocillopora_meandrina_HIv1___RNAseq.g28227.t1,three_way,84.79233333333333,FUN_038474-T1,Q9R0Q6,,,,,53.0,372.0,2.5e-108,393.7,sp|Q9R0Q6|ARC1A_MOUSE Actin-related protein 2/3 complex subunit 1A OS=Mus musculus OX=10090 GN=Arpc1a PE=1 SV=1,,,,,,
OG_00295,0.5065665523937978,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),65.8,225.0,9.999999999999999e-33,143.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00295,0.5065665523937978,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),81.6,38.0,1.9e-07,59.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_09174,0.5062813005380946,OG_09174,FUN_039850-T1,Peve_00002765,Pocillopora_meandrina_HIv1___RNAseq.g7297.t1b,three_way,65.15933333333334,FUN_039850-T1,Q9R0M0,CELR2_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 2 (Flamingo homolog),Mus musculus (Mouse),24.0,484.0,2.4e-22,110.5,sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3,GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0016055; GO:0021591; GO:0021999; GO:0032880; GO:0033326; GO:0060271; GO:0097475,cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0006355; GO:0007018; GO:0007155; GO:0044782; GO:0048856; GO:0048870; GO:0060089,plasma membrane; regulation of DNA-templated transcription; microtubule-based movement; cell adhesion; cilium organization; anatomical structure development; cell motility; molecular transducer activity
OG_05630,0.5061666592193955,OG_05630,FUN_025325-T1,Peve_00027073,Pocillopora_meandrina_HIv1___RNAseq.g13419.t1,three_way,77.61399999999999,FUN_025325-T1,Q02360,,,,,49.5,107.0,1.9e-22,108.2,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_02954,0.5059218827498299,OG_02954,FUN_012097-T1,Peve_00007422,Pocillopora_meandrina_HIv1___RNAseq.g23949.t1,three_way,67.32366666666667,FUN_012097-T1,A0A1W2P884,,,,,30.2,473.0,2.6e-15,85.5,sp|A0A1W2P884|CE85L_MOUSE Centrosomal protein of 85 kDa-like OS=Mus musculus OX=10090 GN=Cep85l PE=3 SV=1,,,,,,
OG_05725,0.5057790770586222,OG_05725,FUN_025644-T1,Peve_00002563,Pocillopora_meandrina_HIv1___RNAseq.g23094.t1,three_way,55.178,,,,,,,,,,,,,,,,,
OG_04645,0.5057472108058363,OG_04645,FUN_022375-T1,Peve_00013232,Pocillopora_meandrina_HIv1___RNAseq.g9298.t2,three_way,64.13066666666667,,,,,,,,,,,,,,,,,
OG_03451,0.5056964230297789,OG_03451,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_09909,0.5049513976648748,OG_09909,FUN_043007-T1,Peve_00017772,Pocillopora_meandrina_HIv1___RNAseq.4691_t,three_way,55.84033333333333,FUN_043007-T1,A3BF39,HMA2_ORYSJ,,Cadmium/zinc-transporting ATPase HMA2 (EC 7.2.2.12) (EC 7.2.2.21) (Protein HEAVY METAL ATPASE 2) (OsHMA2),Oryza sativa subsp. japonica (Rice),39.4,746.0,3.1e-123,444.9,sp|A3BF39|HMA2_ORYSJ Cadmium/zinc-transporting ATPase HMA2 OS=Oryza sativa subsp. japonica OX=39947 GN=HMA2 PE=1 SV=1,GO:0005524; GO:0005886; GO:0008551; GO:0016020; GO:0016463; GO:0016887; GO:0022857; GO:0046872; GO:0055085,transmembrane transport [GO:0055085],membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type cadmium transporter activity [GO:0008551]; P-type zinc transporter activity [GO:0016463]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_02583,0.5048687076383098,OG_02583,FUN_010702-T1,Peve_00022610,Pocillopora_meandrina_HIv1___RNAseq.g20975.t1,three_way,89.09666666666666,FUN_010702-T1,Q922G7,,,,,52.3,354.0,2e-96,354.4,sp|Q922G7|TEKT2_MOUSE Tektin-2 OS=Mus musculus OX=10090 GN=Tekt2 PE=1 SV=1,,,,,,
OG_09015,0.5048401578357475,OG_09015,FUN_038577-T1,Peve_00012107,Pocillopora_meandrina_HIv1___RNAseq.g1011.t1,three_way,67.471,FUN_038577-T1,Q0QWG9,GRD2I_MOUSE,,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Mus musculus (Mouse),28.8,420.0,9.800000000000001e-34,147.1,sp|Q0QWG9|GRD2I_MOUSE Delphilin OS=Mus musculus OX=10090 GN=Grid2ip PE=1 SV=1,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]",,GO:0007010; GO:0043226,cytoskeleton organization; organelle
OG_03981,0.5048337432517814,OG_03981,FUN_016140-T1,Peve_00022584,Pocillopora_meandrina_HIv1___RNAseq.g22032.t2,three_way,82.32233333333333,FUN_016140-T1,Q13247,SRSF6_HUMAN,,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",Homo sapiens (Human),62.1,182.0,6.6e-61,235.7,sp|Q13247|SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens OX=9606 GN=SRSF6 PE=1 SV=2,GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0006376; GO:0010837; GO:0016607; GO:0032868; GO:0036002; GO:0045617; GO:0048025; GO:0060501; GO:0061041; GO:2000675,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_09762,0.5047452513508113,OG_09762,FUN_042036-T1,Peve_00025426,Pocillopora_meandrina_HIv1___RNAseq.g15187.t1,three_way,89.87166666666667,FUN_042036-T1,O00410,IPO5_HUMAN,,Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5),Homo sapiens (Human),54.7,1080.0,0.0,1178.7,sp|O00410|IPO5_HUMAN Importin-5 OS=Homo sapiens OX=9606 GN=IPO5 PE=1 SV=4,GO:0002753; GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0031965; GO:0042307; GO:0045786; GO:0061608; GO:0071230,cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; negative regulation of cell cycle [GO:0045786]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0098772; GO:0140104,immune system process; RNA binding; nucleus; nucleoplasm; nucleolus; Golgi apparatus; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular function regulator activity; molecular carrier activity
OG_00481,0.5045668060392611,OG_00481,FUN_001423-T1,Peve_00008791,Pocillopora_meandrina_HIv1___RNAseq.g2174.t1,three_way,80.44866666666667,FUN_001423-T1,Q5THR3,EFCB6_HUMAN,,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),Homo sapiens (Human),26.7,1522.0,2.7e-164,581.6,sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1,GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005654; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleoplasm; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_05712,0.5045429498302485,OG_05712,FUN_025596-T1,Peve_00037559,Pocillopora_meandrina_HIv1___RNAseq.g23150.t1,three_way,86.92,FUN_025596-T1,Q6NS26,,,,,65.8,549.0,1.3000000000000002e-214,747.3,sp|Q6NS26|CDKAL_XENLA Threonylcarbamoyladenosine tRNA methylthiotransferase OS=Xenopus laevis OX=8355 GN=cdkal1 PE=2 SV=1,,,,,,
OG_08367,0.504297636475974,OG_08367,FUN_036919-T1,Peve_00018354,Pocillopora_meandrina_HIv1___RNAseq.g10824.t1,three_way,88.945,FUN_036919-T1,Q8BWT1,THIM_MOUSE,,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)",Mus musculus (Mouse),65.7,394.0,5.2e-149,528.9,"sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3",GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109,cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617],GO:0003824; GO:0005739; GO:0005815; GO:0006629; GO:0007005; GO:0016740; GO:0016787; GO:0043226; GO:0061024,catalytic activity; mitochondrion; microtubule organizing center; lipid metabolic process; mitochondrion organization; transferase activity; hydrolase activity; organelle; membrane organization
OG_05414,0.5041570870169916,OG_05414,FUN_024351-T1,Peve_00024494,Pocillopora_meandrina_HIv1___RNAseq.g18673.t1,three_way,45.65566666666666,,,,,,,,,,,,,,,,,
OG_01011,0.5041557151554589,OG_01011,FUN_004438-T1,Peve_00033213,Pocillopora_meandrina_HIv1___RNAseq.g11482.t1,three_way,40.127,,,,,,,,,,,,,,,,,
OG_05663,0.5041042801636013,OG_05663,FUN_025432-T1,Peve_00029489,Pocillopora_meandrina_HIv1___RNAseq.g13327.t1,three_way,51.88183333333333,,,,,,,,,,,,,,,,,
OG_08405,0.5040843578296974,OG_08405,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_02944,0.5039418268909756,OG_02944,FUN_012058-T1,Peve_00004101,Pocillopora_meandrina_HIv1___RNAseq.g23641.t1,three_way,54.401,FUN_012058-T1,Q7Z020,,,,,28.9,662.0,1.1999999999999999e-46,190.3,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_01056,0.5038442709139757,OG_01056,FUN_004509-T1,Peve_00012958,Pocillopora_meandrina_HIv1___RNAseq.g11641.t1,three_way,58.72666666666667,,,,,,,,,,,,,,,,,
OG_03425,0.5037949234256622,OG_03425,FUN_014480-T1,Peve_00037298,Pocillopora_meandrina_HIv1___RNAseq.g22815.t1,three_way,78.496,FUN_014480-T1,Q6AZJ9,,,,,63.9,83.0,3e-28,125.9,sp|Q6AZJ9|RS21_XENLA Small ribosomal subunit protein eS21 OS=Xenopus laevis OX=8355 GN=rps21 PE=1 SV=1,,,,,,
OG_08010,0.5037336136648136,OG_08010,FUN_035663-T1,Peve_00038557,Pocillopora_meandrina_HIv1___RNAseq.g28119.t3,three_way,87.50766666666667,FUN_035663-T1,O75081,MTG16_HUMAN,,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),Homo sapiens (Human),42.8,549.0,6.600000000000001e-80,299.7,sp|O75081|MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:1903715,DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666],Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_06397,0.5037306385780919,OG_06397,FUN_029058-T1,Peve_00040067,Pocillopora_meandrina_HIv1___RNAseq.g25430.t1,three_way,34.364333333333335,,,,,,,,,,,,,,,,,
OG_06396,0.5036439096087658,OG_06396,FUN_029057-T1,Peve_00040058,Pocillopora_meandrina_HIv1___TS.g8868.t1,three_way,44.50083333333333,,,,,,,,,,,,,,,,,
OG_01039,0.5034224298826419,OG_01039,FUN_004474-T1,Peve_00007173,Pocillopora_meandrina_HIv1___RNAseq.g4947.t1,three_way,57.66016666666667,FUN_004474-T1,Q7TN02,MED26_MOUSE,,Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26),Mus musculus (Mouse),62.8,78.0,3.2e-18,94.4,sp|Q7TN02|MED26_MOUSE Mediator of RNA polymerase II transcription subunit 26 OS=Mus musculus OX=10090 GN=Med26 PE=1 SV=1,GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_05262,0.5033371023172267,OG_05262,FUN_023774-T1,Peve_00036451,Pocillopora_meandrina_HIv1___RNAseq.g24245.t1,three_way,66.79066666666667,FUN_023774-T1,Q8BXN7,PPM1K_MOUSE,,Protein phosphatase Mn(2+)-dependent 1K (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.16) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52),Mus musculus (Mouse),42.5,358.0,5.8e-70,266.2,sp|Q8BXN7|PPM1K_MOUSE Protein phosphatase Mn(2+)-dependent 1K OS=Mus musculus OX=10090 GN=Ppm1k PE=1 SV=1,GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108,branched-chain amino acid catabolic process [GO:0009083]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0006520; GO:0007005; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; mitochondrion organization; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_01841,0.5032374665181215,OG_01841,FUN_007787-T1,Peve_00022035,Pocillopora_meandrina_HIv1___RNAseq.12156_t,three_way,56.774,,,,,,,,,,,,,,,,,
OG_06963,0.5030237949814909,OG_06963,FUN_032093-T1,Peve_00019993,Pocillopora_meandrina_HIv1___TS.g23987.t2,three_way,67.63983333333334,,,,,,,,,,,,,,,,,
OG_09465,0.5024858841222628,OG_09465,FUN_041488-T1,Peve_00004075,Pocillopora_meandrina_HIv1___RNAseq.g15670.t1,three_way,61.912,FUN_041488-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),36.2,549.0,2.0999999999999998e-95,351.3,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07413,0.5023006439653693,OG_07413,FUN_033871-T1,Peve_00043321,Pocillopora_meandrina_HIv1___RNAseq.g28410.t2,three_way,61.42316666666667,FUN_033871-T1,Q54PQ4,GEFA_DICDI,,Ras guanine nucleotide exchange factor A (Aimless) (RasGEF domain-containing protein A),Dictyostelium discoideum (Social amoeba),35.0,214.0,6.6e-24,114.8,sp|Q54PQ4|GEFA_DICDI Ras guanine nucleotide exchange factor A OS=Dictyostelium discoideum OX=44689 GN=gefA PE=1 SV=1,GO:0000165; GO:0004860; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0010628; GO:0010856; GO:0030250; GO:0030295; GO:0030587; GO:0031152; GO:0043327; GO:0046579; GO:0051602; GO:0051897; GO:1903665; GO:1905742,aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; MAPK cascade [GO:0000165]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; response to electrical stimulus [GO:0051602]; sorocarp development [GO:0030587],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Ras guanyl-nucleotide exchange factor complex [GO:1905742],adenylate cyclase activator activity [GO:0010856]; guanyl-nucleotide exchange factor activity [GO:0005085]; guanylate cyclase activator activity [GO:0030250]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860],GO:0005829; GO:0005886; GO:0048856; GO:0098772,cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_01594,0.5021977081969158,OG_01594,FUN_006636-T1,Peve_00024051,Pocillopora_meandrina_HIv1___RNAseq.g20236.t1,three_way,88.66666666666667,FUN_006636-T1,Q12756,,,,,37.3,475.0,5e-70,267.3,sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2,,,,,,
OG_04473,0.5020787652747207,OG_04473,FUN_020853-T1,Peve_00032915,Pocillopora_meandrina_HIv1___RNAseq.g20812.t1,three_way,73.17133333333334,FUN_020853-T1,Q3MII6,TBC25_HUMAN,,TBC1 domain family member 25,Homo sapiens (Human),34.2,626.0,1.3000000000000001e-89,332.0,sp|Q3MII6|TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens OX=9606 GN=TBC1D25 PE=1 SV=2,GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:1901096,autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410],GTPase activator activity [GO:0005096],GO:0005773; GO:0006914; GO:0031410; GO:0043226; GO:0098772,vacuole; autophagy; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01157,0.5020289631627416,OG_01157,FUN_004768-T1,Peve_00002138,Pocillopora_meandrina_HIv1___RNAseq.g6696.t1,three_way,59.955666666666666,FUN_004768-T1,Q9UDY8,MALT1_HUMAN,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),Homo sapiens (Human),29.2,713.0,3.7e-62,241.1,sp|Q9UDY8|MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051168; GO:0051603; GO:0061133; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09412,0.5020277391051857,OG_09412,FUN_040923-T1,Peve_00012313,Pocillopora_meandrina_HIv1___RNAseq.g27560.t1,three_way,85.5445,FUN_040923-T1,Q4G0P3,HYDIN_HUMAN,,Hydrocephalus-inducing protein homolog,Homo sapiens (Human),43.3,3001.0,0.0,2169.8,sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3,GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718,axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0043226; GO:0048856,cilium; microtubule-based movement; organelle; anatomical structure development
OG_10010,0.5019426217709339,OG_10010,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_04983,0.501934808394679,OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_09375,0.501638013015175,OG_09375,FUN_040550-T1,Peve_00015404,Pocillopora_meandrina_HIv1___RNAseq.g6474.t1,three_way,68.12883333333333,FUN_040550-T1,A7RSH7,,,,,47.5,139.0,4.399999999999999e-24,113.2,sp|A7RSH7|EIF3J_NEMVE Eukaryotic translation initiation factor 3 subunit J OS=Nematostella vectensis OX=45351 GN=v1g240395 PE=3 SV=1,,,,,,
OG_04881,0.5014602955949753,OG_04881,FUN_022915-T1,Peve_00001787,Pocillopora_meandrina_HIv1___RNAseq.g3711.t1,three_way,84.37066666666666,FUN_022915-T1,P55036,PSMD4_HUMAN,,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),Homo sapiens (Human),60.6,383.0,1.1e-98,361.7,sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_04454,0.5010928398641163,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,0.5010928398641163,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_01249,0.4999878236973576,OG_01249,FUN_004949-T1,Peve_00043273,Pocillopora_meandrina_HIv1___RNAseq.g8396.t1,three_way,89.491,FUN_004949-T1,P50211,,,,,57.0,335.0,2.3e-100,367.1,sp|P50211|ISL1_CHICK Insulin gene enhancer protein ISL-1 OS=Gallus gallus OX=9031 GN=ISL1 PE=1 SV=1,,,,,,
OG_04399,0.49986836361594,OG_04399,FUN_018404-T1,Peve_00031698,Pocillopora_meandrina_HIv1___RNAseq.g10163.t1,three_way,62.86966666666667,FUN_018404-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),31.9,138.0,7.2e-09,64.7,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04198,0.499779821154081,OG_04198,FUN_016725-T1,Peve_00014679,Pocillopora_meandrina_HIv1___RNAseq.g233.t1,three_way,87.47433333333333,FUN_016725-T1,Q5FWL3,,,,,62.7,324.0,7.7e-119,428.3,sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1,,,,,,
OG_06273,0.4997469961422042,OG_06273,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00499,0.4996533186800577,OG_00499,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_04954,0.4996444550616074,OG_04954,FUN_023044-T1,Peve_00008510,Pocillopora_meandrina_HIv1___TS.g10041.t2,three_way,72.67383333333333,FUN_023044-T1,Q01085,TIAR_HUMAN,,Nucleolysin TIAR (TIA-1-related protein),Homo sapiens (Human),41.0,373.0,1e-67,258.8,sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637,apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357],cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; nucleoplasm; lysosome; vacuole; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_02795,0.4993759324538145,OG_02795,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_06816,0.4992060490132833,OG_06816,FUN_031719-T1,Peve_00039098,Pocillopora_meandrina_HIv1___RNAseq.g5470.t1,three_way,77.35166666666666,FUN_031719-T1,P80025,PERL_BOVIN,,Lactoperoxidase (LPO) (EC 1.11.1.7),Bos taurus (Bovine),35.0,448.0,4.4e-55,217.2,sp|P80025|PERL_BOVIN Lactoperoxidase OS=Bos taurus OX=9913 GN=LPO PE=1 SV=1,GO:0001580; GO:0004601; GO:0005509; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0019731; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,antibacterial humoral response [GO:0019731]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005615; GO:0016209; GO:0016491; GO:0098542,immune system process; catalytic activity; extracellular space; antioxidant activity; oxidoreductase activity; defense response to other organism
OG_04407,0.4988299682966036,OG_04407,FUN_018425-T1,Peve_00031687,Pocillopora_meandrina_HIv1___RNAseq.g10172.t1,three_way,90.69833333333332,FUN_018425-T1,Q9GT45,,,,,81.4,113.0,5.400000000000001e-44,178.3,sp|Q9GT45|RS26_ANOGA Small ribosomal subunit protein eS26 OS=Anopheles gambiae OX=7165 GN=RpS26 PE=3 SV=2,,,,,,
OG_02990,0.4987323074170333,OG_02990,FUN_012166-T1,Peve_00008632,Pocillopora_meandrina_HIv1___RNAseq.g23449.t1,three_way,81.14583333333333,FUN_012166-T1,Q9HU55,,,,,37.2,78.0,2.7e-11,71.6,sp|Q9HU55|GLRX_PSEAE Glutaredoxin OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=grx PE=3 SV=1,,,,,,
OG_01145,0.4985251004165298,OG_01145,FUN_004737-T1,Peve_00016797,Pocillopora_meandrina_HIv1___RNAseq.g8830.t1,three_way,67.98533333333333,FUN_004737-T1,P41413,,,,,45.9,878.0,2.600000000000001e-196,688.0,sp|P41413|PCSK5_RAT Proprotein convertase subtilisin/kexin type 5 OS=Rattus norvegicus OX=10116 GN=Pcsk5 PE=2 SV=3,,,,,,
OG_03313,0.4984917667517352,OG_03313,FUN_013391-T1,Peve_00028095,Pocillopora_meandrina_HIv1___RNAseq.g22975.t1,three_way,66.52533333333334,,,,,,,,,,,,,,,,,
OG_07826,0.4984243871166251,OG_07826,FUN_035122-T1,Peve_00005905,Pocillopora_meandrina_HIv1___RNAseq.g27642.t1,three_way,59.37683333333334,FUN_035122-T1,Q7T6X2,,,,,32.0,278.0,2.7e-20,102.1,sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R826 PE=3 SV=2,,,,,,
OG_02740,0.4982363908541209,OG_02740,FUN_011283-T1,Peve_00037294,Pocillopora_meandrina_HIv1___RNAseq.g22317.t1,three_way,93.90933333333334,FUN_011283-T1,Q8VHI7,,,,,53.9,453.0,2.5e-124,447.2,sp|Q8VHI7|DRC2_MOUSE Dynein regulatory complex subunit 2 OS=Mus musculus OX=10090 GN=Ccdc65 PE=1 SV=1,,,,,,
OG_01232,0.498210396557405,OG_01232,FUN_004917-T1,Peve_00044500,Pocillopora_meandrina_HIv1___TS.g20092.t1,three_way,76.50533333333333,,,,,,,,,,,,,,,,,
OG_03959,0.4981643928752374,OG_03959,FUN_016104-T1,Peve_00010767,Pocillopora_meandrina_HIv1___RNAseq.g21594.t1,three_way,76.85283333333332,FUN_016104-T1,Q9H3C7,,,,,65.9,355.0,1.6e-133,478.0,sp|Q9H3C7|GGNB2_HUMAN Gametogenetin-binding protein 2 OS=Homo sapiens OX=9606 GN=GGNBP2 PE=1 SV=1,,,,,,
OG_10208,0.4980159425267891,OG_10208,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
OG_06554,0.4979213860350294,OG_06554,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_05470,0.4975600791631305,OG_05470,FUN_024453-T1,Peve_00010317,Pocillopora_meandrina_HIv1___RNAseq.g18578.t1,three_way,82.89666666666666,FUN_024453-T1,Q3SYR7,,,,,65.0,177.0,1.7e-59,230.3,sp|Q3SYR7|RL9_BOVIN Large ribosomal subunit protein uL6 OS=Bos taurus OX=9913 GN=RPL9 PE=2 SV=1,,,,,,
OG_08711,0.4975318472012892,OG_08711,FUN_037963-T1,Peve_00009702,Pocillopora_meandrina_HIv1___RNAseq.17939_t,three_way,61.76616666666666,FUN_037963-T1,Q80YR4,,,,,47.4,310.0,3e-77,291.2,sp|Q80YR4|ZN598_MOUSE E3 ubiquitin-protein ligase ZNF598 OS=Mus musculus OX=10090 GN=Znf598 PE=1 SV=1,,,,,,
OG_07841,0.4975163389585008,OG_07841,FUN_035174-T1,Peve_00036186,Pocillopora_meandrina_HIv1___RNAseq.g27927.t1,three_way,61.35166666666667,FUN_035174-T1,Q5RB37,,,,,38.1,561.0,1.4e-103,379.4,sp|Q5RB37|ITIH3_PONAB Inter-alpha-trypsin inhibitor heavy chain H3 OS=Pongo abelii OX=9601 GN=ITIH3 PE=2 SV=1,,,,,,
OG_06028,0.4973429142213202,OG_06028,FUN_026589-T1,Peve_00043907,Pocillopora_meandrina_HIv1___TS.g21913.t2,three_way,75.30533333333334,FUN_026589-T1,F8WLE0,,,,,39.4,864.0,1.9e-152,541.6,sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1,,,,,,
OG_01387,0.4972343024203089,OG_01387,FUN_005356-T1,Peve_00016032,Pocillopora_meandrina_HIv1___RNAseq.g8215.t1,three_way,63.59766666666667,FUN_005356-T1,Q96I13,ABHD8_HUMAN,,Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8),Homo sapiens (Human),47.5,242.0,2.6e-58,227.6,sp|Q96I13|ABHD8_HUMAN Protein ABHD8 OS=Homo sapiens OX=9606 GN=ABHD8 PE=1 SV=1,GO:0005737; GO:0005739; GO:0006654; GO:0042171; GO:0052689; GO:0055088; GO:0070062; GO:1900226,lipid homeostasis [GO:0055088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; phosphatidic acid biosynthetic process [GO:0006654],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_02930,0.4968051661191761,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_01383,0.4967693120992796,OG_01383,FUN_005349-T1,Peve_00035217,Pocillopora_meandrina_HIv1___RNAseq.g8206.t1,three_way,72.3535,FUN_005349-T1,Q9W0M3,KDM8_DROME,,Jumonji C domain-containing protein 5 (EC 1.14.11.73) (EC 3.4.-.-) (Lysine-specific demethylase 8),Drosophila melanogaster (Fruit fly),23.6,233.0,1.3e-14,82.4,sp|Q9W0M3|KDM8_DROME Jumonji C domain-containing protein 5 OS=Drosophila melanogaster OX=7227 GN=JMJD5 PE=2 SV=2,GO:0000086; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0045892; GO:0046872; GO:0048511; GO:0048512; GO:0051864; GO:0106157; GO:0140680,circadian behavior [GO:0048512]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872]; peptidyl-arginine 3-dioxygenase activity [GO:0106157],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_06497,0.4967470668263619,OG_06497,FUN_029286-T1,Peve_00018583,Pocillopora_meandrina_HIv1___RNAseq.g16621.t1,three_way,73.06333333333333,,,,,,,,,,,,,,,,,
OG_08808,0.4967437282260188,OG_08808,FUN_038129-T1,Peve_00003024,Pocillopora_meandrina_HIv1___TS.g5300.t1,three_way,68.43533333333333,FUN_038129-T1,Q9SVG0,,,,,25.9,491.0,9.6e-31,136.3,sp|Q9SVG0|AVT3C_ARATH Amino acid transporter AVT3C OS=Arabidopsis thaliana OX=3702 GN=AVT3C PE=1 SV=1,,,,,,
OG_01967,0.4967140810742207,OG_01967,FUN_008051-T1,Peve_00045153,Pocillopora_meandrina_HIv1___RNAseq.g30357.t1,three_way,45.46666666666667,,,,,,,,,,,,,,,,,
OG_09087,0.496689908650792,OG_09087,FUN_038834-T1,Peve_00028687,Pocillopora_meandrina_HIv1___RNAseq.g28645.t1,three_way,66.54333333333334,FUN_038834-T1,Q8VBT9,ASPC1_MOUSE,,Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein homolog),Mus musculus (Mouse),31.0,574.0,7.1e-64,246.5,sp|Q8VBT9|ASPC1_MOUSE Tether containing UBX domain for GLUT4 OS=Mus musculus OX=10090 GN=Aspscr1 PE=1 SV=1,GO:0005654; GO:0005829; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0030659; GO:0033116; GO:0042593; GO:0046324; GO:0048471,glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; regulation of D-glucose import [GO:0046324],cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506],,GO:0005654; GO:0005829; GO:0006886,nucleoplasm; cytosol; intracellular protein transport
OG_03443,0.496530532786176,OG_03443,FUN_014505-T1,Peve_00015333,Pocillopora_meandrina_HIv1___RNAseq.g22635.t1,three_way,78.76633333333334,FUN_014505-T1,Q9ULV4,COR1C_HUMAN,,Coronin-1C (Coronin-3) (hCRNN4),Homo sapiens (Human),47.5,472.0,2.9999999999999997e-116,420.2,sp|Q9ULV4|COR1C_HUMAN Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C PE=1 SV=1,GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016600; GO:0021591; GO:0022038; GO:0030017; GO:0030027; GO:0031267; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394,actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; corpus callosum development [GO:0022038]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]; ventricular system development [GO:0021591],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202],actin filament binding [GO:0051015]; small GTPase binding [GO:0031267],GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0061024,cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; cell motility; membrane organization
OG_07573,0.4962600240553062,OG_07573,FUN_034245-T1,Peve_00003830,Pocillopora_meandrina_HIv1___RNAseq.g26610.t1c,three_way,49.638666666666666,FUN_034245-T1,P07949,RET_HUMAN,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Homo sapiens (Human),40.5,328.0,3.6e-57,224.6,sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0010008; GO:0010628; GO:0010976; GO:0030155; GO:0030335; GO:0030424; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241,axon guidance [GO:0007411]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; catalytic activity; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_01425,0.4961650426486783,OG_01425,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02575,0.4961575969713832,OG_02575,FUN_010681-T1,Peve_00044788,Pocillopora_meandrina_HIv1___TS.g26095.t1,three_way,79.83833333333334,,,,,,,,,,,,,,,,,
OG_07361,0.4959546764994358,OG_07361,FUN_033773-T1,Peve_00005280,Pocillopora_meandrina_HIv1___RNAseq.g26658.t2,three_way,82.50433333333334,FUN_033773-T1,B9EJ86,OSBL8_MOUSE,,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),Mus musculus (Mouse),46.7,803.0,3.8e-197,689.9,sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1,GO:0001786; GO:0005789; GO:0015485; GO:0015914; GO:0030336; GO:0031965; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343,fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343],GO:0005215; GO:0008289; GO:0030154,transporter activity; lipid binding; cell differentiation
OG_07902,0.4956617340630794,OG_07902,FUN_035339-T1,Peve_00029658,Pocillopora_meandrina_HIv1___RNAseq.g12265.t1,three_way,70.72233333333334,FUN_035339-T1,B7ZBB8,PP13G_HUMAN,,Protein phosphatase 1 regulatory subunit 3G,Homo sapiens (Human),28.0,225.0,2e-09,64.3,sp|B7ZBB8|PP13G_HUMAN Protein phosphatase 1 regulatory subunit 3G OS=Homo sapiens OX=9606 GN=PPP1R3G PE=1 SV=1,GO:0000164; GO:0005978; GO:0005979; GO:0008157; GO:0042593; GO:0045725; GO:2001069,glucose homeostasis [GO:0042593]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979],protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157],GO:0005975; GO:0006091,carbohydrate metabolic process; generation of precursor metabolites and energy
OG_05823,0.4955453536942204,OG_05823,FUN_025840-T1,Peve_00028313,Pocillopora_meandrina_HIv1___RNAseq.g10336.t1,three_way,94.462,FUN_025840-T1,Q5ZLC5,ATPB_CHICK,,"ATP synthase F(1) complex catalytic subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)",Gallus gallus (Chicken),91.4,466.0,4.6e-241,835.1,"sp|Q5ZLC5|ATPB_CHICK ATP synthase F(1) complex catalytic subunit beta, mitochondrial OS=Gallus gallus OX=9031 GN=ATP5F1B PE=1 SV=1",GO:0001525; GO:0005524; GO:0005739; GO:0005743; GO:0015986; GO:0016887; GO:0042776; GO:0045259; GO:0046933,angiogenesis [GO:0001525]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; transporter activity; mitochondrion; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09299,0.4955125246039568,OG_09299,FUN_040152-T1,Peve_00038144,Pocillopora_meandrina_HIv1___RNAseq.g8496.t1,three_way,65.6315,FUN_040152-T1,P17702,,,,,49.2,122.0,2.2999999999999997e-24,113.2,sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4,,,,,,
OG_04510,0.495510714871,OG_04510,FUN_022042-T1,Peve_00006664,Pocillopora_meandrina_HIv1___RNAseq.g9275.t1,three_way,80.45416666666667,FUN_022042-T1,Q9CYL5,,,,,49.0,145.0,2.7e-33,144.4,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_08513,0.4951659926665462,OG_08513,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_01034,0.4949261382139888,OG_01034,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_03250,0.4945340348962921,OG_03250,FUN_012970-T1,Peve_00000426,Pocillopora_meandrina_HIv1___RNAseq.g12971.t1,three_way,92.84033333333332,FUN_012970-T1,A1Z6E0,GUS_DROME,,Protein gustavus,Drosophila melanogaster (Fruit fly),59.8,281.0,4.3e-97,355.9,sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2,GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005],,GO:0005634; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0048870,nucleus; reproductive process; protein catabolic process; organelle; anatomical structure development; cell motility
OG_09200,0.4943520195373494,OG_09200,FUN_039885-T1,Peve_00021850,Pocillopora_meandrina_HIv1___TS.g1125.t1,three_way,87.84066666666666,FUN_039885-T1,D3Z902,FBXW7_RAT,,F-box/WD repeat-containing protein 7,Rattus norvegicus (Rat),61.1,216.0,4.6000000000000004e-73,277.3,sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2,GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005694; GO:0005730; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; chromosome; nucleolus; mitochondrion; endoplasmic reticulum; Golgi apparatus; DNA repair; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_04616,0.4942323275733724,OG_04616,FUN_022315-T1,Peve_00021692,Pocillopora_meandrina_HIv1___RNAseq.g4632.t1,three_way,88.54166666666667,FUN_022315-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,218.0,3.2e-15,83.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_09155,0.4941468592125622,OG_09155,FUN_039814-T1,Peve_00039067,Pocillopora_meandrina_HIv1___RNAseq.g7502.t1,three_way,68.30133333333333,,,,,,,,,,,,,,,,,
OG_05101,0.4938786568680778,OG_05101,FUN_023353-T1,Peve_00035612,Pocillopora_meandrina_HIv1___RNAseq.g17432.t1,three_way,75.67133333333334,FUN_023353-T1,Q8R367,,,,,35.9,195.0,6.6e-26,119.4,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_03553,0.4936387110800744,OG_03553,FUN_014686-T1,Peve_00004249,Pocillopora_meandrina_HIv1___RNAseq.g22822.t1,three_way,85.706,FUN_014686-T1,Q8BH64,EHD2_MOUSE,,EH domain-containing protein 2,Mus musculus (Mouse),25.2,218.0,9.4e-06,53.1,sp|Q8BH64|EHD2_MOUSE EH domain-containing protein 2 OS=Mus musculus OX=10090 GN=Ehd2 PE=1 SV=1,GO:0005509; GO:0005524; GO:0005525; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0016020; GO:0016787; GO:0019904; GO:0030866; GO:0032456; GO:0042802; GO:0048471; GO:0055038; GO:0072659; GO:0097320; GO:1901741; GO:2001137,cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659],caveola [GO:0005901]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0016787; GO:0061024; GO:0072659,catalytic activity; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; membrane organization; protein localization to plasma membrane
OG_00582,0.4935139324314481,OG_00582,FUN_001655-T1,Peve_00038364,Pocillopora_meandrina_HIv1___RNAseq.g29406.t1,three_way,93.90866666666666,FUN_001655-T1,P53621,COPA_HUMAN,,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],Homo sapiens (Human),75.2,1228.0,0.0,1507.7,sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133],hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198],GO:0003723; GO:0005198; GO:0005615; GO:0005829; GO:0006886; GO:0016192; GO:0022600; GO:0031410; GO:0043226; GO:0048018; GO:0098772,RNA binding; structural molecule activity; extracellular space; cytosol; intracellular protein transport; vesicle-mediated transport; digestive system process; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_01596,0.4935049362074339,OG_01596,FUN_006638-T1,Peve_00031797,Pocillopora_meandrina_HIv1___RNAseq.g20238.t1,three_way,98.24133333333332,FUN_006638-T1,Q2KHX4,,,,,89.9,476.0,2.4e-249,862.4,sp|Q2KHX4|S61A2_BOVIN Protein transport protein Sec61 subunit alpha isoform 2 OS=Bos taurus OX=9913 GN=SEC61A2 PE=2 SV=3,,,,,,
OG_00402,0.4934505444011787,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_10082,0.4932651712711501,OG_10082,FUN_043399-T1,Peve_00024256,Pocillopora_meandrina_HIv1___RNAseq.g9063.t2,three_way,80.929,FUN_043399-T1,Q9NVG8,,,,,60.4,356.0,4.2e-118,426.0,sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3,,,,,,
OG_09018,0.4932327857030462,OG_09018,FUN_038583-T1,Peve_00010568,Pocillopora_meandrina_HIv1___TS.g5537.t1,three_way,51.0455,,,,,,,,,,,,,,,,,
OG_08878,0.4931015908788396,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_04664,0.4929285133483346,OG_04664,FUN_022412-T1,Peve_00037635,Pocillopora_meandrina_HIv1___RNAseq.18822_t,three_way,91.77833333333334,FUN_022412-T1,Q15382,,,,,70.5,156.0,5.100000000000001e-59,228.8,sp|Q15382|RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1,,,,,,
OG_06423,0.4925577489315764,OG_06423,FUN_029112-T1,Peve_00013128,Pocillopora_meandrina_HIv1___RNAseq.g25756.t1,three_way,93.785,FUN_029112-T1,O60830,TI17B_HUMAN,,Mitochondrial import inner membrane translocase subunit Tim17-B,Homo sapiens (Human),66.5,167.0,3.3e-55,216.1,sp|O60830|TI17B_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-B OS=Homo sapiens OX=9606 GN=TIMM17B PE=1 SV=1,GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0006886; GO:0008320; GO:0030150,intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein transmembrane transporter activity [GO:0008320],GO:0005215; GO:0005739; GO:0006886; GO:0043226; GO:0055085,transporter activity; mitochondrion; intracellular protein transport; organelle; transmembrane transport
OG_01029,0.4924856491371382,OG_01029,FUN_004464-T1,Peve_00007170,Pocillopora_meandrina_HIv1___RNAseq.g4957.t1,three_way,65.17666666666668,FUN_004464-T1,P54726,RD23A_MOUSE,,UV excision repair protein RAD23 homolog A (HR23A) (mHR23A),Mus musculus (Mouse),56.6,373.0,1.9e-52,208.0,sp|P54726|RD23A_MOUSE UV excision repair protein RAD23 homolog A OS=Mus musculus OX=10090 GN=Rad23a PE=1 SV=2,GO:0000502; GO:0003684; GO:0005654; GO:0005794; GO:0005829; GO:0006289; GO:0006974; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043161; GO:0045070; GO:0045787; GO:1990381,DNA damage response [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502],damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-specific protease binding [GO:1990381],GO:0003677; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0030163; GO:0043226,DNA binding; nucleoplasm; Golgi apparatus; cytosol; DNA repair; protein catabolic process; organelle
OG_06718,0.4924416962390178,OG_06718,FUN_031469-T1,Peve_00026553,Pocillopora_meandrina_HIv1___RNAseq.g5083.t1,three_way,63.895,,,,,,,,,,,,,,,,,
OG_04647,0.4924201133843471,OG_04647,FUN_022379-T1,Peve_00013225,Pocillopora_meandrina_HIv1___RNAseq.g9304.t1,three_way,65.24716666666666,FUN_022379-T1,Q13439,,,,,31.5,124.0,1.8e-06,57.0,sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,,,,,,
OG_05223,0.4923934130877909,OG_05223,FUN_023635-T1,Peve_00027832,Pocillopora_meandrina_HIv1___RNAseq.g17812.t1,three_way,82.328,FUN_023635-T1,A0A1L8GXY4,,,,,37.3,1717.0,8.1e-300,1031.9,sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1,,,,,,
OG_03680,0.4920728109960959,OG_03680,FUN_014939-T1,Peve_00037138,Pocillopora_meandrina_HIv1___RNAseq.g21096.t2,three_way,83.04633333333334,FUN_014939-T1,Q2KJ16,PHKG2_BOVIN,,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-2)",Bos taurus (Bovine),53.3,360.0,1.2e-111,404.8,"sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus OX=9913 GN=PHKG2 PE=2 SV=1",GO:0004689; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005964; GO:0005977; GO:0005980; GO:0007165; GO:0045819,glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_02729,0.4919203257726193,OG_02729,FUN_011256-T1,Peve_00006851,Pocillopora_meandrina_HIv1___RNAseq.g22321.t1,three_way,72.50033333333333,FUN_011256-T1,Q9R1S4,XBP1_RAT,,"X-box-binding protein 1 (Hepatocarcinogenesis-related transcription factor) (HTF) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]",Rattus norvegicus (Rat),64.4,90.0,3.4e-15,83.6,sp|Q9R1S4|XBP1_RAT X-box-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Xbp1 PE=2 SV=1,GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001889; GO:0001935; GO:0002071; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006355; GO:0006366; GO:0006511; GO:0007517; GO:0007584; GO:0008284; GO:0009410; GO:0010506; GO:0030335; GO:0030968; GO:0031017; GO:0031490; GO:0031648; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0042149; GO:0042632; GO:0042802; GO:0043066; GO:0043565; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0051602; GO:0055089; GO:0055092; GO:0060096; GO:0060612; GO:0060691; GO:0070059; GO:0071222; GO:0071230; GO:0071236; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:0098793; GO:1900100; GO:1902236; GO:1903489; GO:1990418; GO:1990830; GO:1990837; GO:2000347,"adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glandular epithelial cell maturation [GO:0002071]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; presynapse [GO:0098793]; RNA polymerase II transcription regulator complex [GO:0090575],"chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]",GO:0003677; GO:0005634; GO:0005783; GO:0006351; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; DNA-templated transcription; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04353,0.4917555980651213,OG_04353,FUN_018000-T1,Peve_00044834,Pocillopora_meandrina_HIv1___RNAseq.29588_t,three_way,55.3835,FUN_018000-T1,Q8IXF0,NPAS3_HUMAN,,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),Homo sapiens (Human),40.8,424.0,9.4e-76,287.0,sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982,positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005654; GO:0006355; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; transcription regulator activity
OG_01221,0.4916238909423273,OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_07719,0.4916183874915037,OG_07719,FUN_034874-T1,Peve_00005761,Pocillopora_meandrina_HIv1___RNAseq.g27163.t1,three_way,71.02033333333334,FUN_034874-T1,P00172,,,,,52.7,131.0,2.2000000000000002e-30,133.3,sp|P00172|CYB5_PIG Cytochrome b5 OS=Sus scrofa OX=9823 GN=CYB5A PE=1 SV=3,,,,,,
OG_01585,0.4912843940318532,OG_01585,FUN_006622-T1,Peve_00040868,Pocillopora_meandrina_HIv1___RNAseq.g20175.t1,three_way,45.07566666666666,,,,,,,,,,,,,,,,,
OG_03070,0.4911011395478259,OG_03070,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_07552,0.4908601245678626,OG_07552,FUN_034143-T1,Peve_00018766,Pocillopora_meandrina_HIv1___RNAseq.g26306.t1,three_way,76.9615,FUN_034143-T1,Q03168,,,,,61.2,335.0,1.4e-113,411.0,sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2,,,,,,
OG_06488,0.4907996076705958,OG_06488,FUN_029262-T1,Peve_00030746,Pocillopora_meandrina_HIv1___RNAseq.g15033.t1,three_way,67.793,FUN_029262-T1,Q9Y222,DMTF1_HUMAN,,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),Homo sapiens (Human),40.9,599.0,2e-107,391.7,sp|Q9Y222|DMTF1_HUMAN Cyclin-D-binding Myb-like transcription factor 1 OS=Homo sapiens OX=9606 GN=DMTF1 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357,regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_08874,0.4907508292426581,OG_08874,FUN_038271-T1,Peve_00010406,Pocillopora_meandrina_HIv1___RNAseq.g28323.t1,three_way,64.48483333333333,FUN_038271-T1,Q7TN88,,,,,29.4,1654.0,3.4e-170,602.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_06755,0.4907463986904518,OG_06755,FUN_031566-T1,Peve_00021501,Pocillopora_meandrina_HIv1___RNAseq.g5071.t1,three_way,88.431,FUN_031566-T1,Q9H115,,,,,61.9,281.0,5.2e-98,359.0,sp|Q9H115|SNAB_HUMAN Beta-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPB PE=1 SV=2,,,,,,
OG_03548,0.4906661039039327,OG_03548,FUN_014677-T1,Peve_00004255,Pocillopora_meandrina_HIv1___RNAseq.g22586.t1,three_way,75.49233333333333,FUN_014677-T1,Q9SS90,RGLG1_ARATH,,E3 ubiquitin-protein ligase RGLG1 (EC 2.3.2.27) (RING domain ligase 1),Arabidopsis thaliana (Mouse-ear cress),50.8,266.0,1.6999999999999999e-68,261.2,sp|Q9SS90|RGLG1_ARATH E3 ubiquitin-protein ligase RGLG1 OS=Arabidopsis thaliana OX=3702 GN=RGLG1 PE=1 SV=1,GO:0004842; GO:0005634; GO:0005886; GO:0008270; GO:0009738; GO:0009789; GO:0061630; GO:0070534; GO:0080148,abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04002,0.4902908711752807,OG_04002,FUN_016297-T1,Peve_00002880,Pocillopora_meandrina_HIv1___RNAseq.g9883.t1,three_way,94.22166666666666,FUN_016297-T1,P35224,,,,,57.2,711.0,3.1e-203,709.9,sp|P35224|CTNB_URECA Catenin beta OS=Urechis caupo OX=6431 PE=2 SV=1,,,,,,
OG_02420,0.4901882280694988,OG_02420,FUN_009308-T1,Peve_00021835,Pocillopora_meandrina_HIv1___RNAseq.g14442.t1,three_way,91.04433333333331,FUN_009308-T1,Q0MQI6,,,,,83.0,442.0,4.8e-226,785.0,"sp|Q0MQI6|NDUV1_PANTR NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFV1 PE=2 SV=1",,,,,,
OG_01974,0.4901441987199739,OG_01974,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_07674,0.4901413592814909,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08616,0.4900788449990963,OG_08616,FUN_037765-T1,Peve_00014329,Pocillopora_meandrina_HIv1___RNAseq.g1491.t1,three_way,56.507,,,,,,,,,,,,,,,,,
OG_03579,0.4900069759954639,OG_03579,FUN_014734-T1,Peve_00010435,Pocillopora_meandrina_HIv1___RNAseq.1641_t,three_way,71.44800000000001,,,,,,,,,,,,,,,,,
OG_07092,0.4899026776956009,OG_07092,FUN_032349-T1,Peve_00012757,Pocillopora_meandrina_HIv1___RNAseq.g29801.t1,three_way,87.25633333333333,FUN_032349-T1,Q5XHC1,,,,,53.7,296.0,1.2e-84,314.7,sp|Q5XHC1|CFA96_XENLA Cilia-and flagella-associated protein 96 OS=Xenopus laevis OX=8355 GN=cfap96.L PE=2 SV=1,,,,,,
OG_08397,0.4898218934932697,OG_08397,FUN_037044-T1,Peve_00032333,Pocillopora_meandrina_HIv1___RNAseq.9744_t,three_way,73.64533333333333,FUN_037044-T1,X6R8R1,ST15B_HUMAN,,Synaptotagmin-15B,Homo sapiens (Human),37.5,301.0,1.5999999999999998e-49,198.0,sp|X6R8R1|ST15B_HUMAN Synaptotagmin-15B OS=Homo sapiens OX=9606 GN=SYT15B PE=3 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0061891; GO:0070382,regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_04145,0.4896021034960907,OG_04145,FUN_016607-T1,Peve_00010246,Pocillopora_meandrina_HIv1___RNAseq.g9625.t1,three_way,82.545,FUN_016607-T1,Q6AYD3,PA2G4_RAT,,Proliferation-associated protein 2G4,Rattus norvegicus (Rat),62.8,288.0,7.3e-106,385.2,sp|Q6AYD3|PA2G4_RAT Proliferation-associated protein 2G4 OS=Rattus norvegicus OX=10116 GN=Pa2g4 PE=1 SV=1,GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904,negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005634; GO:0005730; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleolus; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01193,0.4895439083228691,OG_01193,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07985,0.4893570294803128,OG_07985,FUN_035612-T1,Peve_00019611,Pocillopora_meandrina_HIv1___RNAseq.g28060.t1,three_way,40.537333333333336,,,,,,,,,,,,,,,,,
OG_00877,0.4892930468009284,OG_00877,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_08561,0.4892833644390886,OG_08561,FUN_037553-T1,Peve_00032237,Pocillopora_meandrina_HIv1___RNAseq.g1625.t1,three_way,70.45266666666666,FUN_037553-T1,Q04861,,,,,40.6,894.0,1.9e-154,548.1,sp|Q04861|NFKB1_CHICK Nuclear factor NF-kappa-B p105 subunit OS=Gallus gallus OX=9031 GN=NFKB1 PE=2 SV=2,,,,,,
OG_07305,0.4890757970812755,OG_07305,FUN_033691-T1,Peve_00010865,Pocillopora_meandrina_HIv1___RNAseq.g25877.t1,three_way,90.88,FUN_033691-T1,A7SMR1,EIF3D_NEMVE,,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7),Nematostella vectensis (Starlet sea anemone),76.6,475.0,2.6000000000000004e-211,736.1,sp|A7SMR1|EIF3D_NEMVE Eukaryotic translation initiation factor 3 subunit D OS=Nematostella vectensis OX=45351 GN=v1g235689 PE=3 SV=1,GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0098808,cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_01660,0.4890545904877314,OG_01660,FUN_006843-T1,Peve_00023777,Pocillopora_meandrina_HIv1___RNAseq.g20469.t1,three_way,55.36333333333334,,,,,,,,,,,,,,,,,
OG_01599,0.488822610052366,OG_01599,FUN_006642-T1,Peve_00040855,Pocillopora_meandrina_HIv1___TS.g29901.t1b,three_way,61.857,FUN_006642-T1,P60924,DELE1_RAT,,"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]",Rattus norvegicus (Rat),35.4,113.0,3.8e-08,61.2,sp|P60924|DELE1_RAT DAP3-binding cell death enhancer 1 OS=Rattus norvegicus OX=10116 GN=Dele1 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0006974; GO:0008625; GO:0033554; GO:0043539; GO:0140467; GO:0140468; GO:1901526; GO:1990641,cellular response to stress [GO:0033554]; DNA damage response [GO:0006974]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; positive regulation of mitophagy [GO:1901526]; response to iron ion starvation [GO:1990641],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine kinase activator activity [GO:0043539],GO:0005739; GO:0005829; GO:0043226; GO:0098772,mitochondrion; cytosol; organelle; molecular function regulator activity
OG_08261,0.4887569438568636,OG_08261,FUN_036173-T1,Peve_00027210,Pocillopora_meandrina_HIv1___RNAseq.g27506.t1,three_way,82.76566666666666,FUN_036173-T1,Q00168,,,,,38.1,310.0,4.599999999999999e-55,216.5,sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster OX=7227 GN=CaMKII PE=1 SV=1,,,,,,
OG_07288,0.488504375297164,OG_07288,FUN_033669-T1,Peve_00006803,Pocillopora_meandrina_HIv1___RNAseq.g28826.t1,three_way,71.8855,,,,,,,,,,,,,,,,,
OG_03064,0.4883544962850414,OG_03064,FUN_012330-T1,Peve_00023487,Pocillopora_meandrina_HIv1___RNAseq.g23754.t1,three_way,75.646,FUN_012330-T1,Q9Y6P5,SESN1_HUMAN,,Sestrin-1 (EC 1.11.1.-) (p53-regulated protein PA26),Homo sapiens (Human),47.5,465.0,7.5e-119,429.1,sp|Q9Y6P5|SESN1_HUMAN Sestrin-1 OS=Homo sapiens OX=9606 GN=SESN1 PE=1 SV=2,GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016239; GO:0016684; GO:0030308; GO:0034198; GO:0042149; GO:0051896; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253,cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016491; GO:0043226; GO:0098754,catalytic activity; nucleus; nucleoplasm; cytosol; oxidoreductase activity; organelle; detoxification
OG_05486,0.4882309820804003,OG_05486,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_03138,0.4881291095449983,OG_03138,FUN_012520-T1,Peve_00014742,Pocillopora_meandrina_HIv1___RNAseq.g23959.t1,three_way,84.107,FUN_012520-T1,A8E4N3,RSPH3_BOVIN,,Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2),Bos taurus (Bovine),64.0,331.0,1.3e-102,374.8,sp|A8E4N3|RSPH3_BOVIN Radial spoke head protein 3 homolog OS=Bos taurus OX=9913 GN=RSPH3 PE=2 SV=1,GO:0001535; GO:0005929; GO:0097729,,9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; radial spoke head [GO:0001535],,GO:0005929; GO:0043226,cilium; organelle
OG_00661,0.4880416287654457,OG_00661,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_07575,0.4877928374206469,OG_07575,FUN_034253-T1,Peve_00007814,Pocillopora_meandrina_HIv1___RNAseq.g26631.t1,three_way,51.3935,FUN_034253-T1,Q91288,FGFR4_PLEWA,,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (PFR4),Pleurodeles waltl (Iberian ribbed newt),31.6,626.0,1.5e-67,259.2,sp|Q91288|FGFR4_PLEWA Fibroblast growth factor receptor 4 OS=Pleurodeles waltl OX=8319 GN=FGFR4 PE=2 SV=1,GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005886; GO:0008284; GO:0017134; GO:0043235; GO:0070374; GO:0070857,positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of bile acid biosynthetic process [GO:0070857],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007],GO:0003824; GO:0005768; GO:0005783; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0060089; GO:0140096,"catalytic activity; endosome; endoplasmic reticulum; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; molecular transducer activity; catalytic activity, acting on a protein"
OG_00365,0.4874940494037569,OG_00365,FUN_001204-T1,Peve_00033826,Pocillopora_meandrina_HIv1___RNAseq.g29520.t1,three_way,71.753,FUN_001204-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),40.4,396.0,2.8000000000000002e-89,330.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_05760,0.4874381513541668,OG_05760,FUN_025701-T1,Peve_00026329,Pocillopora_meandrina_HIv1___RNAseq.g13828.t1,three_way,85.17516666666667,FUN_025701-T1,Q8K268,,,,,58.7,715.0,2.7e-228,793.1,sp|Q8K268|ABCF3_MOUSE ATP-binding cassette sub-family F member 3 OS=Mus musculus OX=10090 GN=Abcf3 PE=1 SV=1,,,,,,
OG_08180,0.4873921874949055,OG_08180,FUN_036004-T1,Peve_00041840,Pocillopora_meandrina_HIv1___RNAseq.g12324.t1,three_way,77.76566666666666,FUN_036004-T1,Q6YI46,,,,,48.0,223.0,3e-49,197.2,sp|Q6YI46|TMM64_HUMAN Transmembrane protein 64 OS=Homo sapiens OX=9606 GN=TMEM64 PE=1 SV=2,,,,,,
OG_07108,0.4873169995646191,OG_07108,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_00487,0.4872547929012521,OG_00487,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_04250,0.4871574330538539,OG_04250,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_07498,0.4870978680713158,OG_07498,FUN_034034-T1,Peve_00019783,Pocillopora_meandrina_HIv1___RNAseq.g26094.t1,three_way,69.25983333333333,FUN_034034-T1,Q6P859,,,,,47.1,187.0,9.3e-41,168.7,sp|Q6P859|GPTC4_XENTR G patch domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=gpatch4 PE=2 SV=1,,,,,,
OG_08304,0.4868567117316905,OG_08304,FUN_036258-T1,Peve_00032885,Pocillopora_meandrina_HIv1___RNAseq.g27585.t1,three_way,77.87166666666667,FUN_036258-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),48.2,475.0,1.2e-123,444.9,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_00109,0.4864413906583029,OG_00109,FUN_000501-T1,Peve_00043828,Pocillopora_meandrina_HIv1___RNAseq.g2406.t1,three_way,59.06433333333334,FUN_000501-T1,P11616,,,,,23.7,299.0,1.8e-08,61.6,sp|P11616|AA1R_CANLF Adenosine receptor A1 OS=Canis lupus familiaris OX=9615 GN=ADORA1 PE=2 SV=1,,,,,,
OG_00273,0.4863690995577625,OG_00273,FUN_001053-T1,Peve_00023870,Pocillopora_meandrina_HIv1___RNAseq.g29644.t1,three_way,85.719,FUN_001053-T1,Q5REU4,,,,,58.1,904.0,2.8e-296,1019.2,sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1,,,,,,
OG_06644,0.4862723191032815,OG_06644,FUN_030656-T1,Peve_00043684,Pocillopora_meandrina_HIv1___RNAseq.g30311.t1,three_way,88.95683333333334,FUN_030656-T1,Q0V9S9,,,,,55.0,789.0,1.4e-246,854.0,sp|Q0V9S9|DRC7_XENTR Dynein regulatory complex subunit 7 OS=Xenopus tropicalis OX=8364 GN=drc7 PE=2 SV=1,,,,,,
OG_07024,0.4860324887756748,OG_07024,FUN_032215-T1,Peve_00015531,Pocillopora_meandrina_HIv1___RNAseq.g24275.t1,three_way,85.61,FUN_032215-T1,Q8BYK6,YTHD3_MOUSE,,YTH domain-containing family protein 3,Mus musculus (Mouse),37.8,614.0,2.1e-84,314.7,sp|Q8BYK6|YTHD3_MOUSE YTH domain-containing family protein 3 OS=Mus musculus OX=10090 GN=Ythdf3 PE=1 SV=2,GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0060339; GO:0061157; GO:0070925; GO:1901163; GO:1990247,mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; regulation of trophoblast cell migration [GO:1901163]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932],N6-methyladenosine-containing RNA reader activity [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0043226; GO:0060090,RNA binding; cytosol; organelle; molecular adaptor activity
OG_08967,0.4858768366246454,OG_08967,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_01668,0.4853156171566885,OG_01668,FUN_006855-T1,Peve_00042995,Pocillopora_meandrina_HIv1___RNAseq.g19915.t1,three_way,55.54816666666667,FUN_006855-T1,Q3KRG3,,,,,36.7,109.0,2.5e-20,100.5,sp|Q3KRG3|TSR2_DANRE Pre-rRNA-processing protein TSR2 homolog OS=Danio rerio OX=7955 GN=tsr2 PE=2 SV=1,,,,,,
OG_04500,0.4852663136212253,OG_04500,FUN_021938-T1,Peve_00023930,Pocillopora_meandrina_HIv1___RNAseq.g2960.t2,three_way,73.7475,FUN_021938-T1,Q4W5Z4,DNM3A_CHICK,,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-),Gallus gallus (Chicken),47.0,651.0,6.4e-174,612.5,sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1,GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_02940,0.4849790306498699,OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_03622,0.4849731315523225,OG_03622,FUN_014809-T1,Peve_00023296,Pocillopora_meandrina_HIv1___RNAseq.g22406.t1,three_way,73.80983333333333,FUN_014809-T1,Q3LFU0,CP1A1_BALAC,,Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Balaenoptera acutorostrata (Common minke whale) (Balaena rostrata),33.7,486.0,1.4e-69,265.8,sp|Q3LFU0|CP1A1_BALAC Cytochrome P450 1A1 OS=Balaenoptera acutorostrata OX=9767 GN=CYP1A1 PE=2 SV=1,GO:0004508; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042446; GO:0042448; GO:0042572; GO:0051879; GO:0101020; GO:0101021; GO:0106256,estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743],estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_10221,0.4849269226836115,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_10094,0.4848892491742918,OG_10094,FUN_043425-T1,Peve_00041795,Pocillopora_meandrina_HIv1___RNAseq.g7842.t1,three_way,85.91533333333334,FUN_043425-T1,A7MBH5,ODAD3_BOVIN,,Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151),Bos taurus (Bovine),36.1,559.0,2.3e-62,241.5,sp|A7MBH5|ODAD3_BOVIN Outer dynein arm-docking complex subunit 3 OS=Bos taurus OX=9913 GN=ODAD3 PE=1 SV=1,GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0035253; GO:0036064; GO:0036158; GO:0097542; GO:0120228; GO:1902017,cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017],axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; outer dynein arm docking complex [GO:0120228],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0065003,microtubule organizing center; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_06599,0.48486832570437,OG_06599,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_01620,0.4847391793298463,OG_01620,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_01542,0.4846904404538867,OG_01542,FUN_006414-T1,Peve_00043556,Pocillopora_meandrina_HIv1___RNAseq.g20274.t1,three_way,74.46766666666667,FUN_006414-T1,Q0ZDF7,,,,,46.1,154.0,4.3e-28,126.3,sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1,,,,,,
OG_02418,0.4846843364361869,OG_02418,FUN_009304-T1,Peve_00005826,Pocillopora_meandrina_HIv1___RNAseq.g14445.t1,three_way,85.81966666666666,FUN_009304-T1,B7PRF6,,,,,65.6,180.0,3.7e-70,265.8,sp|B7PRF6|MTND_IXOSC Acireductone dioxygenase OS=Ixodes scapularis OX=6945 GN=IscW_ISCW007295 PE=3 SV=1,,,,,,
OG_00441,0.4845387779570283,OG_00441,FUN_001354-T1,Peve_00028939,Pocillopora_meandrina_HIv1___RNAseq.g1872.t2,three_way,86.42,FUN_001354-T1,Q6PFX9,TNKS1_MOUSE,,Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1),Mus musculus (Mouse),72.8,1146.0,4.9e-232,806.2,sp|Q6PFX9|TNKS1_MOUSE Poly [ADP-ribose] polymerase tankyrase-1 OS=Mus musculus OX=10090 GN=Tnks PE=1 SV=1,GO:0000139; GO:0000209; GO:0000781; GO:0003950; GO:0005643; GO:0005794; GO:0005813; GO:0005829; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051301; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:0140806; GO:0140807; GO:1904355; GO:1904357; GO:1904908; GO:1990404,"cell division [GO:0051301]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; Wnt signaling pathway [GO:0016055]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]",histone binding [GO:0042393]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_04073,0.484529017874678,OG_04073,FUN_016396-T1,Peve_00006415,Pocillopora_meandrina_HIv1___RNAseq.g9761.t1,three_way,59.46566666666667,FUN_016396-T1,Q9NXE8,CWC25_HUMAN,,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),Homo sapiens (Human),58.0,143.0,1.2e-36,156.0,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006,"mRNA splicing, via spliceosome [GO:0000398]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684],,GO:0005634; GO:0005654; GO:0016071; GO:0043226,nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_08908,0.484398686811417,OG_08908,FUN_038339-T1,Peve_00000097,Pocillopora_meandrina_HIv1___RNAseq.g1109.t1,three_way,75.68266666666666,FUN_038339-T1,P52565,GDIR1_HUMAN,,Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha),Homo sapiens (Human),55.7,194.0,1.4999999999999999e-53,211.1,sp|P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=Homo sapiens OX=9606 GN=ARHGDIA PE=1 SV=3,GO:0001772; GO:0005094; GO:0005096; GO:0005634; GO:0005829; GO:0005856; GO:0007266; GO:0016020; GO:0032880; GO:0035023; GO:0043066; GO:0070062; GO:0071526; GO:0098685; GO:0098693,negative regulation of apoptotic process [GO:0043066]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic vesicle cycle [GO:0098693]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685],GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094],GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0098772,nucleus; cytosol; cytoskeleton; organelle; molecular function regulator activity
OG_04298,0.4843264554091012,OG_04298,FUN_017867-T1,Peve_00020408,Pocillopora_meandrina_HIv1___RNAseq.g9557.t1,three_way,69.84466666666667,FUN_017867-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),68.5,89.0,1.4e-26,121.3,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_00913,0.4841953367784936,OG_00913,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_03475,0.4840448894585341,OG_03475,FUN_014566-T1,Peve_00023547,Pocillopora_meandrina_HIv1___TS.g27470.t1,three_way,72.471,FUN_014566-T1,Q8L870,,,,,35.0,223.0,7.6e-34,145.6,sp|Q8L870|GCC1_ARATH Guanylyl cyclase 1 OS=Arabidopsis thaliana OX=3702 GN=GC1 PE=1 SV=1,,,,,,
OG_02637,0.4840242614795533,OG_02637,FUN_010804-T1,Peve_00021406,Pocillopora_meandrina_HIv1___RNAseq.g21235.t1,three_way,52.90833333333333,,,,,,,,,,,,,,,,,
OG_09365,0.4838995852393514,OG_09365,FUN_040489-T1,Peve_00015394,Pocillopora_meandrina_HIv1___TS.g260.t2,three_way,90.586,FUN_040489-T1,Q8C5T8,,,,,41.3,363.0,5.6e-57,223.0,sp|Q8C5T8|CF263_MOUSE Cilia- and flagella-associated protein 263 OS=Mus musculus OX=10090 GN=Cfap263 PE=2 SV=1,,,,,,
OG_06763,0.4836039078302264,OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_02328,0.4834041147512017,OG_02328,FUN_008921-T1,Peve_00006943,Pocillopora_meandrina_HIv1___TS.g30078.t1,three_way,78.52199999999999,FUN_008921-T1,F1PCT7,,,,,39.1,591.0,6.2e-114,412.9,sp|F1PCT7|RPN2_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Canis lupus familiaris OX=9615 GN=RPN2 PE=1 SV=3,,,,,,
OG_09940,0.4833325972607962,OG_09940,FUN_043101-T1,Peve_00026301,Pocillopora_meandrina_HIv1___TS.g740.t1,three_way,67.05266666666667,FUN_043101-T1,Q8R4K8,PAPP1_MOUSE,,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Mus musculus (Mouse),39.8,1552.0,3.3e-308,1059.7,sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2,GO:0004175; GO:0005615; GO:0006508; GO:0008237; GO:0046872,proteolysis [GO:0006508],extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08837,0.4832489271705369,OG_08837,FUN_038181-T1,Peve_00009435,Pocillopora_meandrina_HIv1___TS.g5496.t3,three_way,80.30433333333333,FUN_038181-T1,Q8TAT6,NPL4_HUMAN,,Nuclear protein localization protein 4 homolog (Protein NPL4),Homo sapiens (Human),53.6,616.0,7.4e-203,708.4,sp|Q8TAT6|NPL4_HUMAN Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006886; GO:0030163; GO:0043226,nucleus; nucleoplasm; endoplasmic reticulum; cytosol; intracellular protein transport; protein catabolic process; organelle
OG_08014,0.4828327247366449,OG_08014,FUN_035668-T1,Peve_00002801,Pocillopora_meandrina_HIv1___TS.g15470.t1,three_way,83.02633333333334,,,,,,,,,,,,,,,,,
